{
  "directed": true,
  "multigraph": true,
  "graph": {
    "pybel_version": "0.14.10-dev",
    "document_metadata": {
      "name": "Macrophage Signaling-2.0-Hs",
      "authors": "Causal Biological Networks Database",
      "licenses": "\t        Please cite:\t\t        - www.causalbionet.com\t        - https://bionet.sbvimprover.com\t\t        as well as any relevant publications.\t\t        The sbv IMPROVER project, the website and the Symposia are part of a collaborative project\t        designed to enable scientists to learn about and contribute to the development of a new crowd\t        sourcing method for verification of scientific data and results. The current challenges, website\t        and biological network models were developed and are maintained as part of a collaboration among\t        Selventa, OrangeBus and ADS. The project is led and funded by Philip Morris International. For more\t        information on the focus of Philip Morris International’s research, please visit www.pmi.com.\t        ",
      "version": "2.0",
      "contact": "CausalBiologicalNetworks.RD@pmi.com",
      "description": "The Macrophage Signaling describes the causal mechanisms in pathways related to the recruitment of macrophages to sites of tissue injury, differentiation of macrophages from hematopoietic progenitors and macrophage activation in response to environmental cues. The network also includes cell surface receptors and signaling pathways involved in macrophage efferocytosis, a process known to be largely inhibited during COPD development.\\nReviewed during Jamboree2014\\nReviewed during Jamboree2015"
    },
    "namespace_url": {},
    "namespace_pattern": {
      "chebi": ".*",
      "mesh": ".*",
      "fplx": ".*",
      "go": ".*",
      "hgnc": ".*"
    },
    "annotation_url": {},
    "annotation_pattern": {
      "doid": ".*",
      "cl": ".*"
    },
    "annotation_list": {}
  },
  "nodes": [
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "acrolein",
        "identifier": "15368"
      },
      "id": "20cef5c558061d71ec7754c4bca9c869",
      "bel": "a(chebi:15368 ! acrolein)"
    },
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "ATP",
        "identifier": "15422"
      },
      "id": "8d0277756fcb738fcbe01550f3b54a27",
      "bel": "a(chebi:15422 ! ATP)"
    },
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "prostaglandin E2",
        "identifier": "15551"
      },
      "id": "042ad5a613c3edb7cdfbb629d874429b",
      "bel": "a(chebi:15551 ! \"prostaglandin E2\")"
    },
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "prostaglandin H2",
        "identifier": "15554"
      },
      "id": "21738e2ebb2bf07ead5c49c7ab658561",
      "bel": "a(chebi:15554 ! \"prostaglandin H2\")"
    },
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "thromboxane A2",
        "identifier": "15627"
      },
      "id": "e9c8145545b7641c0e7055396bb395bc",
      "bel": "a(chebi:15627 ! \"thromboxane A2\")"
    },
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "leukotriene B4",
        "identifier": "15647"
      },
      "id": "e58243d52d8ec8fffcf448f53194016f",
      "bel": "a(chebi:15647 ! \"leukotriene B4\")"
    },
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "hyaluronic acid",
        "identifier": "16336"
      },
      "id": "c67353f967bb4cd9c5d9c2fbdc50ba6c",
      "bel": "a(chebi:16336 ! \"hyaluronic acid\")"
    },
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "lipopolysaccharide",
        "identifier": "16412"
      },
      "id": "4c0f33b1ce0c790c28b9398a8901620a",
      "bel": "a(chebi:16412 ! lipopolysaccharide)"
    },
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "nitric oxide",
        "identifier": "16480"
      },
      "id": "450bcc6227425022a3253f10e4ef33b5",
      "bel": "a(chebi:16480 ! \"nitric oxide\")"
    },
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "calcitriol",
        "identifier": "17823"
      },
      "id": "fd4025d982d7a2c61a3d50ffc0b744a6",
      "bel": "a(chebi:17823 ! calcitriol)"
    },
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "superoxide",
        "identifier": "18421"
      },
      "id": "8e08e5be76c682ee42302022d7e4f6eb",
      "bel": "a(chebi:18421 ! superoxide)"
    },
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "reactive oxygen species",
        "identifier": "26523"
      },
      "id": "daea6f4eb51dba973002f435187fa6d2",
      "bel": "a(chebi:26523 ! \"reactive oxygen species\")"
    },
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "resveratrol",
        "identifier": "27881"
      },
      "id": "9f420e517b9dc0e98ae58ce00bdf8c73",
      "bel": "a(chebi:27881 ! resveratrol)"
    },
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "angiotensin II",
        "identifier": "48432"
      },
      "id": "e2510a6a6ea7cb236f1522e9e2fd0db6",
      "bel": "a(chebi:48432 ! \"angiotensin II\")"
    },
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "muramyl dipeptide",
        "identifier": "59414"
      },
      "id": "910f09901fa9bb2866ee2ed6a367f13b",
      "bel": "a(chebi:59414 ! \"muramyl dipeptide\")"
    },
    {
      "function": "Abundance",
      "concept": {
        "namespace": "chebi",
        "name": "lipoxin A4",
        "identifier": "6498"
      },
      "id": "c41934f04339cbfa415a6c6eacedb15e",
      "bel": "a(chebi:6498 ! \"lipoxin A4\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "monocyte chemotaxis",
        "identifier": "0002548"
      },
      "id": "c9826c3c048255c1c371903d151b7cde",
      "bel": "bp(go:0002548 ! \"monocyte chemotaxis\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "phagocytosis",
        "identifier": "0006909"
      },
      "id": "10773dc2dd45dfcc499c91f410e43255",
      "bel": "bp(go:0006909 ! phagocytosis)"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "cytoskeleton organization",
        "identifier": "0007010"
      },
      "id": "ec2c5009f717aacae34b0969adb1e4f1",
      "bel": "bp(go:0007010 ! \"cytoskeleton organization\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "T cell chemotaxis",
        "identifier": "0010818"
      },
      "id": "a8fe9a67e07cf27d670f2e0001217a4b",
      "bel": "bp(go:0010818 ! \"T cell chemotaxis\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "macrophage differentiation",
        "identifier": "0030225"
      },
      "id": "dc80228801ecf005dfdd44f0f53cf6b1",
      "bel": "bp(go:0030225 ! \"macrophage differentiation\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "neutrophil chemotaxis",
        "identifier": "0030593"
      },
      "id": "050176248059540bb596458cf9d25583",
      "bel": "bp(go:0030593 ! \"neutrophil chemotaxis\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "macrophage activation",
        "identifier": "0042116"
      },
      "id": "b1dd59f3a0d4f85345cb8aee5ab22500",
      "bel": "bp(go:0042116 ! \"macrophage activation\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "apoptotic cell clearance",
        "identifier": "0043277"
      },
      "id": "2e1797d654e170a4da1f4bf61769cdea",
      "bel": "bp(go:0043277 ! \"apoptotic cell clearance\")"
    },
    {
      "function": "BiologicalProcess",
      "concept": {
        "namespace": "go",
        "name": "macrophage chemotaxis",
        "identifier": "0048246"
      },
      "id": "003300291ac2885cd724b3bda84fbf31",
      "bel": "bp(go:0048246 ! \"macrophage chemotaxis\")"
    },
    {
      "function": "Complex",
      "concept": {
        "namespace": "fplx",
        "name": "IKK_complex",
        "identifier": "IKK_complex"
      },
      "id": "6e18bd5d8e6b69d668802c71c895ce85",
      "bel": "complex(fplx:\"IKK_complex\" ! \"IKK_complex\")"
    },
    {
      "function": "Complex",
      "concept": {
        "namespace": "fplx",
        "name": "AP1",
        "identifier": "AP1"
      },
      "id": "0083d297c265cb2ade870cd66cc5abb0",
      "bel": "complex(fplx:AP1 ! AP1)"
    },
    {
      "function": "Complex",
      "concept": {
        "namespace": "fplx",
        "name": "NFkappaB",
        "identifier": "NFkappaB"
      },
      "id": "a7edecc930194d4eff939b226f91107f",
      "bel": "complex(fplx:NFkappaB ! NFkappaB)"
    },
    {
      "function": "Complex",
      "concept": {
        "namespace": "fplx",
        "name": "PI3K",
        "identifier": "PI3K"
      },
      "id": "2de818cb7bd5f3eacdbb22c78861bdd8",
      "bel": "complex(fplx:PI3K ! PI3K)"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "TLR4",
            "identifier": "11850"
          },
          "id": "3757d476c6399f77b225fb8b1522441c",
          "bel": "p(hgnc:11850 ! TLR4)"
        },
        {
          "function": "Protein",
          "concept": {
            "namespace": "hgnc",
            "name": "LY96",
            "identifier": "17156"
          },
          "id": "f45878cdad61f13d25d8de37be34ddd5",
          "bel": "p(hgnc:17156 ! LY96)"
        }
      ],
      "id": "a10589733cb2fc4fd96b62e2fd4e4971",
      "bel": "complex(p(hgnc:11850 ! TLR4), p(hgnc:17156 ! LY96))"
    },
    {
      "function": "miRNA",
      "concept": {
        "namespace": "hgnc",
        "name": "MIR146A",
        "identifier": "31533"
      },
      "id": "42377fe0fdfab9733efcf93006454b3a",
      "bel": "m(hgnc:31533 ! MIR146A)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "PI3K_p110",
        "identifier": "PI3K_p110"
      },
      "id": "8b79e969188c2874eba3fa100a633e65",
      "bel": "p(fplx:\"PI3K_p110\" ! \"PI3K_p110\")"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "JNK",
        "identifier": "JNK"
      },
      "id": "2f6658f9c547f93c3f37c98276d1a287",
      "bel": "p(fplx:JNK ! JNK)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "fplx",
        "name": "STAT5",
        "identifier": "STAT5"
      },
      "id": "552e31c88ae63b744dbd68c35c21cb41",
      "bel": "p(fplx:STAT5 ! STAT5)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CCL2",
        "identifier": "10618"
      },
      "id": "dd9ab9eb67b7e4e63dbde1ec97117509",
      "bel": "p(hgnc:10618 ! CCL2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CCL5",
        "identifier": "10632"
      },
      "id": "9ffa071bf151e5d66fe67d459ae75286",
      "bel": "p(hgnc:10632 ! CCL5)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CXCL10",
        "identifier": "10637"
      },
      "id": "332bc9461b0555e1895dd1d495ceb1b0",
      "bel": "p(hgnc:10637 ! CXCL10)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SFTPA1",
        "identifier": "10798"
      },
      "id": "ce15ae9b261dc35aa3f67cac3aec83e7",
      "bel": "p(hgnc:10798 ! SFTPA1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SKI",
        "identifier": "10896"
      },
      "id": "5326ab759e3b5ab553a751eeb2620c23",
      "bel": "p(hgnc:10896 ! SKI)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SPI1",
        "identifier": "11241"
      },
      "id": "8ba4722272f43573efe594078b535466",
      "bel": "p(hgnc:11241 ! SPI1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SQSTM1",
        "identifier": "11280"
      },
      "id": "415e5eab7297286d7784bed306c1e857",
      "bel": "p(hgnc:11280 ! SQSTM1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SRC",
        "identifier": "11283"
      },
      "id": "bfb8457bb7e17304088e9a033df759aa",
      "bel": "p(hgnc:11283 ! SRC)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "STAT1",
        "identifier": "11362"
      },
      "id": "f7d1b847944e3df57e7f145af8cfee1e",
      "bel": "p(hgnc:11362 ! STAT1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "STAT2",
        "identifier": "11363"
      },
      "id": "a9382a8430b8136bbeeffd119bafe39d",
      "bel": "p(hgnc:11363 ! STAT2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "STAT3",
        "identifier": "11364"
      },
      "id": "16cbb4ba8a8e57b2fe2119d9545dd71a",
      "bel": "p(hgnc:11364 ! STAT3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TBXAS1",
        "identifier": "11609"
      },
      "id": "1bf0c8a9d975cd73b81f082d1b80d983",
      "bel": "p(hgnc:11609 ! TBXAS1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TGM2",
        "identifier": "11778"
      },
      "id": "4bbe782c313c479f6f9af33ff7b56790",
      "bel": "p(hgnc:11778 ! TGM2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TLR2",
        "identifier": "11848"
      },
      "id": "232d82289f579d65f6295b7015f8cea0",
      "bel": "p(hgnc:11848 ! TLR2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TLR3",
        "identifier": "11849"
      },
      "id": "d52e3aab8cf8bfd56cb57d86d4186ab4",
      "bel": "p(hgnc:11849 ! TLR3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TLR4",
        "identifier": "11850"
      },
      "id": "3757d476c6399f77b225fb8b1522441c",
      "bel": "p(hgnc:11850 ! TLR4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TNF",
        "identifier": "11892"
      },
      "id": "000255f3feb3add4cefe963ffea45204",
      "bel": "p(hgnc:11892 ! TNF)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TNFRSF1A",
        "identifier": "11916"
      },
      "id": "6c2a897a0fc06fbfd3c3792f72e4a4c9",
      "bel": "p(hgnc:11916 ! TNFRSF1A)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CD40LG",
        "identifier": "11935"
      },
      "id": "0210088919155804f6f7e88ca8284878",
      "bel": "p(hgnc:11935 ! CD40LG)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TRADD",
        "identifier": "12030"
      },
      "id": "db2dedcc89d5ace41644233286083983",
      "bel": "p(hgnc:12030 ! TRADD)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TRAF2",
        "identifier": "12032"
      },
      "id": "03578fc23fc6a2505a4a99f57c0dd1f4",
      "bel": "p(hgnc:12032 ! TRAF2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "TRAF6",
        "identifier": "12036"
      },
      "id": "37a2e1215f3675b4f3bbc3d43024d047",
      "bel": "p(hgnc:12036 ! TRAF6)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "VDR",
        "identifier": "12679"
      },
      "id": "c3bea6ad64622f54edef384f26df9487",
      "bel": "p(hgnc:12679 ! VDR)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "VIP",
        "identifier": "12693"
      },
      "id": "d8dedfa529cf00c41e694b4fe45ad42e",
      "bel": "p(hgnc:12693 ! VIP)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "VIPR1",
        "identifier": "12694"
      },
      "id": "6201458c8dae0e63c750763392ca621d",
      "bel": "p(hgnc:12694 ! VIPR1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ZBTB16",
        "identifier": "12930"
      },
      "id": "c88734287276abc26677e62b23417dd3",
      "bel": "p(hgnc:12930 ! ZBTB16)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CTCF",
        "identifier": "13723"
      },
      "id": "79874e3a8497e66dd5a861cd26bd85b8",
      "bel": "p(hgnc:13723 ! CTCF)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CAMP",
        "identifier": "1472"
      },
      "id": "30fac27ad7862202b3c7fc3a1d8acd50",
      "bel": "p(hgnc:1472 ! CAMP)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SIRT1",
        "identifier": "14929"
      },
      "id": "ee235c4b7fcc97b9f15cd3eb36039f18",
      "bel": "p(hgnc:14929 ! SIRT1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CASP1",
        "identifier": "1499"
      },
      "id": "2dcf723238fa4963d5ea19359d2cf247",
      "bel": "p(hgnc:1499 ! CASP1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CCND1",
        "identifier": "1582"
      },
      "id": "7948aef17947d3efb076ccc443c7c3a6",
      "bel": "p(hgnc:1582 ! CCND1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CCR2",
        "identifier": "1603"
      },
      "id": "d86e49c0eaea8e8cb526d66774496a73",
      "bel": "p(hgnc:1603 ! CCR2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CD14",
        "identifier": "1628"
      },
      "id": "2635333e54723d9b5ef247f22fa1fee0",
      "bel": "p(hgnc:1628 ! CD14)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CD36",
        "identifier": "1663"
      },
      "id": "69119cdeeb203237ad70bd72ece25c25",
      "bel": "p(hgnc:1663 ! CD36)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CD44",
        "identifier": "1681"
      },
      "id": "28fa80d82ca237c484f8dd5c6baac604",
      "bel": "p(hgnc:1681 ! CD44)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CD69",
        "identifier": "1694"
      },
      "id": "ba66eefa168b67ff06dfc5a3a76f88be",
      "bel": "p(hgnc:1694 ! CD69)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IRAK3",
        "identifier": "17020"
      },
      "id": "ebbbb8cbf75cd26aab8112d42d73a60c",
      "bel": "p(hgnc:17020 ! IRAK3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "LY96",
        "identifier": "17156"
      },
      "id": "f45878cdad61f13d25d8de37be34ddd5",
      "bel": "p(hgnc:17156 ! LY96)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CDK4",
        "identifier": "1773"
      },
      "id": "10af669e3e8e2a8855be9401ca30a72f",
      "bel": "p(hgnc:1773 ! CDK4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CDKN1A",
        "identifier": "1784"
      },
      "id": "c69ccac4eb4c3c60456600ec83f7543f",
      "bel": "p(hgnc:1784 ! CDKN1A)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CDKN2D",
        "identifier": "1790"
      },
      "id": "c835a95311ce774460e7b1ef24342af3",
      "bel": "p(hgnc:1790 ! CDKN2D)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IRAK4",
        "identifier": "17967"
      },
      "id": "ec40f08ca8951d274431a47926fb8ce0",
      "bel": "p(hgnc:17967 ! IRAK4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SOCS3",
        "identifier": "19391"
      },
      "id": "735fdfba2945662cdbf7680ba8d40a73",
      "bel": "p(hgnc:19391 ! SOCS3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CHUK",
        "identifier": "1974"
      },
      "id": "db3393599a0e7a8a656b31553362680e",
      "bel": "p(hgnc:1974 ! CHUK)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CISH",
        "identifier": "1984"
      },
      "id": "4049ddef3180143a47ed8563b2abb58c",
      "bel": "p(hgnc:1984 ! CISH)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CMKLR1",
        "identifier": "2121"
      },
      "id": "e92368c8e5aa8f676071f4c6defac477",
      "bel": "p(hgnc:2121 ! CMKLR1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CRK",
        "identifier": "2362"
      },
      "id": "6a3d8ec67865380a974ff54fc07cbd62",
      "bel": "p(hgnc:2362 ! CRK)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CSF2",
        "identifier": "2434"
      },
      "id": "8cf7afcedebd5238dd6047d2d4698824",
      "bel": "p(hgnc:2434 ! CSF2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CSF3",
        "identifier": "2438"
      },
      "id": "781df3ecabaf3df6a12510006908f0e1",
      "bel": "p(hgnc:2438 ! CSF3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CTSK",
        "identifier": "2536"
      },
      "id": "fd95226fac3d4532a830d11af1f3a008",
      "bel": "p(hgnc:2536 ! CTSK)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CYBB",
        "identifier": "2578"
      },
      "id": "964113881108893d4f3b71e35e8bb456",
      "bel": "p(hgnc:2578 ! CYBB)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ABCA1",
        "identifier": "29"
      },
      "id": "34f78529b620cfd5f3d9192b0101a8dd",
      "bel": "p(hgnc:29 ! ABCA1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IRGM",
        "identifier": "29597"
      },
      "id": "48ae0145d7673e3e4acd637b4ff08aee",
      "bel": "p(hgnc:29597 ! IRGM)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "DOCK1",
        "identifier": "2987"
      },
      "id": "247212764f0cd006ab786545566395b1",
      "bel": "p(hgnc:2987 ! DOCK1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "AGTR1",
        "identifier": "336"
      },
      "id": "1ce0646ca7c8b1eef0ab59c82b77ce71",
      "bel": "p(hgnc:336 ! AGTR1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "FPR2",
        "identifier": "3827"
      },
      "id": "bd7fcd21172299d7338a4862ba40aabd",
      "bel": "p(hgnc:3827 ! FPR2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "GAS6",
        "identifier": "4168"
      },
      "id": "0a0c8f2c8f77d0a7d1e7ca3dd9c96400",
      "bel": "p(hgnc:4168 ! GAS6)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "GATA1",
        "identifier": "4170"
      },
      "id": "b6890d36e7e29dcc0fbe2d5c42c84d42",
      "bel": "p(hgnc:4170 ! GATA1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ALOX12",
        "identifier": "429"
      },
      "id": "bd887fb9cd92227dd72609136213603a",
      "bel": "p(hgnc:429 ! ALOX12)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ALOX15",
        "identifier": "433"
      },
      "id": "acff5b55d8546481824307286831bf94",
      "bel": "p(hgnc:433 ! ALOX15)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ALOX5",
        "identifier": "435"
      },
      "id": "d45d3e7af13a1c2b344b4568d62547ce",
      "bel": "p(hgnc:435 ! ALOX5)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "GPR32",
        "identifier": "4487"
      },
      "id": "27cbad019c53790867b889edd4df5a33",
      "bel": "p(hgnc:4487 ! GPR32)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CXCR3",
        "identifier": "4540"
      },
      "id": "77011f5500949aef21d289c3f86a20b8",
      "bel": "p(hgnc:4540 ! CXCR3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CXCL1",
        "identifier": "4602"
      },
      "id": "d25246c0151a1aff0059445a0ea736be",
      "bel": "p(hgnc:4602 ! CXCL1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CXCL2",
        "identifier": "4603"
      },
      "id": "86f9b14beaa9ac5107f78995c359f8f1",
      "bel": "p(hgnc:4603 ! CXCL2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "HDAC3",
        "identifier": "4854"
      },
      "id": "76131eef330ded34627b6734905dec44",
      "bel": "p(hgnc:4854 ! HDAC3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "HMGB1",
        "identifier": "4983"
      },
      "id": "398b09638fb3ccb8b0fa665e9b95658b",
      "bel": "p(hgnc:4983 ! HMGB1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ANXA1",
        "identifier": "533"
      },
      "id": "6f14665d84ee46724dfd2fae1d9d5dcf",
      "bel": "p(hgnc:533 ! ANXA1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NOD2",
        "identifier": "5331"
      },
      "id": "412f3724ebcb3432a56ef722aa1f47a7",
      "bel": "p(hgnc:5331 ! NOD2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IFNG",
        "identifier": "5438"
      },
      "id": "8d5ef5447b27e0c7ddc305f191ba0bed",
      "bel": "p(hgnc:5438 ! IFNG)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IGF1",
        "identifier": "5464"
      },
      "id": "4d7442aeba6e8dd1fe329e9d1e57eea0",
      "bel": "p(hgnc:5464 ! IGF1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IGF1R",
        "identifier": "5465"
      },
      "id": "b55ce217b1b1d243cfef99a3306fbc45",
      "bel": "p(hgnc:5465 ! IGF1R)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IGFBP3",
        "identifier": "5472"
      },
      "id": "9424e3e1a1d8d91ab8ce75175631ffab",
      "bel": "p(hgnc:5472 ! IGFBP3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IKBKB",
        "identifier": "5960"
      },
      "id": "7a4749b50b3cb8b62deb0877730ffbce",
      "bel": "p(hgnc:5960 ! IKBKB)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IKBKB",
        "identifier": "5960"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 177
        }
      ],
      "id": "371fe0ff8b204c13fba9d531feea3f69",
      "bel": "p(hgnc:5960 ! IKBKB, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 177))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IKBKB",
        "identifier": "5960"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 181
        }
      ],
      "id": "b62e75d57cea6c2701117373069dcb4c",
      "bel": "p(hgnc:5960 ! IKBKB, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 181))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IKBKG",
        "identifier": "5961"
      },
      "id": "b57d2b2b7d37a0917ab8f7e2986c2a1c",
      "bel": "p(hgnc:5961 ! IKBKG)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IL10",
        "identifier": "5962"
      },
      "id": "d8c40c6a1f13eedcc2609d52f062607c",
      "bel": "p(hgnc:5962 ! IL10)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IL10RA",
        "identifier": "5964"
      },
      "id": "efd6bd7676d9bf6b7383d88e47a2f575",
      "bel": "p(hgnc:5964 ! IL10RA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IL12A",
        "identifier": "5969"
      },
      "id": "6051b00924e029743acb4fb37328917c",
      "bel": "p(hgnc:5969 ! IL12A)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IL1B",
        "identifier": "5992"
      },
      "id": "a47b7e81e6919ae516ff58b51cca978d",
      "bel": "p(hgnc:5992 ! IL1B)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IL1R1",
        "identifier": "5993"
      },
      "id": "cffd2f4fb62372801c5eaefac17732a0",
      "bel": "p(hgnc:5993 ! IL1R1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IL2",
        "identifier": "6001"
      },
      "id": "03965642c6a230d83212d22d0e2e4533",
      "bel": "p(hgnc:6001 ! IL2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IL6",
        "identifier": "6018"
      },
      "id": "aa9c1c139b580c6add7164eef64ebb80",
      "bel": "p(hgnc:6018 ! IL6)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CXCL8",
        "identifier": "6025"
      },
      "id": "ff6d8ebf56ab67532ff6ab8e1ad8745c",
      "bel": "p(hgnc:6025 ! CXCL8)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IRAK1",
        "identifier": "6112"
      },
      "id": "3ca6a22c2e3d76a60409eb45e5c12106",
      "bel": "p(hgnc:6112 ! IRAK1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IRAK2",
        "identifier": "6113"
      },
      "id": "f3bbad00d94f0f33a568d6ec0e48cb66",
      "bel": "p(hgnc:6113 ! IRAK2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IRF1",
        "identifier": "6116"
      },
      "id": "6ea817f34e5b8dda26e41e8126d9fbc3",
      "bel": "p(hgnc:6116 ! IRF1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IRF3",
        "identifier": "6118"
      },
      "id": "9aec7805943771168c74ad61e15f4c09",
      "bel": "p(hgnc:6118 ! IRF3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "IRF5",
        "identifier": "6120"
      },
      "id": "db104b1d8fd39c21710b1252077641b4",
      "bel": "p(hgnc:6120 ! IRF5)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "JAK2",
        "identifier": "6192"
      },
      "id": "b5b3a121a985286d7064022b07a0a559",
      "bel": "p(hgnc:6192 ! JAK2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ARG1",
        "identifier": "663"
      },
      "id": "1ab8ffdf7ab46373365499cf9a24d89a",
      "bel": "p(hgnc:663 ! ARG1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RHOA",
        "identifier": "667"
      },
      "id": "7d595d03c52521703630f503febe384c",
      "bel": "p(hgnc:667 ! RHOA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "LRP1",
        "identifier": "6692"
      },
      "id": "d550e3aa59c5861889f4ba45705f59e7",
      "bel": "p(hgnc:6692 ! LRP1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAP3K3",
        "identifier": "6855"
      },
      "id": "b97a9b2ca3e481c773d4b1d3e9368f88",
      "bel": "p(hgnc:6855 ! MAP3K3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAP3K7",
        "identifier": "6859"
      },
      "id": "e78712bc62bb428b8e61d97e9c0da6a7",
      "bel": "p(hgnc:6859 ! MAP3K7)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAP3K8",
        "identifier": "6860"
      },
      "id": "ecc38e38313e94f3d8963659b8d7035f",
      "bel": "p(hgnc:6860 ! MAP3K8)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAPK1",
        "identifier": "6871"
      },
      "id": "e0c0225b558aed46aa00177aa93224b5",
      "bel": "p(hgnc:6871 ! MAPK1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MAPK3",
        "identifier": "6877"
      },
      "id": "6dd741794d73ab1e916725d3d79849b7",
      "bel": "p(hgnc:6877 ! MAPK3)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MERTK",
        "identifier": "7027"
      },
      "id": "83c980f0708c50c778be08090f8f9568",
      "bel": "p(hgnc:7027 ! MERTK)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "CXCL9",
        "identifier": "7098"
      },
      "id": "381972d193eb1b738dac49f3af41d1b5",
      "bel": "p(hgnc:7098 ! CXCL9)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MMP12",
        "identifier": "7158"
      },
      "id": "8246826d8afef202b2181e0b35d7a4ae",
      "bel": "p(hgnc:7158 ! MMP12)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MMP9",
        "identifier": "7176"
      },
      "id": "f6fc79beb30e63df945575f6f15f77e3",
      "bel": "p(hgnc:7176 ! MMP9)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ABCG1",
        "identifier": "73"
      },
      "id": "e936fa74a6f0062cba0cbb12f168ec41",
      "bel": "p(hgnc:73 ! ABCG1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MSR1",
        "identifier": "7376"
      },
      "id": "ad532fe1ffd1515bcbee365b01931c80",
      "bel": "p(hgnc:7376 ! MSR1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MST1",
        "identifier": "7380"
      },
      "id": "b57f6a7db58287f0b56e6ce552570cce",
      "bel": "p(hgnc:7380 ! MST1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MST1R",
        "identifier": "7381"
      },
      "id": "826f6a25ca954892d694e14753249860",
      "bel": "p(hgnc:7381 ! MST1R)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "MYD88",
        "identifier": "7562"
      },
      "id": "a66b4f47c38485fdb26a921e52772507",
      "bel": "p(hgnc:7562 ! MYD88)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NFKB1",
        "identifier": "7794"
      },
      "id": "fb631cdd688dc0faeec8f219cae55fb8",
      "bel": "p(hgnc:7794 ! NFKB1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NFKB2",
        "identifier": "7795"
      },
      "id": "74edda87fa21f94aa6594b9bca0dc600",
      "bel": "p(hgnc:7795 ! NFKB2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NFKBIA",
        "identifier": "7797"
      },
      "id": "00d5e69a95ae1215066cce653d9249d5",
      "bel": "p(hgnc:7797 ! NFKBIA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NFKBIA",
        "identifier": "7797"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 32
        }
      ],
      "id": "b7a1888e9d86a9e2ea68c2fabdb501bf",
      "bel": "p(hgnc:7797 ! NFKBIA, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 32))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NFKBIA",
        "identifier": "7797"
      },
      "variants": [
        {
          "kind": "pmod",
          "concept": {
            "namespace": "go",
            "name": "protein phosphorylation",
            "identifier": "0006468"
          },
          "code": "Ser",
          "pos": 36
        }
      ],
      "id": "bd2a5debda128ab761b0a6ed3177458a",
      "bel": "p(hgnc:7797 ! NFKBIA, pmod(go:0006468 ! \"protein phosphorylation\", Ser, 36))"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NFKBIE",
        "identifier": "7799"
      },
      "id": "d6a3e8f0f105ec220ac7ec13f12cf736",
      "bel": "p(hgnc:7799 ! NFKBIE)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "NOS2",
        "identifier": "7873"
      },
      "id": "fb8b89fef3aee8c9a32d26e699b4f4b7",
      "bel": "p(hgnc:7873 ! NOS2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "ATF6",
        "identifier": "791"
      },
      "id": "bf463dd32fab9cb79708e6fd437dd966",
      "bel": "p(hgnc:791 ! ATF6)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "OLR1",
        "identifier": "8133"
      },
      "id": "95da70f31ef4b38cf95891a0da037355",
      "bel": "p(hgnc:8133 ! OLR1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "OSM",
        "identifier": "8506"
      },
      "id": "9c11286f0acbc0a8298205eb2bf8bb3c",
      "bel": "p(hgnc:8506 ! OSM)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "P2RX7",
        "identifier": "8537"
      },
      "id": "41938b5ce5ed73a779cf69a545010316",
      "bel": "p(hgnc:8537 ! P2RX7)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "SERPINE1",
        "identifier": "8583"
      },
      "id": "8cfda9a9ba6a4ba16abe74bd3c2c92ce",
      "bel": "p(hgnc:8583 ! SERPINE1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PIM1",
        "identifier": "8986"
      },
      "id": "d2e7964c201e80aa67835655b2769831",
      "bel": "p(hgnc:8986 ! PIM1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PPARA",
        "identifier": "9232"
      },
      "id": "6ec335b16b97c1cffba83bb911ab1da9",
      "bel": "p(hgnc:9232 ! PPARA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PPARD",
        "identifier": "9235"
      },
      "id": "cf66a4b072f8f8a16284205b6ba99cde",
      "bel": "p(hgnc:9235 ! PPARD)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PPARG",
        "identifier": "9236"
      },
      "id": "19eee700eebc88d791c3eaae48ecba82",
      "bel": "p(hgnc:9236 ! PPARG)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PRKCZ",
        "identifier": "9412"
      },
      "id": "0837cdb40569b0c05b9e699b4cc8ddb3",
      "bel": "p(hgnc:9412 ! PRKCZ)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PTGER4",
        "identifier": "9596"
      },
      "id": "fb678c8d44011d6c5485d575e86d9cf5",
      "bel": "p(hgnc:9596 ! PTGER4)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PTGS2",
        "identifier": "9605"
      },
      "id": "a599840205cea50660db6b94062760db",
      "bel": "p(hgnc:9605 ! PTGS2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "PTK2",
        "identifier": "9611"
      },
      "id": "1045d07f02ab51325b28218a8804e558",
      "bel": "p(hgnc:9611 ! PTK2)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RAC1",
        "identifier": "9801"
      },
      "id": "1833ca3c80fe75acb1c59c3ffc45f2ec",
      "bel": "p(hgnc:9801 ! RAC1)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "REL",
        "identifier": "9954"
      },
      "id": "26d182db0899e6bcdbf4bcc98c9908a3",
      "bel": "p(hgnc:9954 ! REL)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RELA",
        "identifier": "9955"
      },
      "id": "b21bc29a07e8a2299916f8a95bdd0528",
      "bel": "p(hgnc:9955 ! RELA)"
    },
    {
      "function": "Protein",
      "concept": {
        "namespace": "hgnc",
        "name": "RELB",
        "identifier": "9956"
      },
      "id": "5d57a39d82836535cb07ef932751096d",
      "bel": "p(hgnc:9956 ! RELB)"
    },
    {
      "function": "Pathology",
      "concept": {
        "namespace": "mesh",
        "name": "Pulmonary Disease, Chronic Obstructive",
        "identifier": "D029424"
      },
      "id": "98cb883d84a9775f973f1e99c68ba3a2",
      "bel": "path(mesh:D029424 ! \"Pulmonary Disease, Chronic Obstructive\")"
    },
    {
      "function": "RNA",
      "concept": {
        "namespace": "hgnc",
        "name": "IL10",
        "identifier": "5962"
      },
      "id": "0a12c8bcbc0edab5ae9e0337396525f1",
      "bel": "r(hgnc:5962 ! IL10)"
    },
    {
      "function": "RNA",
      "concept": {
        "namespace": "hgnc",
        "name": "MRC1",
        "identifier": "7228"
      },
      "id": "7b559169a3aef0fa4f3c6d6bfcb13f82",
      "bel": "r(hgnc:7228 ! MRC1)"
    }
  ],
  "links": [
    {
      "line": 289,
      "relation": "increases",
      "evidence": "The requirement for CD44 binding and hyaluronan internalization could be bypassed by intracellular administration of hyaluronan oligosaccharides (10-18-mer) in lipopolysaccharide-primed macrophages",
      "citation": {
        "db": "PubMed",
        "db_id": "19258328"
      },
      "annotations": {
        "cl": {
          "0000581": true
        }
      },
      "source": 6,
      "target": 68,
      "key": "468b8212b425d69a078a382db0e40887"
    },
    {
      "line": 215,
      "relation": "decreases",
      "evidence": "LXA4 (100 nM) inhibited IL-8 production by airway epithelial cells , stimulated an intracellular Ca2+ signaling , increased Z0–1 expression and transepithelial electrical resistance , and enhanced epithelial repair after an acid injury .",
      "citation": {
        "db": "PubMed",
        "db_id": "22662206"
      },
      "annotations": {
        "cl": {
          "0002328": true
        }
      },
      "source": 15,
      "target": 118,
      "key": "fd92524a1ac872e25802086c9f54da02"
    },
    {
      "line": 215,
      "relation": "decreases",
      "evidence": "Nanomolar concentrations of LXA4 and LXB4 inhibited the IL-8 released by peripheral blood mononuclear cells from the two groups of patients with asthma: a maximal inhibition of 29.4% (p < 0.01) was observed for patients with mild asthma, and 41.5% inhibition (p < 0.001) for patients with severe asthma at 1 nM and 100 nM LXA4 concentrations, respectively.",
      "citation": {
        "db": "PubMed",
        "db_id": "12045128"
      },
      "annotations": {
        "cl": {
          "2000001": true
        }
      },
      "source": 15,
      "target": 118,
      "key": "40357057134aa3668d21ec7a95fe097f"
    },
    {
      "line": 216,
      "relation": "directlyIncreases",
      "evidence": "Lipoxin A4 treatment of peripheral blood mononuclear cells (PBMC) from two groups of subjects with asthma (mild and severe) for 24 hours inhibited IL-8 release at nanomolar concentrations. PBMC from patients with asthma expressed the LXA4 receptor, ALXR. These results indicated that the inhibitory effect of LXA4 on IL-8 release was mediated via ALXR.",
      "citation": {
        "db": "PubMed",
        "db_id": "12045128"
      },
      "annotations": {
        "cl": {
          "2000001": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 15,
      "target": 89,
      "key": "20c436b2830549ea721d41ceee16c2c2"
    },
    {
      "line": 217,
      "relation": "increases",
      "evidence": "LipoxinA4 rapidly stimulates macrophages to phagocytose apoptotic neutrophils, induces RhoA- and Rac-dependent cytoskeleton re-organization of macrophages and inhibits macrophage CXCL8 release, supporting macrophage-mediated resolution of inflammation. In turn,as a result of engulfment of apoptotic neutrophils, macrophages themselves become a primary source of lipoxins",
      "citation": {
        "db": "PubMed",
        "db_id": "22566854"
      },
      "annotations": {},
      "source": 15,
      "target": 17,
      "key": "49351d9522526760917e8bfc3178a42a"
    },
    {
      "line": 217,
      "relation": "increases",
      "evidence": "In this study, we report that LXA4 promotes another important step in the resolution phase of inflammation, namely, phagocytosis of apoptotic PMN by monocyte-derived macrophages.",
      "citation": {
        "db": "PubMed",
        "db_id": "10657608"
      },
      "annotations": {},
      "source": 15,
      "target": 17,
      "key": "cae13bc2a5a1e7c9bfd76bd392a05acf"
    },
    {
      "line": 218,
      "relation": "increases",
      "evidence": "LipoxinA4 rapidly stimulates macrophages to phagocytose apoptotic neutrophils, induces RhoA- and Rac-dependent cytoskeleton re-organization of macrophages and inhibits macrophage CXCL8 release, supporting macrophage-mediated resolution of inflammation. In turn,as a result of engulfment of apoptotic neutrophils, macrophages themselves become a primary source of lipoxins",
      "citation": {
        "db": "PubMed",
        "db_id": "22566854"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "source": 15,
      "target": 126,
      "key": "527731fdbf668673fe4467797555d70c"
    },
    {
      "line": 218,
      "relation": "increases",
      "evidence": "When cells were stimulated with LXA4 (10?9 mol/L) or the two analogues (10?11 mol/L) for 15 minutes, a threefold increase in membrane-associated RhoA, an index of Rho activation, 27 was observed, whereas 15-(S)-HETE was without effect (Figure 5)",
      "citation": {
        "db": "PubMed",
        "db_id": "12057930"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "source": 15,
      "target": 126,
      "key": "be803aaf3b864f669e804eae98c94dea"
    },
    {
      "line": 219,
      "relation": "increases",
      "evidence": "Like LXA4, Annexin A1\nhas also been shown to enhance efferocytosis of apoptotic\nneutrophils by macrophages [reviewed in (52)], thereby\nfacilitating catabasis of the inflamed tissue to homeostasis.",
      "citation": {
        "db": "PubMed",
        "db_id": "25478196"
      },
      "annotations": {},
      "source": 15,
      "target": 23,
      "key": "77684d2b290f25e330ec09c8306e84f9"
    },
    {
      "line": 317,
      "relation": "directlyIncreases",
      "evidence": "Specifically, NOD2 senses the cytosolic presence of muramyldipeptide (MDP) [[6, 7]]. Activation of NOD2 by bacterial products can stimulate two major signaling pathways to activate caspase-1 and pro-inflammatory responses, including the NF-κB pathway and the inflammasome pathway [[5]].",
      "citation": {
        "db": "PubMed",
        "db_id": "22531915"
      },
      "annotations": {
        "cl": {
          "0000583": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 14,
      "target": 102,
      "key": "3f8b113a9168ddfcbce31e2e06ebbaec"
    },
    {
      "line": 304,
      "relation": "positiveCorrelation",
      "evidence": "The total counts of iNOS-\nexpressing cells assessed by immunoreactivity were almost the same in COPD and asthma patients, indicating that NO hyper production occurs in COPD as well as in asthmatic airways",
      "citation": {
        "db": "PubMed",
        "db_id": "10934109"
      },
      "annotations": {},
      "source": 8,
      "target": 166,
      "key": "71d946f34d76d33d34f8a8b25efa6ed9"
    },
    {
      "line": 57,
      "relation": "directlyIncreases",
      "evidence": "Among various prostanoids affected by NSAIDs, prostaglandin E2 (PGE2), in particular, seems to play critical roles in IBD via the EP4 receptor, one of the four PGE2 receptor subtypes (EP1-4). An EP4 agonist for example, when topically applied, has been reported to ameliorate typical colitis symptoms by suppressing the production of cytotoxic cytokines in the dextran sodium sulfate (DSS)-induced colitis model. EP4 agonists are also known, however, for their ability to protect epithelial cells from apoptosis in vitro, which may contribute to the protection of mucosal barrier functions. To investigate this potential application, we have tested another EP4-selective agonist in the DSS-indomethacin mouse colitis model.",
      "citation": {
        "db": "PubMed",
        "db_id": "17008451"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 2,
      "target": 159,
      "key": "7b87a2c8d2ab0687b6cd84a918629138"
    },
    {
      "line": 57,
      "relation": "directlyIncreases",
      "evidence": "Our data indicate that in R2C cells the COX-2-derived prostaglandin E2 (PGE2) binds the PGE2 receptor EP4 and activates protein kinase A (PKA) and ultimately CREB.",
      "citation": {
        "db": "PubMed",
        "db_id": "19679653"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 2,
      "target": 159,
      "key": "2c73fa885c38db0726097dd526cd519b"
    },
    {
      "line": 21,
      "relation": "increases",
      "evidence": "Figure 1. Pathways to MUC5AC expression in COPD",
      "citation": {
        "db": "PubMed",
        "db_id": "17615396"
      },
      "annotations": {},
      "source": 3,
      "target": 2,
      "key": "c36abf4bca1f2c71abdf48b1edb391c3"
    },
    {
      "line": 116,
      "relation": "decreases",
      "evidence": "H(2)O(2) reduced SIRT1 expression and activity in U937 cells; furthermore, cigarette smoke exposure also caused reduction of SIRT1 expression in lung tissue of A/J mice, with concomitant elevation of MMP9.",
      "citation": {
        "db": "PubMed",
        "db_id": "19376817"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 11,
      "target": 62,
      "key": "ddcc52b2d70022694cbbabeaaf1d0d81"
    },
    {
      "line": 125,
      "relation": "increases",
      "evidence": "These observations suggested that the inverse gene expression of PGIS and TXS in macrophages contributes to immune responses by modulating the relative levels of prostacyclin and thromboxane A2.",
      "citation": {
        "db": "PubMed",
        "db_id": "9202154"
      },
      "annotations": {},
      "source": 4,
      "target": 22,
      "key": "6d12fcddc2cbd0616e724dea13a47098"
    },
    {
      "line": 122,
      "relation": "increases",
      "evidence": "\"We found that acrolein (10-100 microM) significantly stimulated the release of both IL-8 and TNF-alpha from U937...cells.\" (p. 619)",
      "citation": {
        "db": "PubMed",
        "db_id": "17600310"
      },
      "annotations": {},
      "source": 0,
      "target": 118,
      "key": "a6914050157adba326b7c004da2f41f4"
    },
    {
      "line": 123,
      "relation": "increases",
      "evidence": "\"We found that acrolein (10-100 microM) significantly stimulated the release of both IL8 and TNF-alpha from U937...cells.\" (p. 619)",
      "citation": {
        "db": "PubMed",
        "db_id": "17600310"
      },
      "annotations": {},
      "source": 0,
      "target": 50,
      "key": "0182587d8e7ad4eb5801978592a784ef"
    },
    {
      "line": 124,
      "relation": "increases",
      "evidence": "RANTES and MCP-1 [CCL2], on the other hand, were increased in both wild-type and Cd8(-/-) mice exposed to acrolein, but this increase was significantly greater in wild-type mice compared to Cd8(-/-) mice.",
      "citation": {
        "db": "PubMed",
        "db_id": "17950725"
      },
      "annotations": {},
      "source": 0,
      "target": 34,
      "key": "a8143d2fec5c6a3226fe9f968562dfd2"
    },
    {
      "line": 60,
      "relation": "directlyIncreases",
      "evidence": "1alpha,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)] regulates mineral homeostasis and exhibits potent anti-proliferative, prodifferentiative, and immunomodulatory activities. It mediates these effects by binding to the vitamin D receptor (VDR),; Finally, quantitative differences in gene expression revealed a vitamin D-regulated differentiation network and identified peptidylarginine deiminases, kallikreins, serine proteinase inhibitor family members, Kruppel-like factor 4, and c-fos as vitamin D-responsive genes,",
      "citation": {
        "db": "PubMed",
        "db_id": "15816836"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 9,
      "target": 56,
      "key": "2389626c5fb44bfc1732931d563d3b04"
    },
    {
      "line": 61,
      "relation": "increases",
      "evidence": "the proportion of cells differentiating into macrophages in serum-free medium, as assessed by expression of the alpha-subunit of the beta2 integrin CD11b, increased from 5 +/- 1% to 25 +/- 3%. Addition of IGF-I increased the proportion of cells differentiating into CD11b-positive macrophages to 78 +/- 5%. In the absence of vitamin D3, IGF-I did not induce expression of CD11b (6 +/- 1%).....These data establish that PKC-zeta is a putative downstream target of PI 3-kinase that is activated during IGF-I-promoted macrophage differentiation.",
      "citation": {
        "db": "PubMed",
        "db_id": "9570559"
      },
      "annotations": {},
      "source": 9,
      "target": 20,
      "key": "ca06586c9bef084f70b23383105dab9c"
    },
    {
      "line": 61,
      "relation": "increases",
      "evidence": "In addition, stable, inducible expression of PLZF in U937 cells inhibited the ability of 1,25(OH)(2)D(3) to induce surface expression of the monocytic marker CD14 and morphologic changes associated with differentiation",
      "citation": {
        "db": "PubMed",
        "db_id": "11719366"
      },
      "annotations": {},
      "source": 9,
      "target": 20,
      "key": "d9df0479610852e0a9d20e1ceae394e2"
    },
    {
      "line": 61,
      "relation": "increases",
      "evidence": "Different types of acute myeloid leukemia blast cells were induced to differentiate in vitro with all-trans-retinoic acid (ATRA) and vitamin D3 (VD).",
      "citation": {
        "db": "PubMed",
        "db_id": "10446999"
      },
      "annotations": {
        "doid": {
          "1240": true
        }
      },
      "source": 9,
      "target": 20,
      "key": "121feacc22a8cd7409bc189ac682d427"
    },
    {
      "line": 62,
      "relation": "increases",
      "evidence": "1alpha,25-dihydroxyvitamin D(3) (D(3)) promotes the maturation of myeloid cells and surface expressions of CD14 and CD11b, markers of cell differentiation in response to D(3).",
      "citation": {
        "db": "PubMed",
        "db_id": "10587349"
      },
      "annotations": {},
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "go",
            "name": "intracellular",
            "identifier": "0005622"
          },
          "toLoc": {
            "namespace": "go",
            "name": "cell surface",
            "identifier": "0009986"
          }
        }
      },
      "source": 9,
      "target": 66,
      "key": "b1c0414e8cc6ac474afe2d9fb0b11fc6"
    },
    {
      "line": 62,
      "relation": "increases",
      "evidence": "In addition, stable, inducible expression of PLZF in U937 cells inhibited the ability of 1,25(OH)(2)D(3) to induce surface expression of the monocytic marker CD14 and morphologic changes associated with differentiation",
      "citation": {
        "db": "PubMed",
        "db_id": "11719366"
      },
      "annotations": {},
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "go",
            "name": "intracellular",
            "identifier": "0005622"
          },
          "toLoc": {
            "namespace": "go",
            "name": "cell surface",
            "identifier": "0009986"
          }
        }
      },
      "source": 9,
      "target": 66,
      "key": "52fbad7beab9f7e2c5157c4c02e2c27d"
    },
    {
      "line": 144,
      "relation": "directlyIncreases",
      "evidence": "In response to lipopolysaccharide (LPS) exposure, macrophages activate the transcription of a large number of pro-inflammatory genes by way of signaling pathways downstream of the LPS receptor, Toll-Like Receptor 4.",
      "citation": {
        "db": "PubMed",
        "db_id": "15107417"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity"
      },
      "source": 7,
      "target": 49,
      "key": "491e3a0b4e04de62ad42c8229e0417f0"
    },
    {
      "line": 144,
      "relation": "directlyIncreases",
      "evidence": "Finally, we show that Syk associates with Toll-like receptor 4 (TLR4) upon LPS stimulation further implicating Syk in the LPS-induced signaling pathway in neutrophils.",
      "citation": {
        "db": "PubMed",
        "db_id": "14699155"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity"
      },
      "source": 7,
      "target": 49,
      "key": "fd1915d300931e6f5215152f14f5a531"
    },
    {
      "line": 144,
      "relation": "directlyIncreases",
      "evidence": "Mammalian innate immune system recognizes bacteria and their cell wall components through two pattern-recognition receptors, CD14 (1, 2) and Toll-like receptors (TLR)4 2 and 4. TLR2 seems to serve as the primary receptor for Gram-positive bacteria and their cell wall components, whereas TLR4 (but not TLR2) serves as the primary LPS receptor.",
      "citation": {
        "db": "PubMed",
        "db_id": "11160242"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity"
      },
      "source": 7,
      "target": 49,
      "key": "f26d3b080342c75721bb8e1dcfdb1702"
    },
    {
      "line": 144,
      "relation": "directlyIncreases",
      "evidence": "LPS, which ligates TLR-4, preferentially upregulated MICA and not MICB......LPS preferentially upregulated MICAand not MICB,CL097 stimulation resulted in upregulation of both MICA and MICB, and poly(I:C) upregulated neither (Fig. 1A, 1B).",
      "citation": {
        "db": "PubMed",
        "db_id": "20488792"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity"
      },
      "source": 7,
      "target": 49,
      "key": "f7b0d278954c476ed42fdef64bde2d47"
    },
    {
      "line": 144,
      "relation": "directlyIncreases",
      "evidence": "lipopolysaccharide (LPS; endotoxin) from Gram-negative bacteria, which stimulates TLR4; bacterial lipoproteins and lipotechoic acid and fungal zymosan, which stimulate TLR1, TLR2 and TLR6; bacterial flagellin, which activates TLR5; a profilin-like molecule from the protozoan Toxoplasma gondii, which activates TLR11; unmethylated CpG motifs present in DNA that function as stimulators of TLR9; double-stranded RNA that activates TLR3; and singlestranded RNA that can stimulate TLR7 and TLR8",
      "citation": {
        "db": "PubMed",
        "db_id": "19052556"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity"
      },
      "source": 7,
      "target": 49,
      "key": "0cbfe3ce487e3955ec38498959b60d3e"
    },
    {
      "line": 144,
      "relation": "directlyIncreases",
      "evidence": "Lipopolysaccharides (LPS), which activate Toll-like receptor 4 (TLR4), reduced PPARgamma expression and function in peritoneal macrophages and macrophage cell lines",
      "citation": {
        "db": "PubMed",
        "db_id": "18422969"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity"
      },
      "source": 7,
      "target": 49,
      "key": "da639b4ff8ec588a2ed49724b481e839"
    },
    {
      "line": 144,
      "relation": "directlyIncreases",
      "evidence": "From Full Paper Introduction The TLRs agonist include LPS for Tlr4, peptidglycan for Tlr2 and 6...",
      "citation": {
        "db": "PubMed",
        "db_id": "12865424"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity"
      },
      "source": 7,
      "target": 49,
      "key": "ba413508bfbc06806d7d35412c167bf0"
    },
    {
      "line": 144,
      "relation": "directlyIncreases",
      "evidence": "LPS-induced Bambi downregulation and sensitization to TGF-beta is mediated by a MyD88-NF-kappaB-dependent pathway",
      "citation": {
        "db": "PubMed",
        "db_id": "17952090"
      },
      "annotations": {
        "cl": {
          "0000632": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 7,
      "target": 49,
      "key": "426dd711b2dad5d6fdd7bbbfa49e3ede"
    },
    {
      "line": 144,
      "relation": "directlyIncreases",
      "evidence": "Prototypic examples of PAMPs include lipopolysaccharide (LPS), a outer membrane component of Gram-negative bacteria that stimulates TLR4 [8,9], bacterial lipoproteins that stimulate TLR2 in conjunction with either TLR1 or TLR6 [10], and flagellin, the protein monomer of bacterial flagella that activates TLR5 [11]. Nucleic acids are recognized by endosomal TLRs; double-stranded DNA with unmethylated CpG motifs activates TLR9 in a host species-specific manner while TLR3 and TLR7/8 are activated by dsRNA including synthetic poly (I:C) [12] and ssRNA, respectively [13,14].",
      "citation": {
        "db": "PubMed",
        "db_id": "21108806"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity"
      },
      "source": 7,
      "target": 49,
      "key": "24033dfc6f2b638fb464fd39f321de57"
    },
    {
      "line": 145,
      "relation": "directlyIncreases",
      "evidence": "MD-2, is requisite for LPS signaling of TLR4. MD-2 is physically associated with TLR4 on the cell surface and confers responsiveness to LPS. MD-2 is thus a link between TLR4 and LPS signaling.",
      "citation": {
        "db": "PubMed",
        "db_id": "10359581"
      },
      "annotations": {},
      "source": 7,
      "target": 29,
      "key": "288045c13d4ea63b37d06e4779b8be03"
    },
    {
      "line": 146,
      "relation": "increases",
      "evidence": "\"Primary mouse peritoneal macrophages were also used to observe the relationship between TNF-alpha and miR-146a expression stimulated by different doses of LPS or PGN for 6, 12, and 24 h...In contrast, miR-146a showed gradual increase for all the time points shown.\" (p. 1726)",
      "citation": {
        "db": "PubMed",
        "db_id": "21178010"
      },
      "annotations": {},
      "source": 7,
      "target": 30,
      "key": "dd6f7ef32ecc218f5968e26bce622aed"
    },
    {
      "line": 147,
      "relation": "increases",
      "evidence": "Here we show that Toll-like receptor 2 (TLR2) is a signalling receptor that is activated by LPS in a response that depends on LPS-binding protein and is enhanced by CD14.",
      "citation": {
        "db": "PubMed",
        "db_id": "9751057"
      },
      "annotations": {},
      "source": 7,
      "target": 47,
      "key": "25aa6b89d411435f820ecf152f88cd62"
    },
    {
      "line": 133,
      "relation": "increases",
      "evidence": "Further analyses indicate that activation of SIRT1 (deacetylase) by resveratrol (a natural antioxidant) induces SIRT1-p300 association and acetyltransferase inactivation, leading to deacetylation of HA/CD44-induced beta-catenin and NFkappaB-p65, inhibition of beta-catenin-T-cell factor/lymphocyte enhancer factor and NFkappaB-specific transcriptional activation, and the impairment of MDR1 and Bcl-x(L) gene expression.",
      "citation": {
        "db": "PubMed",
        "db_id": "19047049"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 12,
      "target": 62,
      "key": "873486b291ebcf820e1db0aa1e44de5c"
    },
    {
      "line": 133,
      "relation": "increases",
      "evidence": "Pre-treatment of endothelial cells with resveratrol significantly attenuated the CSE- and oxidant-mediated SIRT1 levels and eNOS acetylation.",
      "citation": {
        "db": "PubMed",
        "db_id": "20102704"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 12,
      "target": 62,
      "key": "3948597f18906e273beee38ecbcfbc7f"
    },
    {
      "line": 133,
      "relation": "increases",
      "evidence": "resveratrol (trans-3, 5, 4''-trihydroxystibene) treatment and caloric restriction increased silent information regulator 2/sirtuin 1 activity,",
      "citation": {
        "db": "PubMed",
        "db_id": "16395277"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 12,
      "target": 62,
      "key": "30aefac02192a4c00e82f5b7b258a770"
    },
    {
      "line": 133,
      "relation": "increases",
      "evidence": "CSE (1, 2.5, and 5%) dose dependently and significantly decreased SIRT1 activity after 4 and 24 h (P  0.001). Sirtuin inhibitors suramin and nicotinamide abolished sirtuin activity, whereas resveratrol, a SIRT1 activator, significantly increased sirtuin activity (P  0.001) (Fig. 1).",
      "citation": {
        "db": "PubMed",
        "db_id": "17041012"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 12,
      "target": 62,
      "key": "d3d4614a30fd4bbd85d26d11081b0c2e"
    },
    {
      "line": 133,
      "relation": "increases",
      "evidence": "Miyazaki used resveratrol to activate and nicotinamide to inhibit SIRT1 function.",
      "citation": {
        "db": "PubMed",
        "db_id": "21293192"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 12,
      "target": 62,
      "key": "830744b4a539f765fd6767feb4258ac6"
    },
    {
      "line": 134,
      "relation": "increases",
      "evidence": "DBP has been directly implicated in the activation of macrophages. Activated macrophages develop the capacity for specialized tasks such as chemotaxis, phagocytosis and the lysis of intracellular parasites, as well as destruction of tumor cells. Lysophosphatidylcholine (lyso-Pc) or dodecylglycerol (DDG) injected into the mouse peritoneum normally activate macrophages to generate reactive oxygen intermediates (ROIs) and to ingest cellular debris during the inflammatory response.",
      "citation": {
        "db": "PubMed",
        "db_id": "10996527"
      },
      "annotations": {},
      "source": 22,
      "target": 17,
      "key": "3b76d47bc6cb843407e199e354671ca4"
    },
    {
      "line": 135,
      "relation": "increases",
      "evidence": "Tissue macrophages synthesize neutrophil chemoattractants CXCL1/CXCL2 (CXC chemokine ligands 1/2) in response to LPS. Both in vivo studies with blocking monoclonal antibodies and in vitro chemotaxis experiments show the neutrophil response to mast cells and macrophages to be CXCL1/CXCL2-dependent.",
      "citation": {
        "db": "PubMed",
        "db_id": "23645836"
      },
      "annotations": {
        "cl": {
          "0000235": true
        }
      },
      "source": 22,
      "target": 97,
      "key": "ef9f2a92ac51bfaf3877afae0c8593fa"
    },
    {
      "line": 136,
      "relation": "increases",
      "evidence": "Tissue macrophages synthesize neutrophil chemoattractants CXCL1/CXCL2 (CXC chemokine ligands 1/2) in response to LPS. Both in vivo studies with blocking monoclonal antibodies and in vitro chemotaxis experiments show the neutrophil response to mast cells and macrophages to be CXCL1/CXCL2-dependent.",
      "citation": {
        "db": "PubMed",
        "db_id": "23645836"
      },
      "annotations": {
        "cl": {
          "0000235": true
        }
      },
      "source": 22,
      "target": 98,
      "key": "3108704ea1c0971d18f0ad9c03288971"
    },
    {
      "line": 137,
      "relation": "increases",
      "evidence": "We investigated the effects and possible mechanisms of AF-1 on LPS-induced alveolar macrophage (AM) activation in vitro...simultaneous incubation of AMs with LPS and various concentration of AF-1 for 20h resulted in a reduction in IL-1 beta and IL-6 release compared to cells stimulated with LPS alone.",
      "citation": {
        "db": "PubMed",
        "db_id": "18541446"
      },
      "annotations": {
        "cl": {
          "0000235": true
        }
      },
      "source": 22,
      "target": 117,
      "key": "99cb3918d4d79a65d22171dd7843e5f8"
    },
    {
      "line": 271,
      "relation": "decreases",
      "evidence": "VDR mRNA and protein were constitutively expressed in MO, whereas VDR was downregulated in mature MAC on both the mRNA and protein levels",
      "citation": {
        "db": "PubMed",
        "db_id": "8394753"
      },
      "annotations": {},
      "source": 20,
      "target": 56,
      "key": "4ec3170b85a8a070c57f56bf5d42dd03"
    },
    {
      "line": 272,
      "relation": "increases",
      "evidence": "IL-12 and IL-18 together, but not alone, prevented spontaneous apoptosis of cultured monocytes, promoted monocyte clustering and subsequent differentiation into macrophages. These morphological changes were accompanied by increased secretion of CXC chemokine ligands (CXCL)9, CXCL10 (up to 100-fold, P < 0.001) and CXCL8 (up to 10-fold, P < 0.001)",
      "citation": {
        "db": "PubMed",
        "db_id": "16907924"
      },
      "annotations": {
        "cl": {
          "0000235": true
        }
      },
      "source": 20,
      "target": 134,
      "key": "0c44423c0a8c2ff2d38708c2f09c3fce"
    },
    {
      "line": 273,
      "relation": "increases",
      "evidence": "IL-12 and IL-18 together, but not alone, prevented spontaneous apoptosis of cultured monocytes, promoted monocyte clustering and subsequent differentiation into macrophages. These morphological changes were accompanied by increased secretion of CXC chemokine ligands (CXCL)9, CXCL10 (up to 100-fold, P < 0.001) and CXCL8 (up to 10-fold, P < 0.001)",
      "citation": {
        "db": "PubMed",
        "db_id": "16907924"
      },
      "annotations": {
        "cl": {
          "0000235": true
        }
      },
      "source": 20,
      "target": 36,
      "key": "517d2d8e44c6bafb3e439c21e6d1682a"
    },
    {
      "line": 274,
      "relation": "increases",
      "evidence": "IL-12 and IL-18 together, but not alone, prevented spontaneous apoptosis of cultured monocytes, promoted monocyte clustering and subsequent differentiation into macrophages. These morphological changes were accompanied by increased secretion of CXC chemokine ligands (CXCL)9, CXCL10 (up to 100-fold, P < 0.001) and CXCL8 (up to 10-fold, P < 0.001)",
      "citation": {
        "db": "PubMed",
        "db_id": "16907924"
      },
      "annotations": {
        "cl": {
          "0000235": true
        }
      },
      "source": 20,
      "target": 118,
      "key": "50d2f5859af86916ba4705342c3e35fb"
    },
    {
      "line": 268,
      "relation": "increases",
      "evidence": "Some of the major stimuli that activate macrophages and cause them to secrete chemotactic factors have been identified as CS, wood smoke, ozone, bacterial endotoxin, and proinflammatory cytokines such as interleukin (IL)-1beta and tumor necrosis factor (TNF)-alpha. These stimuli seem to activate mainly redox-sensitive transcription factors such as nuclear factor (NF)-kappa B and activator protein (AP)-1, both of which play a major role in the synthesis and secretion of chemotactic factors such as IL-8 and leukotriene B(4) (LTB(4)).",
      "citation": {
        "db": "PubMed",
        "db_id": "19842832"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 26,
      "target": 5,
      "key": "816138fae2736e2e0b9ba65e999871a7"
    },
    {
      "line": 270,
      "relation": "increases",
      "evidence": "To inhibit AP-1 activation, cells were transfected with either an RNAi directed against the AP-1 activating kinase JNK or a scrambled  RNAi (negative control) followed by exposure to 95% O2 for 24 h [27] and [28]. Western blot analysis revealed that JNK1 levels were significantly decreased after hyperoxia  when cells were transfected with JNK  RNAi compared to the SCR or mock controls (Fig. 5A). Whereas the transfection with the SCR RNAi resulted in minimal reduction in both JNK and IL-8 levels, inhibition of JNK did result in a significant reduction in JNK levels (Fig. 5B, p < 0.01) and IL-8 production in hyperoxia (Fig. 5C, p < 0.0001 compared to mock and SCR controls). These results indicate that AP-1 plays a central role in regulating IL-8  expression in response to hyperoxia.",
      "citation": {
        "db": "PubMed",
        "db_id": "18692129"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 26,
      "target": 118,
      "key": "3699a9ca5211ab59b1ddeedbe6a2a6f2"
    },
    {
      "line": 131,
      "relation": "directlyIncreases",
      "evidence": "The IKK immunoprecipitates from thrombin-treated cells showed increased phosphorylation of GST-IkBalpha compared with the immunoprecipitates from control cells (Fig. 6), indicating the activation of IKK by thrombin.",
      "citation": {
        "db": "PubMed",
        "db_id": "15843586"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 25,
      "target": 145,
      "key": "29f3ffb3beccf1ae3b6520d6e1d1cb04"
    },
    {
      "line": 131,
      "relation": "directlyIncreases",
      "evidence": "In the classical NF-{kappa}B signaling pathway, IKK{beta} is both necessary and sufficient for phosphorylation of I{kappa}B{alpha} on Ser 32 and Ser 36, and I{kappa}B{beta} on Ser 19 and Ser 23.",
      "citation": {
        "db": "PubMed",
        "db_id": "15371334"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 25,
      "target": 145,
      "key": "17755f2f4da1751cc4f1e32eecaa1b2e"
    },
    {
      "line": 132,
      "relation": "directlyIncreases",
      "evidence": "The IKK immunoprecipitates from thrombin-treated cells showed increased phosphorylation of GST-IkBalpha compared with the immunoprecipitates from control cells (Fig. 6), indicating the activation of IKK by thrombin.",
      "citation": {
        "db": "PubMed",
        "db_id": "15843586"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 25,
      "target": 146,
      "key": "8e0bdc5d22071968c64a82b5003fc6cd"
    },
    {
      "line": 132,
      "relation": "directlyIncreases",
      "evidence": "In the classical NF-{kappa}B signaling pathway, IKK{beta} is both necessary and sufficient for phosphorylation of I{kappa}B{alpha} on Ser 32 and Ser 36, and I{kappa}B{beta} on Ser 19 and Ser 23.",
      "citation": {
        "db": "PubMed",
        "db_id": "15371334"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 25,
      "target": 146,
      "key": "d1eac546f6cc0a3d618ea28cf9ae0d15"
    },
    {
      "relation": "hasComponent",
      "source": 27,
      "target": 164,
      "key": "d7946658060d248bd232e82ba1dce8c5"
    },
    {
      "line": 192,
      "relation": "directlyIncreases",
      "evidence": "In addition, NFkappaB-inhibitor blocked cigarette smoke-induced IL-8 production.",
      "citation": {
        "db": "PubMed",
        "db_id": "16620395"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 27,
      "target": 118,
      "key": "55138bcfd7c09e50fc340c5e4aa066b7"
    },
    {
      "line": 194,
      "relation": "increases",
      "evidence": "Some of the major stimuli that activate macrophages and cause them to secrete chemotactic factors have been identified as CS, wood smoke, ozone, bacterial endotoxin, and proinflammatory cytokines such as interleukin (IL)-1beta and tumor necrosis factor (TNF)-alpha. These stimuli seem to activate mainly redox-sensitive transcription factors such as nuclear factor (NF)-kappa B and activator protein (AP)-1, both of which play a major role in the synthesis and secretion of chemotactic factors such as IL-8 and leukotriene B(4) (LTB(4)).",
      "citation": {
        "db": "PubMed",
        "db_id": "19842832"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 27,
      "target": 5,
      "key": "9445cc6844b61583925fe4a4262cf0e9"
    },
    {
      "line": 195,
      "relation": "increases",
      "evidence": "In support of activation of NF-kB in COPD, NF-{kappa}B was clearly responsible for enhancing the levels of IL-1 and TNF-{alpha}, via depletion of GSH and generation of ROS in the human macrophage-like cell line MonoMac6 stimulated by aqueous CSE (361).",
      "citation": {
        "db": "PubMed",
        "db_id": "17615396"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 27,
      "target": 11,
      "key": "b920d3eded6c59912db358277b5f4472"
    },
    {
      "line": 195,
      "relation": "increases",
      "evidence": "Taken together, these findings suggest that CpG ODN stimulates Nox1-mediated ROS generation through the NFkB signaling pathway.",
      "citation": {
        "db": "PubMed",
        "db_id": "18817866"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 27,
      "target": 11,
      "key": "e0b7b25cd72deb782e047dd4dc30370d"
    },
    {
      "line": 195,
      "relation": "increases",
      "evidence": "visfatin-induced ROS generation is partially dependent on activation of the NFkB pathway",
      "citation": {
        "db": "PubMed",
        "db_id": "19898975"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 27,
      "target": 11,
      "key": "303ec5ae944232068c6d56e53901f4c8"
    },
    {
      "line": 195,
      "relation": "increases",
      "evidence": "Inhibition of the enzyme inducible cyclooxygenase (COX-2) and the transcription factor nuclear factor-kappaB (NF-kappaB) significantly diminished the free radicals' signal intensity, implicating these factors in the formation of free radicals",
      "citation": {
        "db": "PubMed",
        "db_id": "12882915"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 27,
      "target": 11,
      "key": "2aa78adcd0bb8ec779a7ac2642c69a20"
    },
    {
      "line": 196,
      "relation": "increases",
      "evidence": "Accordingly, the activation of NF-?B pathways is also crucial in atherogenesis and macrophage activation/survival [46–48].",
      "citation": {
        "db": "PubMed",
        "db_id": "19390623"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 27,
      "target": 22,
      "key": "8c773a05d494c87026f2e7599d1f9a66"
    },
    {
      "relation": "partOf",
      "source": 49,
      "target": 29,
      "key": "d4263b4468cb4b1d3f251fa04a80da0e"
    },
    {
      "relation": "hasComponent",
      "source": 49,
      "target": 29,
      "key": "5e730865e56683e6817d31103308de8e"
    },
    {
      "line": 3,
      "relation": "increases",
      "evidence": "MyD88 also interacts with IRF5 and IRF1 and is required for the activation of these IRFs. IRF5 was identified as being crucial for the induction of proinflammatory cytokines and type I IFNs by all TLRs tested...other TLR4-mediated MyD88-dependent signals, such as IRF5 activation,",
      "citation": {
        "db": "PubMed",
        "db_id": "17457343"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 49,
      "target": 141,
      "key": "5fe9f001aee420edf42b041aec529cdd"
    },
    {
      "line": 3,
      "relation": "increases",
      "evidence": "TLR4 links to both MyD88 and Trif, TLR3 exclusively uses Trif, and the other TLRs use MyD88 as their major adaptor to transduce signals to downstream effectors (4).",
      "citation": {
        "db": "PubMed",
        "db_id": "18772134"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 49,
      "target": 141,
      "key": "fe3b27ab9f1b91fd45c3a96b56a6acf4"
    },
    {
      "line": 3,
      "relation": "increases",
      "evidence": "Triggering of the IL-1R or TLR causes the adaptor protein MyD88 to be recruited to the receptor complex, which in turn promotes association with the IL-1R-associated kinases IRAK4 and IRAK1. \nTLR4-mediated response to LPS may involve both MyD88-dependent and -independent pathways.",
      "citation": {
        "db": "PubMed",
        "db_id": "12893815"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 49,
      "target": 141,
      "key": "4b6fab133e198f0aafdc06181d1d782b"
    },
    {
      "line": 3,
      "relation": "increases",
      "evidence": "Aggregation through TLR4 and 2 involved the production of NO, increase in cellular cGMP, and activation of PKG.",
      "citation": {
        "db": "PubMed",
        "db_id": "19945154"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 49,
      "target": 141,
      "key": "a55754f27b6cea261dba1cee43af29d8"
    },
    {
      "line": 3,
      "relation": "increases",
      "evidence": "TLR4, in addition, activates NF-kappaB and MAP kinases via the MyD88-dependent pathway",
      "citation": {
        "db": "PubMed",
        "db_id": "16143103"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 49,
      "target": 141,
      "key": "4f898e9ab9f226883818c09c7dc73474"
    },
    {
      "line": 3,
      "relation": "increases",
      "evidence": "An impaired IRAK4 activation was observed with TLR4 mutant PMN, in which the HMGB1-induced IRAK4 activity was attenuated by 64% compared with that in TLR4 WT PMN (Fig. 5B).",
      "citation": {
        "db": "PubMed",
        "db_id": "17475888"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 49,
      "target": 141,
      "key": "2487db809358d70901227799509990dd"
    },
    {
      "line": 4,
      "relation": "increases",
      "evidence": "Previously, we demonstrated that lipopolysaccharide (LPS, TLR4 ligand)-increased macrophage motility required the participation of Src and FAK, which was inducible nitric oxide synthase (iNOS)-dependent.",
      "citation": {
        "db": "PubMed",
        "db_id": "20849883"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 49,
      "target": 148,
      "key": "d1322cd1dfe3a80df58f520ccf59128c"
    },
    {
      "line": 4,
      "relation": "increases",
      "evidence": "Modified assertion",
      "citation": {
        "db": "PubMed",
        "db_id": "11896392"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 49,
      "target": 148,
      "key": "6ea6a822ad4ab0e501f269a02a0887f7"
    },
    {
      "line": 5,
      "relation": "increases",
      "evidence": "A dominant-negative form of TRIF inhibited TLR2-, TLR4-, and TLR7-dependent NF-kappaB activation",
      "citation": {
        "db": "PubMed",
        "db_id": "12471095"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 49,
      "target": 27,
      "key": "f2eeb92a2897b21a33a51cfd57d87e39"
    },
    {
      "line": 5,
      "relation": "increases",
      "evidence": "Exposure of neutrophils, monocytes, or macrophages to HMGB1 results in increased nuclear translocation of NF-kappaB and enhanced expression of proinflammatory cytokines.....Culture of neutrophils or macrophages with HMGB1 produced activation of NF-kappaB through TLR 4-independent mechanisms.",
      "citation": {
        "db": "PubMed",
        "db_id": "14660645"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 49,
      "target": 27,
      "key": "63ba19fc64868a795a182a4e206d4629"
    },
    {
      "line": 5,
      "relation": "increases",
      "evidence": "Lipopolysaccharide failed to stimulate NF-kappaB activation in rip1-/-MyD88-/- cells, revealing that Rip1 is also required for the Trif-dependent TLR4-induced NF-kappaB pathway.",
      "citation": {
        "db": "PubMed",
        "db_id": "16115877"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 49,
      "target": 27,
      "key": "1a4d1459f1b63fea4cc99a24597d5024"
    },
    {
      "line": 5,
      "relation": "increases",
      "evidence": "Modified assertion",
      "citation": {
        "db": "PubMed",
        "db_id": "11470918"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 49,
      "target": 27,
      "key": "7f7b22aa7d42483ee05f8343d7c5e85d"
    },
    {
      "line": 5,
      "relation": "increases",
      "evidence": "Toll-like receptors (TLRs) signal through two main pathways: a myeloid differentiation factor (MyD)88-dependent pathway that acts via nuclear factor kappaB (NF-kappaB) to induce proinflammatory cytokines such as tumour necrosis factor-alpha (TNF-alpha); In this study we have shown that, whilst NF-kappaB activation and production of TNF-alpha and interleukin-12 by murine RAW264.7 and J774.2 cells in response to stimulation by TLR4, -5, -7 or -9,",
      "citation": {
        "db": "PubMed",
        "db_id": "17034424"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 49,
      "target": 27,
      "key": "d4469a13fb477c86986867a86853684b"
    },
    {
      "line": 5,
      "relation": "increases",
      "evidence": "Transient transfection of either gene individually was not sufficient to restore LPS signaling, but cotransfection of TLR4 and MD-2 in IEC led to synergistic activation of NF-kappaB and IL-8 reporter genes in response to LPS.",
      "citation": {
        "db": "PubMed",
        "db_id": "11466383"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 49,
      "target": 27,
      "key": "382572d0d306599667db6a34d90eaed7"
    },
    {
      "line": 5,
      "relation": "increases",
      "evidence": "Overexpression of a dominant-negative form of TIRAP was shown to inhibit LPS- induced NFKB activation",
      "citation": {
        "db": "PubMed",
        "db_id": "12893815"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 49,
      "target": 27,
      "key": "98da01dec02454b2cada15103fe41718"
    },
    {
      "line": 5,
      "relation": "increases",
      "evidence": "FFAs activate NF-KappaB reporter in 293 cell and cytokine expression in macrophages via TLR4 signaling.",
      "citation": {
        "db": "PubMed",
        "db_id": "17053832"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 49,
      "target": 27,
      "key": "61a730282e99fb66758810f7968aebcd"
    },
    {
      "line": 5,
      "relation": "increases",
      "evidence": "TLR4, in addition, activates NF-kappaB and MAP kinases via the MyD88-dependent pathway",
      "citation": {
        "db": "PubMed",
        "db_id": "16143103"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 49,
      "target": 27,
      "key": "ed879438691adc989aec1ee1d1e3ead0"
    },
    {
      "line": 5,
      "relation": "increases",
      "evidence": "ZNF216 also inhibited tumor necrosis factor (TNF)-, interleukin-1-, and Toll-like receptor 4-induced NFkappaB activation in a dose-dependent manner.",
      "citation": {
        "db": "PubMed",
        "db_id": "14754897"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 49,
      "target": 27,
      "key": "70b1faab8877f5e088ddaa6de53710d2"
    },
    {
      "line": 5,
      "relation": "increases",
      "evidence": "LPS-induced NF-kappaB signaling is similar in IL-10(-/-) and WT BMDCs as measured by IkappaBalpha phosphorylation and degradation, RelA phosphorylation and nuclear translocation, and NF-kappaB transcriptional activity,",
      "citation": {
        "db": "PubMed",
        "db_id": "15251981"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 49,
      "target": 27,
      "key": "a40eacedadca6340c751ababb030917c"
    },
    {
      "line": 5,
      "relation": "increases",
      "evidence": "Our data indicate that activation of TLR4 inhibits PPARgamma mRNA synthesis by an NF-kappaB-dependent mechanism.",
      "citation": {
        "db": "PubMed",
        "db_id": "18422969"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 49,
      "target": 27,
      "key": "61effe11c5d05d42b74c829c77bf746d"
    },
    {
      "line": 5,
      "relation": "increases",
      "evidence": "we studied the translocation of NF-kB subunit p65 to the nucleus following CS activation. As shown in Figure 5C an increase in p65 level was detected in the CS stimulated sample. In contrast, p65 level in nuclear extracts was not detected upon anti-TLR4 antibody treatment of the cells prior to CS exposure.",
      "citation": {
        "db": "PubMed",
        "db_id": "16620395"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 49,
      "target": 27,
      "key": "b873dc0a4513ea1fe879d1220a8214da"
    },
    {
      "line": 5,
      "relation": "increases",
      "evidence": "LPS stimulation was shown to activate the JNK signaling pathway in addition to NF-kB via the TLR4 signaling pathway. Similar to NF-kB activation, the Kdo2-Lipid A-induced phosphorylation of JNK was completely blocked in ATF3-/- MEF cells, whereas these pathways were potently activated in ATF3+/+ MEF cells at 30 min (Fig. 1B).",
      "citation": {
        "db": "PubMed",
        "db_id": "21152039"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 49,
      "target": 27,
      "key": "6547b0db577a89018cd6da9836afa51e"
    },
    {
      "line": 5,
      "relation": "increases",
      "evidence": "NF-kappaB activation in WT mice was stronger than that in TLR4 mutant mice, and both were stronger than those in the sham operated mice (P < 0.01).",
      "citation": {
        "db": "PubMed",
        "db_id": "17439747"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 49,
      "target": 27,
      "key": "0908dec9cb4c9f52a6b8f7d859a15033"
    },
    {
      "line": 5,
      "relation": "increases",
      "evidence": "pretreatment with either anti-human TLR-4 antibody or with the NF- kB inhibitor curcumin (~85% inhibition) markedly inhibited the secretion of IL-8, demonstrating the involvement of the TLR-4–NF-kB pathway in IL-8 secretion [35].",
      "citation": {
        "db": "PubMed",
        "db_id": "19842832"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 49,
      "target": 27,
      "key": "c7592cd9db8dec66c96c315e033c994a"
    },
    {
      "line": 6,
      "relation": "increases",
      "evidence": "The use of macrophages deficient in various components of the TLR signaling pathway led us to conclude that TLR3/4-dependent inhibition of LXR is mediated by the viral response transcription factor IRF3",
      "citation": {
        "db": "PubMed",
        "db_id": "14580333"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 49,
      "target": 122,
      "key": "2f77d114a0c5414296483f38c485bdeb"
    },
    {
      "line": 6,
      "relation": "increases",
      "evidence": "In addition to activating NF-kappaB, TLR3/4 pathways also stimulate interferon regulatory factor 3 activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "16115877"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 49,
      "target": 122,
      "key": "3018712096b135027281fff1d4371cf1"
    },
    {
      "line": 6,
      "relation": "increases",
      "evidence": "TLR3 and TLR4 activate IRF3 and NF-kappaB through the TRIF-dependent pathway",
      "citation": {
        "db": "PubMed",
        "db_id": "16143103"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 49,
      "target": 122,
      "key": "7914399c291ee35eed8ebb930aa154de"
    },
    {
      "line": 6,
      "relation": "increases",
      "evidence": "F ig. 2. Effect of Toll-like receptor signalling on macrophage cholesterol metabolism. Stimulation of TLR3 or TLR4 leads to TRIFdependent activation of IRF3, which inhibits transcription of liver X receptor-dependent genes, many of which (e.g. ATP-binding cassette transporter A1, PLTP, apoE and ABCG-1) are critically involved in the efflux of cholesterol from macrophages.",
      "citation": {
        "db": "PubMed",
        "db_id": "20375591"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 49,
      "target": 122,
      "key": "2159613d817eaf2d32dda1fd4c378e67"
    },
    {
      "relation": "partOf",
      "source": 71,
      "target": 29,
      "key": "803d52b22f98689dc35a66d2cdd27141"
    },
    {
      "line": 96,
      "relation": "decreases",
      "evidence": "As predicted, the expression of TRAF6 and IRAK1, two known miR-146a targets, were decreased in macrophages transfected with miR-146a compared with that of control cells, and inhibition of miR-146a enhanced the expression of TRAF6 and IRAK1 (Fig 4A). (p. 2154)",
      "citation": {
        "db": "PubMed",
        "db_id": "19596990"
      },
      "annotations": {},
      "source": 30,
      "target": 119,
      "key": "5a9aa346ae27560d36e6f94f8f5961ce"
    },
    {
      "line": 97,
      "relation": "decreases",
      "evidence": "Furthermore, transfection of miR-146a mimics decreased IRA2K expression in macrophages at both the protein and mRNA levels, whereas miR-146a inhibitors increased IRAK2 expression (Fig. 4, E and F), suggesting that IARK2 expression could be inhibited by miR-146a via both translational inhibition and mRNA degradation. Together, the results show that expression of endogenous mouse IRAK2 is targeted and regulated by MiR-146a, and mouse IRAK2 is a new target of miR-146a. (p. 2155)",
      "citation": {
        "db": "PubMed",
        "db_id": "19596990"
      },
      "annotations": {},
      "source": 30,
      "target": 120,
      "key": "ee3d6dcc2f1c33d6513f3a9ed1fbb935"
    },
    {
      "line": 98,
      "relation": "decreases",
      "evidence": "As predicted, the expression of TRAF6 and IRAK1, two known miR-146a targets, were decreased in macrophages transfected with miR-146a, as compared with that of control cells, and inhibition of miR-146a enhanced the expression of TRAF6 and IRAK1 (Fig 4A). (p. 2154)",
      "citation": {
        "db": "PubMed",
        "db_id": "19596990"
      },
      "annotations": {},
      "source": 30,
      "target": 55,
      "key": "28cb583c8efec2989c38ba75da9b9b84"
    },
    {
      "line": 68,
      "relation": "increases",
      "evidence": "AT(1) receptor enhances the activation of nuclear factor NF-kappaB, which stimulates the production of proinflammatory cytokines",
      "citation": {
        "db": "PubMed",
        "db_id": "18221099"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 88,
      "target": 27,
      "key": "5a656e014a8d9da940adddf5bb490e76"
    },
    {
      "line": 68,
      "relation": "increases",
      "evidence": "The binding between angiotensin II and AT1 receptor induced proinflammatory effect mainly through the down-stream activation of intracellular signaling cascade, which involves nuclear factorkappaB (NF-?B) activation [41–43].",
      "citation": {
        "db": "PubMed",
        "db_id": "19390623"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 88,
      "target": 27,
      "key": "1c1e29710f3c585a6e34bc8e1062876d"
    },
    {
      "line": 68,
      "relation": "increases",
      "evidence": "Treatment with AECI and AT-1 receptor blocker attenuate hepatic fibrosis and NF-?B activity in liver",
      "citation": {
        "db": "PubMed",
        "db_id": "16971004"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 88,
      "target": 27,
      "key": "a83cece171d2426c51b1f3e017973c48"
    },
    {
      "line": 68,
      "relation": "increases",
      "evidence": "Incubation of adipocytes with Ang II resulted in an increased phosphorylation of the p65 subunit of NF-kappaB and an increased translocation of NF-kappaB to the nucleus. CONCLUSIONS: Ang II stimulates IL-6 and IL-8 production and release from human adipocytes by a NF-kappaB-dependent pathway. This proinflammatory action of Ang II seems to be mediated by the AT1 and less by the AT2 receptor subtype.",
      "citation": {
        "db": "PubMed",
        "db_id": "15130920"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 88,
      "target": 27,
      "key": "83734f9a137eda8e4053fb8a67679cc1"
    },
    {
      "line": 259,
      "relation": "increases",
      "evidence": "Lipoxin A(4) (LXA(4)) and docosahexaenoic acid-derived neuroprotectin D1 (NPD1) are lipid autacoids formed by 12/15-lipoxygenase (LOX) pathways",
      "citation": {
        "db": "PubMed",
        "db_id": "15708862"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 92,
      "target": 15,
      "key": "4d5ef916d19be55eb03301976192d13d"
    },
    {
      "line": 253,
      "relation": "increases",
      "evidence": "Lipoxin A(4) (LXA(4)) and docosahexaenoic acid-derived neuroprotectin D1 (NPD1) are lipid autacoids formed by 12/15-lipoxygenase (LOX) pathways",
      "citation": {
        "db": "PubMed",
        "db_id": "15708862"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 93,
      "target": 15,
      "key": "6a013d00b9fed548bb7ae21ebbbdef44"
    },
    {
      "line": 99,
      "relation": "increases",
      "evidence": "The balance of arachidonic acid-derived mediators in leukocytes is thought to be achieved through intracellular localization of 5-lipoxygenase (5-LOX): nuclear 5-LOX favors the biosynthesis of proinflammatory leukotriene B4 (LTB4)",
      "citation": {
        "db": "PubMed",
        "db_id": "25246560"
      },
      "annotations": {
        "cl": {
          "0000235": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 94,
      "target": 5,
      "key": "9b807f54e492ab86f66d051751eaf2f3"
    },
    {
      "line": 306,
      "relation": "increases",
      "evidence": "Like LXA4, Annexin A1\nhas also been shown to enhance efferocytosis of apoptotic\nneutrophils by macrophages [reviewed in (52)], thereby\nfacilitating catabasis of the inflamed tissue to homeostasis.",
      "citation": {
        "db": "PubMed",
        "db_id": "25478196"
      },
      "annotations": {},
      "source": 101,
      "target": 23,
      "key": "ddb57d6064853213287f050b16d81259"
    },
    {
      "line": 113,
      "relation": "increases",
      "evidence": "from full text - In another study, ATG16L1 deficiency in mice macrophages produced high amounts of inflammatory cytokines IL-1beta and IL-18 when these macrophages were exposed to bacterial lipopolysaccharide [29]. The increased production of IL-1beta and IL-18 is due to Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-dependent activation of caspase-1; where caspase 1 is thought to cleave pro?IL-1beta to yield active cytokine [29].",
      "citation": {
        "db": "PubMed",
        "db_id": "19903423"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 63,
      "target": 114,
      "key": "4cac19783dc763d45778cd4206f556e9"
    },
    {
      "line": 113,
      "relation": "increases",
      "evidence": "from full text - Increased levels of IL-1 in IBD may be result of stimulation of colonic macrophages that can activate interleukin (IL)-1 converting enzyme (ICE) and hence release mature IL-1beta into the colonic mucosa[20].",
      "citation": {
        "db": "PubMed",
        "db_id": "18666314"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 63,
      "target": 114,
      "key": "71309b419cf05ee397a4ba11072daa16"
    },
    {
      "line": 113,
      "relation": "increases",
      "evidence": "The production of mature IL-1beta in OA cartilage explants and chondrocytes was completely blocked by treatment with a specific ICE inhibitor, which also markedly diminished the number of IL-18-positive cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "10446854"
      },
      "annotations": {
        "cl": {
          "0000138": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 63,
      "target": 114,
      "key": "414d45de6baed5926f97d802a861a57b"
    },
    {
      "line": 113,
      "relation": "increases",
      "evidence": "We report here that the serine proteinase inhibitor (serpin) PI-9 accounts for the endogenous caspase-1 inhibitory activity in human SMCs and prevents processing of the enzyme's natural substrates, IL-1beta and IL-18 precursor.",
      "citation": {
        "db": "PubMed",
        "db_id": "10790428"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 63,
      "target": 114,
      "key": "d4eb3e131264184bee2a1eaa5f425b20"
    },
    {
      "line": 113,
      "relation": "increases",
      "evidence": "Activation of the inflammasome is responsible for the generation of active caspase-1, which cleaves a number of pro-inflammatory cytokines into their bio-active form, including IL-1B , IL-18, and IL-33.",
      "citation": {
        "db": "PubMed",
        "db_id": "19262504"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 63,
      "target": 114,
      "key": "f0c00e1cd46023091dc1ba20353b6da5"
    },
    {
      "line": 113,
      "relation": "increases",
      "evidence": "Modified assertion",
      "citation": {
        "db": "PubMed",
        "db_id": "11606779"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 63,
      "target": 114,
      "key": "e15cf110f58196ac5569b8c2e352256f"
    },
    {
      "line": 113,
      "relation": "increases",
      "evidence": "Interestingly, BLP also activates caspase 1 through TLR2, resulting in proteolysis and secretion of mature IL-1beta.",
      "citation": {
        "db": "PubMed",
        "db_id": "10880445"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 63,
      "target": 114,
      "key": "3f92ae882e56f2a8e9d20542815ce9c1"
    },
    {
      "line": 113,
      "relation": "increases",
      "evidence": "Upon activation, NLRP3 forms a so-called inflammasome complex with the adaptor molecule ASC, which controls the activation of caspase-1. Activated caspase-1, in turn, cleaves pro-IL-1b and pro-IL-18 into the biologically active, secreted forms (9).",
      "citation": {
        "db": "PubMed",
        "db_id": "19570822"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 63,
      "target": 114,
      "key": "6f69871e0f542825444d293a8ba4c14a"
    },
    {
      "line": 114,
      "relation": "increases",
      "evidence": "Upon activation, NLRP3 forms a so-called inflammasome complex with the adaptor molecule ASC, which controls the activation of caspase-1. Activated caspase-1, in turn, cleaves pro-IL-1b and pro-IL-18 into the biologically active, secreted forms (9).",
      "citation": {
        "db": "PubMed",
        "db_id": "19570822"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 63,
      "target": 118,
      "key": "cd9f88898cf7976f8d9c67603a552f01"
    },
    {
      "line": 206,
      "relation": "directlyIncreases",
      "evidence": "CCL2 binds and activates CCR2...CCR2 deficiency abolished the protective effect of CCL2 to lung injury and leukocyte recruitment",
      "citation": {
        "db": "PubMed",
        "db_id": "22287613"
      },
      "annotations": {
        "cl": {
          "0000235": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 34,
      "target": 65,
      "key": "4a1a2504425edc083a5ddc401a386cf5"
    },
    {
      "line": 207,
      "relation": "increases",
      "evidence": "Apo2L/TRAIL induced secretion of interleukin-8 and monocyte chemoattractant protein-1, augmenting macrophage migration.",
      "citation": {
        "db": "PubMed",
        "db_id": "16227629"
      },
      "annotations": {},
      "source": 34,
      "target": 24,
      "key": "a472cad57b02b780d03d19a2ba782b39"
    },
    {
      "line": 207,
      "relation": "increases",
      "evidence": "Chung (48, 49) summarized in detail the cytokines overexpressed in COPD (48, 49). IL-6, IL-1beta, TNF-{alpha}, growth-related gene-{alpha} (Gro-{alpha})/keratinocyte-derived chemokine (KC) (CXCL1), monocyte chemoattractant protein-1 (MCP-1), and IL-8 were increased in sputum, with further increases during exacerbations of COPD, and the bronchiolar epithelium overexpressed MCP-1, its receptor CCR2, MIP1{alpha}, and IL-8. MCP-1 and CCR2 were involved in the recruitment of macrophages and mast cells into the airway epithelium in COPD (62).",
      "citation": {
        "db": "PubMed",
        "db_id": "17615396"
      },
      "annotations": {},
      "source": 34,
      "target": 24,
      "key": "94a191bf5cd661864b29e8c4cda62802"
    },
    {
      "line": 207,
      "relation": "increases",
      "evidence": "Peritoneal macrophages pre-attached to Transwell membranes were exposed to media, fMLP, GM-CSF, or MCP-1. After 21 h incubation, the concentration of migrated CD44-deficient macrophages was significantly less than that of migrated C57BL/6 macrophages under all conditions",
      "citation": {
        "db": "PubMed",
        "db_id": "17446529"
      },
      "annotations": {
        "cl": {
          "0000581": true
        }
      },
      "source": 34,
      "target": 24,
      "key": "00eb5445a6dc2d042a3a159f3f56b8b4"
    },
    {
      "line": 207,
      "relation": "increases",
      "evidence": "Airway administration of CCL2 also resulted in a significant reduction of macrophage recruitment to the lungs of DAP12-deficient mice compared with that in controls.",
      "citation": {
        "db": "PubMed",
        "db_id": "20421649"
      },
      "annotations": {
        "cl": {
          "0000235": true
        }
      },
      "source": 34,
      "target": 24,
      "key": "bb1ed84a56f8b03f6cf7a1ee16c649d2"
    },
    {
      "line": 207,
      "relation": "increases",
      "evidence": "Upon weight gain and as the adipocytes increase in size, expression of cytokines are induced and secreted.  This stimulates the cells in the adipose tissue to secrete chemoattractants like monocyte chemoattractant protein-1, which recruit monocytes and macrophages.  The recruited macrophages lead to insulin resistance.",
      "citation": {
        "db": "PubMed",
        "db_id": "15936183"
      },
      "annotations": {},
      "source": 34,
      "target": 24,
      "key": "6f468697d664da14b64d7229f9ece994"
    },
    {
      "line": 172,
      "relation": "increases",
      "evidence": "Neutralizing antibodies to RANTES and to MCP-1 and immunoprecipitation of GM-CSF decreased the chemotactic activity of alveolar epithelial cells conditioned medium (AEC-CM) by 58%, 29%, and 47%... Peritoneal macrophages also migrated in response to AEC-CM and each of the recombinant cytokines; however, alveolar macrophage were much more sensitive",
      "citation": {
        "db": "PubMed",
        "db_id": "9605106"
      },
      "annotations": {
        "cl": {
          "0000235": true
        }
      },
      "source": 35,
      "target": 24,
      "key": "dbda0855792f4f7a0c4ec79ce739e181"
    },
    {
      "line": 265,
      "relation": "decreases",
      "evidence": "overexpressions of cyclin D1 or bcl-2 inhibited only differentiation or apoptosis, respectively",
      "citation": {
        "db": "PubMed",
        "db_id": "10666199"
      },
      "annotations": {},
      "source": 64,
      "target": 20,
      "key": "1b13e988b9e6868560bddf4fa20eca21"
    },
    {
      "line": 266,
      "relation": "directlyIncreases",
      "evidence": "expression of CDK4/cyclin D1, which stimulated RB phosphorylation",
      "citation": {
        "db": "PubMed",
        "db_id": "10939590"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 64,
      "target": 72,
      "key": "af72e62f138cf3941e7d2bdfe9052c69"
    },
    {
      "line": 266,
      "relation": "directlyIncreases",
      "evidence": "Breaking down CDKx:CCNDx to just CDK so modulation of CDKs is consolidated to the CDKx node. CDK4&CCND1 CDK4_CCND1=CDK4:CCND1 \\\"PD 0183812\\\"-|kaof(CDK4_CCND1) CDK6&CCND2 CDK6_CCND2=CDK6:CCND2 \\\"PD 0183812\\\"-|kaof(CDK6_CCND2) CDK6&CCND3 CDK6_CCND3=CDK6:CCND3 \\\"PD 0183812\\\"-|kaof(CDK6_CCND3)",
      "citation": {
        "db": "PubMed",
        "db_id": "11278443"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 64,
      "target": 72,
      "key": "c6721afbb5967c306f5f11e129d857e3"
    },
    {
      "line": 266,
      "relation": "directlyIncreases",
      "evidence": "By inhibiting selectively either cdk4/6 or cdk2, we show that endogenous D-type cyclins, acting with cdk4/6, are able to phosphorylate pRb only partially, a process that is likely to be completed by cyclin E-cdk2 complexes. Furthermore, cyclin E-cdk2 is unable to phosphorylate pRb in the absence of prior phosphorylation by cyclin D-cdk4/6 complexes.",
      "citation": {
        "db": "PubMed",
        "db_id": "9447971"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 64,
      "target": 72,
      "key": "d9a186431b648b6e51a492ee364146d1"
    },
    {
      "line": 100,
      "relation": "increases",
      "evidence": "Either deletion of CCR2 or treatment of wild-type mice with CCL2 neutralizing Ab produced significant and comparable reductions in macrophage and T cell recruitment into the lungs",
      "citation": {
        "db": "PubMed",
        "db_id": "11971015"
      },
      "annotations": {
        "cl": {
          "0000235": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 65,
      "target": 16,
      "key": "ece7e2f097b6e960cc2fe76e6b77b7ee"
    },
    {
      "line": 290,
      "relation": "increases",
      "evidence": "Here we show that the glycosylphosphatidylinositol-linked plasma-membrane glycoprotein CD14 on the surface of human macrophages is important for the recognition and clearance of apoptotic cells. CD14 can also act as a receptor that binds bacterial lipopolysaccharide (LPS), triggering inflammatory responses. Overstimulation of CD14 by LPS can cause the often fatal toxic-shock syndrome. Here we show that apoptotic cells interact with CD14, triggering phagocytosis of the apoptotic cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "9548256"
      },
      "annotations": {},
      "source": 66,
      "target": 17,
      "key": "3200099e6d4ca1ae70aa8d6c20cf0a6e"
    },
    {
      "line": 178,
      "relation": "increases",
      "evidence": "Blockade of either CD36 or TSP1 on apoptotic fibroblasts inhibited phagocytosis. Blockade of alpha v beta 3 integrins as well as CD36 and TSP1 on macrophages inhibited phagocytosis. In contrast, phosphatidylserine or lectins were not involved.",
      "citation": {
        "db": "PubMed",
        "db_id": "12598312"
      },
      "annotations": {},
      "source": 67,
      "target": 17,
      "key": "71a660daa91be6b9fd1fc41d4b9c7c89"
    },
    {
      "line": 291,
      "relation": "decreases",
      "evidence": "Suppression of the NLRP3 inflammasome requires cell-to-cell contact and can be mimicked by macrophage stimulation with selected ligands of the tumour necrosis factor family, such as CD40L (also known as CD40LG)",
      "citation": {
        "db": "PubMed",
        "db_id": "19494813"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 52,
      "target": 63,
      "key": "519d144bdb6a3f753260e147f9ece36e"
    },
    {
      "line": 119,
      "relation": "increases",
      "evidence": "A key observation of our study is that patients with COPD show a reduced surface expression of CD44 in lung macrophages (Figure 2). CD44 plays a pivotal role in efferocytosis and, hence, in the regulation of catabasis [8,31]",
      "citation": {
        "db": "PubMed",
        "db_id": "23148928"
      },
      "annotations": {},
      "source": 68,
      "target": 23,
      "key": "563c1866465404e675944b9b1e748368"
    },
    {
      "line": 120,
      "relation": "increases",
      "evidence": "A key observation of our study is that patients with COPD show a reduced surface expression of CD44 in lung macrophages (Figure 2). CD44 plays a pivotal role in efferocytosis and, hence, in the regulation of catabasis [8,31]",
      "citation": {
        "db": "PubMed",
        "db_id": "23148928"
      },
      "annotations": {},
      "source": 68,
      "target": 17,
      "key": "b3dd47f9e4c8bc3f08181f50019b00de"
    },
    {
      "line": 120,
      "relation": "increases",
      "evidence": "CD44 mediates efficient phagocytosis in primary murine peritoneal macrophages and in the murine macrophage cell line RAW 264.7.",
      "citation": {
        "db": "PubMed",
        "db_id": "16455948"
      },
      "annotations": {},
      "source": 68,
      "target": 17,
      "key": "3c20bf37341ce1ffa10f8e9826a7b15c"
    },
    {
      "line": 121,
      "relation": "increases",
      "evidence": "IL-1beta release was inhibited in peritoneal macrophages derived from CD44-deficient mice, in an MH-S macrophage cell line treated with antibodies to CD44, or by inhibitors of lysosome function.",
      "citation": {
        "db": "PubMed",
        "db_id": "19258328"
      },
      "annotations": {
        "cl": {
          "0000581": true
        }
      },
      "source": 68,
      "target": 114,
      "key": "9188fb77cffa5cbc153e70e7b9233937"
    },
    {
      "line": 20,
      "relation": "increases",
      "evidence": "After the exposure with CS, the expression of CD69 in the lung of WT mice was significantly induced, it was predominantly observed in macrophages... CS-induced accumulation of inflammatory cells and cytokines expression were significantly lower in CD69-KO mice than in WT mice.",
      "citation": {
        "db": "PubMed",
        "db_id": "22070386"
      },
      "annotations": {
        "cl": {
          "0000235": true
        }
      },
      "source": 69,
      "target": 22,
      "key": "cf6955b7a59b11fb39632075945474cd"
    },
    {
      "line": 128,
      "relation": "directlyDecreases",
      "evidence": "The kinase activity of P-TEFb derepresses transcription imposed by inhibitory factors including the negative elongation factors, DRB sensitivity-inducing factor (DSIF) and the negative elongation factor (NELF). Two broad types of CDK inhibitory proteins are known - the INK4s and the CIP/KIP family. Members of the former group include p16INK4a, p15INK4b, p18INK4c, and p19INK4d, which inhibit CDK4 and CDK6 and contain conserved ankyrin repeats. Members of the latter group include p21CIP1/WAF1, p27KIP1, and p57KIP2, which share structural homology and inhibit CDKs in a concentrationdependent manner.",
      "citation": {
        "db": "PubMed",
        "db_id": "15320717"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 74,
      "target": 72,
      "key": "c26cbc02e0e0483c4a2f140ae39025c3"
    },
    {
      "line": 261,
      "relation": "decreases",
      "evidence": "Modified assertion",
      "citation": {
        "db": "PubMed",
        "db_id": "9520401"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 77,
      "target": 147,
      "key": "56a6736e2b91eb380388f419a16cad80"
    },
    {
      "line": 262,
      "relation": "directlyDecreases",
      "evidence": "This finding agrees with previous studies that showed that IkBa is a better substrate for the IKKs than IkBb (17). The kinetics of IkBa and IkBb phosphorylation were coincident with the degradation of endogenous IkBa as well as the appearance of DNA-binding NF-kB complexes in the nucleus at approximately 15–30 min (Fig. 1B, bottom three panels).",
      "citation": {
        "db": "PubMed",
        "db_id": "10553070"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 77,
      "target": 144,
      "key": "080ba5f9159d0cfeb5f0d48e28ea4bb4"
    },
    {
      "line": 212,
      "relation": "increases",
      "evidence": "We show that EGF stimulation activates the catalytic activity of Brk, which in turn phosphorylates paxillin at Y31 and Y118. These phosphorylation events promote the activation of small GTPase Rac1 via the function of CrkII",
      "citation": {
        "db": "PubMed",
        "db_id": "15572663"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "source": 80,
      "target": 162,
      "key": "005b94b2ec9d257446c67a19d87239ba"
    },
    {
      "line": 155,
      "relation": "increases",
      "evidence": "Granulocyte-macrophage colony-stimulating factor (GM-CSF) has long been found to have growth-promoting effects on multipotent haematopoietic lineages, specifically granulocytes and macrophages.",
      "citation": {
        "db": "PubMed",
        "db_id": "17433076"
      },
      "annotations": {},
      "source": 81,
      "target": 20,
      "key": "07791eecfefa6185b982cf6c52052698"
    },
    {
      "line": 155,
      "relation": "increases",
      "evidence": "PLZF overexpression inhibited myeloid differentiation of 32Dcl3 cells in response to granulocyte and granulocyte-macrophage colony-stimulating factors.",
      "citation": {
        "db": "PubMed",
        "db_id": "9710637"
      },
      "annotations": {},
      "source": 81,
      "target": 20,
      "key": "f795d193d37067e9fbc35faa7fa51f32"
    },
    {
      "line": 155,
      "relation": "increases",
      "evidence": "Monocytes stimulated with GM-CSF alone survived and developed into macrophages",
      "citation": {
        "db": "PubMed",
        "db_id": "11564774"
      },
      "annotations": {},
      "source": 81,
      "target": 20,
      "key": "fbf7cec3e958d2c204ce3c8371e4661c"
    },
    {
      "line": 156,
      "relation": "increases",
      "evidence": "GM-CSF treatment of human neutrophils activates the Janus kinase/signal transducers and activators of transcription (Jak/STAT) pathway and, more specifically, Jak2, STAT3, and STAT5B in neutrophils.",
      "citation": {
        "db": "PubMed",
        "db_id": "10026141"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 81,
      "target": 124,
      "key": "8dd960f441bd8033e171348e63b83fa5"
    },
    {
      "line": 156,
      "relation": "increases",
      "evidence": "Dominant negative JAK2 (delta JAK2) lacking the C-terminus kinase domain, suppressed IL-3/GM-CSF induced c-fos activation",
      "citation": {
        "db": "PubMed",
        "db_id": "9209304"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 81,
      "target": 124,
      "key": "22595bf6ff48997eef2b03c93f7aeb08"
    },
    {
      "line": 156,
      "relation": "increases",
      "evidence": "GM-CSF signals through JAK2 and STAT5 and stimulates the expression of STAT5 target genes, such as pim-1 and CIS.",
      "citation": {
        "db": "PubMed",
        "db_id": "11867689"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 81,
      "target": 124,
      "key": "b5d7c0671e63a7c8cceb2cb7bcae6f3b"
    },
    {
      "line": 157,
      "relation": "increases",
      "evidence": "ethanol ingestion decreased cellular expression and nuclear binding of PU.1, the master transcription factor that activates GM-CSF-dependent macrophage functions",
      "citation": {
        "db": "PubMed",
        "db_id": "16272341"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 81,
      "target": 39,
      "key": "41ee91c02df23e14ba418f59295887f4"
    },
    {
      "line": 158,
      "relation": "increases",
      "evidence": "PU.1, and cytokine production were blunted in GM-CSF(-/-) macrophages.",
      "citation": {
        "db": "PubMed",
        "db_id": "22696442"
      },
      "annotations": {
        "cl": {
          "0000235": true
        }
      },
      "source": 81,
      "target": 39,
      "key": "6101b08b4a8524dd38afed3d44a34185"
    },
    {
      "line": 223,
      "relation": "increases",
      "evidence": "PLZF overexpression inhibited myeloid differentiation of 32Dcl3 cells in response to granulocyte and granulocyte-macrophage colony-stimulating factors.",
      "citation": {
        "db": "PubMed",
        "db_id": "9710637"
      },
      "annotations": {},
      "source": 82,
      "target": 20,
      "key": "6b2881248d26e186d9442c4ed2899109"
    },
    {
      "line": 295,
      "relation": "increases",
      "evidence": "Ctcf-deficient macrophages demonstrated a normal surface phenotype and phagocytosis capacity. Upon Toll-like receptor (TLR) stimulation, they produced normal levels of the pro-inflammatory cytokines IL-12 and IL-6, but manifested a strongly impaired capacity to produce tumor-necrosis factor (TNF) and IL-10, as well as to express the IL-10 family members IL-19, IL-20 and IL-24.",
      "citation": {
        "db": "PubMed",
        "db_id": "24013844"
      },
      "annotations": {
        "cl": {
          "0000235": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 60,
      "target": 111,
      "key": "2bcba4468aa5501df73e94a7e584ff27"
    },
    {
      "line": 296,
      "relation": "increases",
      "evidence": "Ctcf-deficient macrophages demonstrated a normal surface phenotype and phagocytosis capacity. Upon Toll-like receptor (TLR) stimulation, they produced normal levels of the pro-inflammatory cytokines IL-12 and IL-6, but manifested a strongly impaired capacity to produce tumor-necrosis factor (TNF) and IL-10, as well as to express the IL-10 family members IL-19, IL-20 and IL-24.",
      "citation": {
        "db": "PubMed",
        "db_id": "24013844"
      },
      "annotations": {
        "cl": {
          "0000235": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 60,
      "target": 50,
      "key": "fa5c666f1190ccd9d3836eea3facdd47"
    },
    {
      "line": 58,
      "relation": "increases",
      "evidence": "Cathepsin K deficient mice (CatK-/-) reduced macrophage infiltration in response to injury.",
      "citation": {
        "db": "PubMed",
        "db_id": "24343118"
      },
      "annotations": {
        "cl": {
          "0000235": true
        }
      },
      "source": 83,
      "target": 24,
      "key": "e36d7056de4453227a873355d1e5c891"
    },
    {
      "line": 12,
      "relation": "increases",
      "evidence": "Tissue macrophages synthesize neutrophil chemoattractants CXCL1/CXCL2 (CXC chemokine ligands 1/2) in response to LPS. Both in vivo studies with blocking monoclonal antibodies and in vitro chemotaxis experiments show the neutrophil response to mast cells and macrophages to be CXCL1/CXCL2-dependent.",
      "citation": {
        "db": "PubMed",
        "db_id": "23645836"
      },
      "annotations": {
        "cl": {
          "0000235": true
        }
      },
      "source": 97,
      "target": 21,
      "key": "84af465e96dd90c87ceb8a0ed1cb000c"
    },
    {
      "line": 130,
      "relation": "increases",
      "evidence": "CXCL10/IP-10 (IFNgamma-inducible protein 10) and CXCL9/Mig (monokine induced by IFN-gamma) are up-regulated in CS-induced lung injury and may attract T-cell recruitment to the lung. These chemokines together with CXCL11/ITAC (IFN-inducible T-cell alpha chemoattractant) are ligands for the chemokine receptor CXCR3 which is preferentially expressed chiefly in activated CD8+ T cells... CXCR3 KO mice showed less CS-induced lung inflammation as evidenced by less infiltration of inflammatory cells in airways and lung tissue, particularly fewer CD8+ T cells, lower levels of IFNgamma and CXCR3 ligands (particularly CXCL10).",
      "citation": {
        "db": "PubMed",
        "db_id": "19087279"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 36,
      "target": 96,
      "key": "bfd0cd80f43272e5cd704ae900e6a216"
    },
    {
      "line": 28,
      "relation": "increases",
      "evidence": "Tissue macrophages synthesize neutrophil chemoattractants CXCL1/CXCL2 (CXC chemokine ligands 1/2) in response to LPS. Both in vivo studies with blocking monoclonal antibodies and in vitro chemotaxis experiments show the neutrophil response to mast cells and macrophages to be CXCL1/CXCL2-dependent.",
      "citation": {
        "db": "PubMed",
        "db_id": "23645836"
      },
      "annotations": {
        "cl": {
          "0000235": true
        }
      },
      "source": 98,
      "target": 21,
      "key": "2e41c458bcba792175c3add0de15dc06"
    },
    {
      "line": 70,
      "relation": "increases",
      "evidence": "Apo2L/TRAIL induced secretion of interleukin-8 and monocyte chemoattractant protein-1, augmenting macrophage migration.",
      "citation": {
        "db": "PubMed",
        "db_id": "16227629"
      },
      "annotations": {},
      "source": 118,
      "target": 24,
      "key": "ecffa87bcdbca5408d8cba94c355c0b4"
    },
    {
      "line": 71,
      "relation": "increases",
      "evidence": "IL-8-induced NF-kB was shown in a dose-dependent manner in THP-1 cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "15591054"
      },
      "annotations": {},
      "source": 118,
      "target": 27,
      "key": "2d3d6398ca396ccbef31af5cfb2ba325"
    },
    {
      "line": 71,
      "relation": "increases",
      "evidence": "Interleukin-8 induces nuclear transcription factor-kappaB through a TRAF6-dependent pathway.",
      "citation": {
        "db": "PubMed",
        "db_id": "15591054"
      },
      "annotations": {},
      "source": 118,
      "target": 27,
      "key": "4a74a4f0d46932d413411fd584474e1f"
    },
    {
      "line": 52,
      "relation": "increases",
      "evidence": "CXCL10/IP-10 (IFNgamma-inducible protein 10) and CXCL9/Mig (monokine induced by IFN-gamma) are up-regulated in CS-induced lung injury and may attract T-cell recruitment to the lung. These chemokines together with CXCL11/ITAC (IFN-inducible T-cell alpha chemoattractant) are ligands for the chemokine receptor CXCR3 which is preferentially expressed chiefly in activated CD8+ T cells... CXCR3 KO mice showed less CS-induced lung inflammation as evidenced by less infiltration of inflammatory cells in airways and lung tissue, particularly fewer CD8+ T cells, lower levels of IFNgamma and CXCR3 ligands (particularly CXCL10).",
      "citation": {
        "db": "PubMed",
        "db_id": "19087279"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 134,
      "target": 96,
      "key": "d9a77746e550dc2e5762fd6155ce069e"
    },
    {
      "line": 153,
      "relation": "increases",
      "evidence": "CXCL10/IP-10 (IFNgamma-inducible protein 10) and CXCL9/Mig (monokine induced by IFN-gamma) are up-regulated in CS-induced lung injury and may attract T-cell recruitment to the lung. These chemokines together with CXCL11/ITAC (IFN-inducible T-cell alpha chemoattractant) are ligands for the chemokine receptor CXCR3 which is preferentially expressed chiefly in activated CD8+ T cells... CXCR3 KO mice showed less CS-induced lung inflammation as evidenced by less infiltration of inflammatory cells in airways and lung tissue, particularly fewer CD8+ T cells, lower levels of IFNgamma and CXCR3 ligands (particularly CXCL10).",
      "citation": {
        "db": "PubMed",
        "db_id": "19087279"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 96,
      "target": 19,
      "key": "ea0e035ebabde8159f787f9845700b9b"
    },
    {
      "line": 305,
      "relation": "directlyIncreases",
      "evidence": "Among ROS-producer enzymes, the NADPH oxidase family, a complex including a catalytic subunit called NOX associated with regulatory subunits 7,8, is thought to be responsible for lung damage found in several lung pathologies. NOX2, which is highly expressed in inflammatory cells, plays an essential role in non-specific host defence against pathogens and is defective in the genetic disorder chronic granulomatous disease",
      "citation": {
        "db": "PubMed",
        "db_id": "25116588"
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 84,
      "target": 11,
      "key": "0a50085872f84a3b7b4e32b7257e5b03"
    },
    {
      "line": 91,
      "relation": "directlyIncreases",
      "evidence": "DOCK180, via its DHR-1 and DHR-2 domains, couples PtdIns(3,4,5)P(3) signalling to Rac GTP-loading, which is essential for directional cell movement.",
      "citation": {
        "db": "PubMed",
        "db_id": "16025104"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "source": 87,
      "target": 162,
      "key": "8521c36b07d5494c2dacae7a462272fb"
    },
    {
      "line": 91,
      "relation": "directlyIncreases",
      "evidence": "FA-CRKL induced cotranslocation of a Rac1 activator, Dock1, to focal adhesions. These results therefore indicate a role for CrkL in mediating Src signaling by activating small G proteins at focal adhesions. Furthermore, MEFs lacking CrkL show impaired integrin-induced migration despite expression of a closely related protein, Crk-II, in these cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "12665586"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "source": 87,
      "target": 162,
      "key": "57ef8e61d20b1038e08910782891200b"
    },
    {
      "line": 38,
      "relation": "increases",
      "evidence": "in monocytes lipoxin A4 and ALX interactions stimulate chemotaxis and nonphlogistic responses",
      "citation": {
        "db": "PubMed",
        "db_id": "18437155"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 89,
      "target": 16,
      "key": "16133d75469b4126b3aa266e80de24ad"
    },
    {
      "line": 84,
      "relation": "directlyIncreases",
      "evidence": "Here we identify Gas6, the product of a growth arrest specific gene, as a ligand for Mer. Gas6 has previously been shown to activate both Axl and Rse/Tyro3, two other receptor tyrosine kinases in the same family as Mer. The apparent relative association and dissociation rate constants of Gas6 for soluble Axl, Rse/Tyro3 and Mer were compared using surface plasmon resonance. Gas6 was shown to induce rapid phosphorylation of Mer expressed in several different types of cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "9160883"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 90,
      "target": 133,
      "key": "47e66e7d3072890b2486719918726306"
    },
    {
      "line": 84,
      "relation": "directlyIncreases",
      "evidence": "The current study evaluated the contribution of each of the three known Gas6 receptors (Axl, Sky and Mer) in human and mouse platelet function.",
      "citation": {
        "db": "PubMed",
        "db_id": "15733062"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 90,
      "target": 133,
      "key": "aac33f2910a2f985d27fcb34ea183eb9"
    },
    {
      "line": 84,
      "relation": "directlyIncreases",
      "evidence": "C-mer is a receptor tyrosine kinase activated by the ligand Gas6 (C-mer = MERTK)",
      "citation": {
        "db": "PubMed",
        "db_id": "15479819"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 90,
      "target": 133,
      "key": "49b046aff4b65792ce4d4df11c0eadb1"
    },
    {
      "line": 292,
      "relation": "increases",
      "evidence": "During IL-6-induced macrophage differentiation of M1 cells, IL-6 down-regulated cyclin D1 expression and induced p19(INK4D) expression, leading to reduction in cdk4 activities. In contrast, sustained expression of cyclin D1 and a significantly lesser amount of p19(INK4D) induction were observed in IL-6-treated M1 cells overexpressing GATA-1.",
      "citation": {
        "db": "PubMed",
        "db_id": "10666199"
      },
      "annotations": {},
      "source": 91,
      "target": 64,
      "key": "cb5271e9b2d98191b40da792787f0a0f"
    },
    {
      "line": 292,
      "relation": "increases",
      "evidence": "GATA-1-expressing fibroblasts expressed D1, A, and B1 cyclin mRNAs under conditions of serum starvation or at confluence, whereas these cyclin mRNAs were downregulated in the parental NIH3T3 cells cultured under the same conditions.",
      "citation": {
        "db": "PubMed",
        "db_id": "8611696"
      },
      "annotations": {},
      "source": 91,
      "target": 64,
      "key": "f3837845e5dee7e35305c6662be36087"
    },
    {
      "line": 181,
      "relation": "directlyDecreases",
      "evidence": "we provide evidence that Ski-mediated repression of PU.1 is due to Ski's ability to recruit histone deacetylase 3 to PU.1 bound to DNA.",
      "citation": {
        "db": "PubMed",
        "db_id": "17621263"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 99,
      "target": 39,
      "key": "3aa5e6a244e3bc1b99228cd1f77b59c5"
    },
    {
      "line": 101,
      "relation": "directlyIncreases",
      "evidence": "Those known or hypothesized to be increased in atherosclerosis include fibronectin extra domain A (EDA) (48?50), hyaluronan (51?53), biglycan (54,55), high-mobility box chromosomal protein 1 (HMGB1) (56,57), and components of minimally oxidized or oxidized low-density lipoprotein (mmLDL and OxLDL, respectively) (58,59). It is noteworthy that all these ligands activate either TLR4 or TLR2 (or both) (Fig. 1).",
      "citation": {
        "db": "PubMed",
        "db_id": "16891671"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity"
      },
      "source": 100,
      "target": 49,
      "key": "2dcb3f80d1ae0f3a485a635d3082d382"
    },
    {
      "line": 101,
      "relation": "directlyIncreases",
      "evidence": "FRET images in RAW264.7 macrophages demonstrated association of HMGB1 with TLR2 and TLR4 but not RAGE. Transient transfections into human embryonic kidney-293 cells showed that HMGB1 induced cellular activation and NF-kappaB-dependent transcription through TLR2 or TLR4 but not RAGE. Coimmunoprecipitation also found interaction between HMGB1 and TLR2 as well as TLR4, but not with RAGE. These studies provide the first direct evidence that HMGB1 can interact with both TLR2 and TLR4 and also supply an explanation for the ability of HMGB1 to induce cellular activation and generate inflammatory responses that are similar to those initiated by LPS.",
      "citation": {
        "db": "PubMed",
        "db_id": "16267105"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity"
      },
      "source": 100,
      "target": 49,
      "key": "10df650a5a0c08b1f1addd17edb8227b"
    },
    {
      "line": 101,
      "relation": "directlyIncreases",
      "evidence": "The list of endogenous TLR2 and 4 activators has expanded quickly and encompasses other intracellular molecules such as heat shock proteins including HSP70, Gp96 [15-17], HSP22, and HSP72 [18, 19] and high-mobility group box-1 protein (HMGB1) [20-22] as well as ECMmolecules such as biglycan [23], tenascin-C [24], versican [25], and fragments of ECM molecules including oligosaccharides of hyaluronic acid (HA) [26] and heparan sulfate (HS) [27].",
      "citation": {
        "db": "PubMed",
        "db_id": "20706656"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity"
      },
      "source": 100,
      "target": 49,
      "key": "abe3e80656ed797773276976cf4050bd"
    },
    {
      "line": 43,
      "relation": "increases",
      "evidence": "We have characterized the expression of STAT and IFN regulatory factor (IRF) family transcription factors in primary human blood mononuclear cells and macrophages in response to IFN-alpha and IFN-gamma stimulation. We show that IFN-alpha and IFN-gamma rapidly and efficiently enhanced STAT1, STAT2, p48, and IRF-1 gene expression. IFN-gamma induced IRF-1 gene expression more strongly than IFN-alpha.",
      "citation": {
        "db": "PubMed",
        "db_id": "9218597"
      },
      "annotations": {},
      "source": 103,
      "target": 121,
      "key": "175cbb35a1ba5ed21eabb9ff816e3543"
    },
    {
      "line": 44,
      "relation": "directlyIncreases",
      "evidence": "We have characterized the expression of STAT and IFN regulatory factor (IRF) family transcription factors in primary human blood mononuclear cells and macrophages in response to IFN-alpha and IFN-gamma stimulation. We show that IFN-alpha and IFN-gamma rapidly and efficiently enhanced STAT1, STAT2, p48, and IRF-1 gene expression. IFN-gamma induced IRF-1 gene expression more strongly than IFN-alpha.",
      "citation": {
        "db": "PubMed",
        "db_id": "9218597"
      },
      "annotations": {},
      "source": 103,
      "target": 42,
      "key": "c0e6294673d88da6255582eaffeb14d6"
    },
    {
      "line": 45,
      "relation": "directlyIncreases",
      "evidence": "We show that IFN-alpha and IFN-gamma rapidly and efficiently enhanced STAT1, STAT2, p48, and IRF-1 gene expression.",
      "citation": {
        "db": "PubMed",
        "db_id": "9218597"
      },
      "annotations": {},
      "source": 103,
      "target": 43,
      "key": "6c442f799bcff26c06c2ecad302ae65f"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "It has been demonstrated that macrophages can produce 1alpha,25(OH)2D3 on activation with interferon gamma (IFN-gamma)",
      "citation": {
        "db": "PubMed",
        "db_id": "16118315"
      },
      "annotations": {},
      "source": 103,
      "target": 9,
      "key": "0a62861880b6e66f5c8783288beb0c96"
    },
    {
      "line": 46,
      "relation": "increases",
      "evidence": "Interferon-gamma (IFN-gamma) increased baseline 1,25(OH)2D3-synthesis approximately twofold during all phases of differentiation.",
      "citation": {
        "db": "PubMed",
        "db_id": "8394753"
      },
      "annotations": {},
      "source": 103,
      "target": 9,
      "key": "f63afbea7747ce632f0ff6deaffb0c2c"
    },
    {
      "line": 48,
      "relation": "increases",
      "evidence": "our experiments also revealed a critical role for NF-kappaB in mediating IFN-gamma-induced MIG expression independent of HA",
      "citation": {
        "db": "PubMed",
        "db_id": "12226082"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 103,
      "target": 27,
      "key": "11e960521df257d8b7f427457e2d84d0"
    },
    {
      "line": 48,
      "relation": "increases",
      "evidence": "Both IFN-gamma and IL-2 treatments alone caused some activation of NF kappa B, as evidenced by the appearance of a characteristic DNA-protein complex in electrophoretic mobility shift assays; in combination, the two agents cooperated to increase binding activity markedly, to a level equivalent to that seen in macrophages stimulated with LPS, another potent stimulus of macrophage cytokine gene expression.",
      "citation": {
        "db": "PubMed",
        "db_id": "1624799"
      },
      "annotations": {
        "cl": {
          "0000581": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 103,
      "target": 27,
      "key": "a7647b686029317c1be6fd1fe0edaac7"
    },
    {
      "line": 48,
      "relation": "increases",
      "evidence": "Induction of necroptosis by IFN-g was found to depend on Jak1 and partially on STAT1. We also demonstrate that IFN-g activates IkB kinaseb (IKKb)-dependent NF-bB to regulate a transcriptional program that protects cells from necroptosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "21576359"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 103,
      "target": 27,
      "key": "4f5fab37a7493e09ee40307b2783b072"
    },
    {
      "line": 49,
      "relation": "increases",
      "evidence": "stimulation of human blood monocytes with IFN-gamma induces the binding of PU.1 to the gp91(phox) promoter and the consequent expression of gp91(phox)  PU.1 = SPI1 gp91(phox) = CYBB",
      "citation": {
        "db": "PubMed",
        "db_id": "15067074"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 103,
      "target": 39,
      "key": "84d71cbdf8e5a1dbe50644034dc16cf8"
    },
    {
      "line": 239,
      "relation": "directlyIncreases",
      "evidence": "p85 is a direct in vitro substrate of the IGF-I receptor kinase a tight association occurs between phosphorylated IGF-I receptor and phosphatidylinositol 3-kinase, that the region of phosphatidylinositol 3-kinase that contains its SH2 domains is directly involved in this association, and that this region is a direct substrate for IGF-I receptor tyrosine kinase",
      "citation": {
        "db": "PubMed",
        "db_id": "1317864"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 104,
      "target": 105,
      "key": "3afde49370ad87154c4e16b289ea6a8d"
    },
    {
      "line": 239,
      "relation": "directlyIncreases",
      "evidence": "Recent studies have shown that the expression of two musclespecific ubiquitin ligases,MuRF1 [11] and Atrogin-1/MAFbx [11,12], is upregulated in multiple settings of atrophy. Mice in which either the MuRF1 or the Atrogin-1/MAFbx genes were deleted demonstrated sparing of skeletal muscle during atrophy conditions, as assessed by maintenance of skeletal muscle mass [11]. Stimulation of muscle cells with IGF-1 is sufficient to induce hypertrophy [3]. Transgenic mice in which IGF-1 expression is increased using a muscle-specific promoter have muscles that are at least twofold greater in mass when compared with wild-type mice [4,5]. IGF-1 binding activates the IGF-1 receptor (IGFR), a receptor tyrosine kinase.",
      "citation": {
        "db": "PubMed",
        "db_id": "12928036"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 104,
      "target": 105,
      "key": "cb2eb066f34f1916e54deff9ae8985eb"
    },
    {
      "line": 239,
      "relation": "directlyIncreases",
      "evidence": "We examined the effect of blockade of type 1 IGF tyrosine kinase receptor (IGF-IR) in a murine model of bleomycin-induced lung injury and fibrosis. Mice were treated with a monoclonal antibody against the IGF-I receptor (A12) or vehicle after intratracheal bleomycin instillation. MEASUREMENTS AND MAIN RESULTS: Mice treated with A12 antibody had significantly improved survival after bleomycin injury compared with control mice. Both groups of mice had a similar degree of fibrosis on days 7 and 14, but by Day 28 the A12-treated group had significantly less fibrosis. Delayed treatment with A12 also resulted in decreased fibrosis. A12-treated mice had significantly decreased apoptotic cells on Day 28 compared with control mice. We confirmed that A12 treatment induced mouse lung fibroblast apoptosis in vitro. In addition, IGF-I increased lung fibroblast migration. The primary pathway activated by IGF-I in lung fibroblasts was the insulin receptor substrate-2/phosphatidylinositol 3-kinase/Akt axis.",
      "citation": {
        "db": "PubMed",
        "db_id": "19011156"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 104,
      "target": 105,
      "key": "014d604a428305084cffe678e71a85b4"
    },
    {
      "line": 239,
      "relation": "directlyIncreases",
      "evidence": "LDL, in pathophysiological concentrations, affect the IGF-I signaling pathway at multiple levels: 1) they induce phosphorylation of IGF-I receptor beta and IRS-1 in a time- and dose-dependent manner; 2) they up-regulate IRS-1-associated PI3 kinase/Akt activation in response to IGF-I at early times; and 3) they show additive effects with IGF-I on extracellular signal-regulated MAPK 1/2 phosphorylation.",
      "citation": {
        "db": "PubMed",
        "db_id": "11606453"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 104,
      "target": 105,
      "key": "1f0781ff9a009bb00fef94f4ab14bc9b"
    },
    {
      "line": 239,
      "relation": "directlyIncreases",
      "evidence": "from full text - Figure 2",
      "citation": {
        "db": "PubMed",
        "db_id": "11739335"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 104,
      "target": 105,
      "key": "bde543d1b0c0fa5fab68a16b9dc4b6a6"
    },
    {
      "line": 239,
      "relation": "directlyIncreases",
      "evidence": "The IGF-I-promoted macrophage differentiation was blocked specifically by preincubation of HL-60 cells with a mAb (alphaIR3) directed against the IGF type I receptor.",
      "citation": {
        "db": "PubMed",
        "db_id": "9570559"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 104,
      "target": 105,
      "key": "7d3df1a39ff7733086a59b2c3e8b9dea"
    },
    {
      "line": 239,
      "relation": "directlyIncreases",
      "evidence": "IGF-I-stimulated activation of IGF-IR and downstream signaling intermediates were enhanced in the intestine of SOCS2 null mice and were decreased by SOCS2 overexpression in Caco-2 cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "16574995"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 104,
      "target": 105,
      "key": "a7dddbdea2e76c86766c3408ff885672"
    },
    {
      "line": 240,
      "relation": "increases",
      "evidence": "the proportion of cells differentiating into macrophages in serum-free medium, as assessed by expression of the alpha-subunit of the beta2 integrin CD11b, increased from 5 +/- 1% to 25 +/- 3%. Addition of IGF-I increased the proportion of cells differentiating into CD11b-positive macrophages to 78 +/- 5%. In the absence of vitamin D3, IGF-I did not induce expression of CD11b (6 +/- 1%).....These data establish that PKC-zeta is a putative downstream target of PI 3-kinase that is activated during IGF-I-promoted macrophage differentiation.",
      "citation": {
        "db": "PubMed",
        "db_id": "9570559"
      },
      "annotations": {},
      "source": 104,
      "target": 20,
      "key": "0bc6f161955a8a94266c8a1ba31d2358"
    },
    {
      "line": 228,
      "relation": "increases",
      "evidence": "The IGF-I-promoted macrophage differentiation was blocked specifically by preincubation of HL-60 cells with a mAb (alphaIR3) directed against the IGF type I receptor.",
      "citation": {
        "db": "PubMed",
        "db_id": "9570559"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 105,
      "target": 20,
      "key": "bd68f6c592da39821f9cc7fdc046630f"
    },
    {
      "line": 25,
      "relation": "decreases",
      "evidence": "pretreatment of cells with either alphaIR3 or an IGF-binding protein, IGFBP-3, led to a 75% inhibition of CD11b expression when cells were cultured with vitamin D3 in serum-containing medium.",
      "citation": {
        "db": "PubMed",
        "db_id": "9570559"
      },
      "annotations": {},
      "source": 106,
      "target": 20,
      "key": "60244db2dcbfd6aec3f75c38e8b326f7"
    },
    {
      "relation": "hasVariant",
      "source": 107,
      "target": 108,
      "key": "09b8d15333299a7def87660da0607c47"
    },
    {
      "relation": "hasVariant",
      "source": 107,
      "target": 109,
      "key": "08831b388c3e14449cf4902d6ae04187"
    },
    {
      "line": 174,
      "relation": "directlyDecreases",
      "evidence": "Since activation of NF-B in A549 cells is dependent on IKK2, which phosphorylates serines 32 and 36 of IB as a prelude to IB degradation and activation of NF-B (Catley et al., 2005",
      "citation": {
        "db": "PubMed",
        "db_id": "17322026"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 107,
      "target": 144,
      "key": "c1340a66cee063276389f5e2681039e5"
    },
    {
      "line": 64,
      "relation": "directlyIncreases",
      "evidence": "The ability of IL-10 to activate Stat3 tyrosine phosphorylation and SOCS-3 synthesis and to regulate IL-1 receptor antagonist and macrophage-inflammatory protein 1beta release in LPS-treated neutrophils correlated with this increased IL-10R1 expression, and was abolished by neutralizing anti-IL-10R1 and anti-IL-10R2 Abs.",
      "citation": {
        "db": "PubMed",
        "db_id": "11490020"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 111,
      "target": 112,
      "key": "2ffe5df2632dcbd820e5ffe23c66d81e"
    },
    {
      "line": 154,
      "relation": "increases",
      "evidence": "Figure 4. IFN-g suppresses TLR2-induced feedback inhibition by decreasing IL-10 production and downstream Stat3 activation, thereby interrupting a TLR2-induced feedback-inhibition loop. Suppression of IL-10 expression results in increased production of the inflammatory cytokines such as TNF (curated directly from figure image) - bw",
      "citation": {
        "db": "PubMed",
        "db_id": "17502339"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 112,
      "target": 44,
      "key": "1a1c61e7b0933ec26ea50e2b49069dc5"
    },
    {
      "line": 154,
      "relation": "increases",
      "evidence": "The ability of IL-10 to activate Stat3 tyrosine phosphorylation and SOCS-3 synthesis and to regulate IL-1 receptor antagonist and macrophage-inflammatory protein 1beta release in LPS-treated neutrophils correlated with this increased IL-10R1 expression, and was abolished by neutralizing anti-IL-10R1 and anti-IL-10R2 Abs.",
      "citation": {
        "db": "PubMed",
        "db_id": "11490020"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 112,
      "target": 44,
      "key": "1d578a2ed5454c7624b623b074223a0c"
    },
    {
      "line": 139,
      "relation": "directlyIncreases",
      "evidence": "After IL-1 binds to IL-1RI, an IL-1RAcP is recruited to form a high affinity IL-1R1-IL-1RAcP heterodimeric receptor, which initiates the downstream signaling cascade.",
      "citation": {
        "db": "PubMed",
        "db_id": "21776333"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 114,
      "target": 115,
      "key": "a0dea30314bf4fbedfa07b7b4190aebf"
    },
    {
      "line": 139,
      "relation": "directlyIncreases",
      "evidence": "Furthermore, IL-18R at least partly shares the signal transducing system with IL-1R. Thus, the IL-18-IL-18R system has a striking similarity to the IL-1-IL-1R system. From entrez gene summary of IL1R1: The protein encoded by this gene is a cytokine receptor that belongs to the interleukin 1 receptor family. This protein is a receptor for interleukin alpha (IL1A), interleukin beta (IL1B), and interleukin 1 receptor, type I(IL1R1/IL1RA). It is an important mediator involved in many cytokine induced immune and inflammatory responses.",
      "citation": {
        "db": "PubMed",
        "db_id": "10653850"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 114,
      "target": 115,
      "key": "4be17199877fd98c0f559a9fdbc18ba7"
    },
    {
      "line": 10,
      "relation": "increases",
      "evidence": "IL-1 treatment of 293 cells induces the association of TRAF6 with IRAK, a serine/threonine kinase that is rapidly recruited  to the IL-1 receptor  after IL-1 induction",
      "citation": {
        "db": "PubMed",
        "db_id": "8837778"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 115,
      "target": 55,
      "key": "201dca05ff5cbf238441e5608cd211d8"
    },
    {
      "line": 42,
      "relation": "increases",
      "evidence": "Both IFN-gamma and IL-2 treatments alone caused some activation of NF kappa B, as evidenced by the appearance of a characteristic DNA-protein complex in electrophoretic mobility shift assays; in combination, the two agents cooperated to increase binding activity markedly, to a level equivalent to that seen in macrophages stimulated with LPS, another potent stimulus of macrophage cytokine gene expression.",
      "citation": {
        "db": "PubMed",
        "db_id": "1624799"
      },
      "annotations": {
        "cl": {
          "0000581": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 116,
      "target": 27,
      "key": "e98cb8b21726e2e4f1a37c840400e3fa"
    },
    {
      "line": 164,
      "relation": "decreases",
      "evidence": "During IL-6-induced macrophage differentiation of M1 cells, IL-6 down-regulated cyclin D1 expression and induced p19(INK4D) expression, leading to reduction in cdk4 activities. In contrast, sustained expression of cyclin D1 and a significantly lesser amount of p19(INK4D) induction were observed in IL-6-treated M1 cells overexpressing GATA-1.",
      "citation": {
        "db": "PubMed",
        "db_id": "10666199"
      },
      "annotations": {},
      "source": 117,
      "target": 64,
      "key": "1eccd9e5f2e3465ee54694cc965cba82"
    },
    {
      "line": 165,
      "relation": "increases",
      "evidence": "IL-6 inhibited the proliferation of normal fibroblasts due to the sustained phosphorylation of STAT-3 and production of the cyclin-dependent kinase inhibitor p19(INK4D).",
      "citation": {
        "db": "PubMed",
        "db_id": "12819039"
      },
      "annotations": {},
      "source": 117,
      "target": 74,
      "key": "574d909344bd9f0c9412588fe586d20f"
    },
    {
      "line": 165,
      "relation": "increases",
      "evidence": "During IL-6-induced macrophage differentiation of M1 cells, IL-6 down-regulated cyclin D1 expression and induced p19(INK4D) expression, leading to reduction in cdk4 activities. In contrast, sustained expression of cyclin D1 and a significantly lesser amount of p19(INK4D) induction were observed in IL-6-treated M1 cells overexpressing GATA-1.",
      "citation": {
        "db": "PubMed",
        "db_id": "10666199"
      },
      "annotations": {},
      "source": 117,
      "target": 74,
      "key": "4c0f9c4c27c2a08de68a9fa92fab560f"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "We have previously demonstrated that interleukin-6 (IL-6) increases the levels of the heat shock protein 90 (Hsp-90) and activates the Hsp-90beta promoter via the IL-6-activated transcription factors NF-IL6 and signal transducer and activator of transcription-3 (STAT-3).",
      "citation": {
        "db": "PubMed",
        "db_id": "9880553"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "93dc25ae5b077d422f8f725610dbb63a"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "IL-6 promotes tumor growth and metastasis by up-regulating VEGF expression and VEGF-mediated angiogenesis, and is closely associated with disease status and outcome of gastric cancer[27,28]. Recent studies demonstrated that IL-6 induced VEGF expression and angiogenesis via Stat3 in multiple tumors[29-31] and gastric cancer[32]. Blocking Stat3 signaling pathway down-regulated VEGF promoter activity, and effectively abolished IL-6-induced VEGF expression and angiogenesis[33,34].",
      "citation": {
        "db": "PubMed",
        "db_id": "21633597"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "c54b4cef7dd3d8acd5e557fd670d32ef"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "The mouse tumors mimic molecular hallmarks of their human tumor counterparts, including elevated IL-6/Stat3/Bcl-X(L) signaling. The newly developed mouse strains may provide a good preclinical research tool for the design and testing of new approaches to target IL-6 in treatment and prevention of human PCNs.",
      "citation": {
        "db": "PubMed",
        "db_id": "20018915"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "f531dc010be1002451c647726e0effe8"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "Stimulation of ABCA1-mediated cholesterol efflux by IL-6 was, however, abolished by selective inhibition of the Jak-2/Stat3 signaling pathway. In addition, we observed that the expression of molecules described to promote efferocytosis, i.e. c-mer proto-oncogene-tyrosine kinase, thrombospondin-1, and transglutaminase 2, was significantly induced in human macrophages upon treatment with IL-6. Consistent with these findings, IL-6 enhanced the capacity of human macrophages to phagocytose apoptotic cells; moreover, we observed that IL-6 stimulates the ABCA1-mediated efflux of cholesterol derived from the ingestion of free cholesterol-loaded apoptotic macrophages.",
      "citation": {
        "db": "PubMed",
        "db_id": "21757719"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "28efd8a6e6df2a90a457b770ed99e872"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "A549 cells were infected with either control adenovirus (Ad-GFP) or Ad- STAT3C for 13 h along with low levels of IL-6 for an additional 5 h to enhance STAT3C tyrosine phosphorylation. mRNA levels of MUC1 expression were determined by real-time RT-PCR assay and normalized to GAPDH mRNA",
      "citation": {
        "db": "PubMed",
        "db_id": "19578748"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "f63ae54bb8806346990b5a2f6a6c527a"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "In T47D cells, IL-6 stimulated the activation of Janus-activated kinase 1 tyrosine kinase and signal transducers and activators of transcription (STAT) 1 and STAT3 transcription factors. Expression of dominant negative STAT3 in the cells strongly reduced IL-6-mediated growth inhibition but did not prevent IL-6-induced cell migration.",
      "citation": {
        "db": "PubMed",
        "db_id": "11196191"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "2d7bbe57db05c9f4204a72990ed36470"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "Stat3 controls cell death and tissue remodeling in the mouse mammary gland during involution, which is partially induced by IL6 and LIF.",
      "citation": {
        "db": "PubMed",
        "db_id": "15292206"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "d616bf13d5c23791d2a00d14565bce78"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "from full text - IL-6 signalling through signal transducer and activator of transcription- 3 (STAT3)",
      "citation": {
        "db": "PubMed",
        "db_id": "18666314"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "54fa4d5cbc46dce7605557f2be51df65"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "CRP is predominately synthesized by hepatocytes when stimulated by interleukin-6 (IL-6). In response to IL-6, the signal transducer and activator of transcription 3 (STAT3) becomes phosphorylated on tyrosine and serine residues. Phosphorylated STAT3 then activates CRP gene transcription.",
      "citation": {
        "db": "PubMed",
        "db_id": "20978825"
      },
      "annotations": {
        "cl": {
          "0000182": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "2f98703d2f3563a7950d443dae187187"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "Fig. 1  Ashows that phosphorylation of STAT3 at Tyr705 was detected after 5 min of exposure to 10 ng/ml IL-6, reached a maximum at 15 min, and then declined within 1 h. These results demonstrate that IL-6 activates a STAT3 signaling in adult rat ventricular myocytes.",
      "citation": {
        "db": "PubMed",
        "db_id": "12595539"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "fd445a460b29f24e93a248327b63ad25"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "We next determined whether the ?EGFR-expressing MCF-10A cells produced high levels of IL-6, leading to activation of STAT3, as was observed in lung adenocarcinoma–derived cell lines harboring mutant EGFR. The ?EGFR–MCF-10A cells were treated with P6, gp130, and IL-6 blocking antibodies, which inhibited STAT3 activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "18060032"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "8f8c6e232ee84f2202c488c9d6ecc902"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "A tetrameric Stat3 complex was found to be essential in transfection experiments for maximal interleukin-6-inducible activation of alpha2-macroglobulin gene promoter.",
      "citation": {
        "db": "PubMed",
        "db_id": "11438543"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "07cfcc608582315aff1b277deb0433cb"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "Except for rat gammaFBG, attempts to demonstrate direct binding of IL-6-activated Stat3 to FBG CTGGGAA promoter elements have not been successful. Herein we show the presence of three functional type II IL-6 response elements (IL-6REs) on the human gammaFBG promoter and that the magnitude of Stat3 binding to these elements correlates negatively with their functional activity in reporter gene assays Together these data suggest that Stat3 transactivation via IL-6REs on FBG promoters likely involves participation of additional transcription factors and/or coactivators to achieve optimal coordinated up-regulation during an APR.",
      "citation": {
        "db": "PubMed",
        "db_id": "12900415"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "b753f6d65fac3fa2888cacfb2b6eab80"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "Stat3 binds the c-maf promoter in CD4 T cells after IL-6 stimulation, and also transactivates the c-maf promoter in reporter gene assays",
      "citation": {
        "db": "PubMed",
        "db_id": "15728480"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "a534508474e2f22eebeeb83c35b69dad"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "Signal transducer and activator of transcription 3 (STAT3) is activated by the IL-6 family of cytokines and growth factors. STAT3 requires phosphorylation on Ser-727, in addition to tyrosine phosphorylation on Tyr-705, to be transcriptionally active.",
      "citation": {
        "db": "PubMed",
        "db_id": "15764709"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "84abd6b57cd6f093d4299756fcac2fb6"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "IL-6 induced STAT3 transactivation was reduced from sixfold to 2.5-fold when cells were pre- treated with the JAK2 inhibitor (Figure 2b).",
      "citation": {
        "db": "PubMed",
        "db_id": "11536047"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "f1fb184746c2e7d3635db85346e74284"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "that IL-6 and IL-10, two cytokines that are known to activate STAT3, confer a drug-resistant phenotype in renal carcinomas, which was subsequently confirmed in different cancer cell lines such as multiple myeloma [72,73].",
      "citation": {
        "db": "PubMed",
        "db_id": "17118707"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "8c7014b64c072ea0197a9f8d11b7454d"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "IL-6-induced activation of signal transducer and activator of transcription 3 (STAT3) was augmented by AR in the presence of dihydrotestosterone (DHT).",
      "citation": {
        "db": "PubMed",
        "db_id": "11322786"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "c4b95ffd7147edd94bdf965024aa8858"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "The CASR gene has two promoters (P1 and P2) yielding transcripts having alternative 5'-untranslated regions but encoding the same receptor protein. Activities of P1 and P2 promoter/luciferase reporter constructs were stimulated approximately 2-3-fold by IL-6 in proximal tubule HKC cells and TT thyroid C-cells. Studies with P1 deleted and mutated promoter-reporter and Stat1 and/or Stat3 dominant-negative constructs showed that a Stat1/3 element downstream of the P1 start site accounted for the IL-6 induction.",
      "citation": {
        "db": "PubMed",
        "db_id": "18348986"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "529cc3aee3f1f769a3b27826b7ae2398"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "IFN-gamma treatment of human hepatoma Hep3B cells attenuates IFN-alpha activation of STAT1 (signal transducers and activators of transcription factor 1), STAT2 and STAT3, but enhances IFN-gamma and interleukin 6 activation of STATs",
      "citation": {
        "db": "PubMed",
        "db_id": "14690454"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "290d7fd6e1b371eb5460b92b80513caf"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "Although STAT3 is essential for IL-6-induced macrophage differentiation of M1 cells, GATA-1 had little or no effect on tyrosine phosphorylation, DNA binding, and transcriptional activities of STAT3 in Western blot analysis, electropholic mobility shift assay (EMSA), and luciferase assays.",
      "citation": {
        "db": "PubMed",
        "db_id": "10666199"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "44d87f9dadde12f4c64a5934ea78b7dc"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "Blockade of either IL-6 or IL-10 caused dramatic reductions in STAT3 activation in IC-injured rat lungs",
      "citation": {
        "db": "PubMed",
        "db_id": "16785559"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "687ca3cc97c13f72f3c016392d8f8262"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "Hypercitrullination is known to promote focal demyelination through reduced myelin compaction.",
      "citation": {
        "db": "PubMed",
        "db_id": "23118341"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "c5cda2302671b7b9252b75119e545309"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "Il6 activates STAT1 and STAT5 in addition to STAT3",
      "citation": {
        "db": "PubMed",
        "db_id": "12110143"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "0883681748a8d4785bcd3f0752966b0c"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "IL-6 family cytokines (Interleukin-6 and Oncostatin M (OSM))-increase STAT3 phosphorylation (pSTAT3), increase CCAAT enhancer binding protein delta (C/EBPdelta) gene expression",
      "citation": {
        "db": "PubMed",
        "db_id": "15389879"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "0a7f22897a1d36c14ebe8f4f82131ad9"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "Infusion IL-6 resulted in an increase in the phosphorylation state of STAT3 (Fig. 3C) and a decrease in the phosphorylation of STAT5",
      "citation": {
        "db": "PubMed",
        "db_id": "15542570"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "2b92e702bc91e0916113ec7439a17f9d"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "We demonstrate that exposure of CCL39 cells to TGF-beta completely inhibits IL-6-induced Stat3 tyrosine phosphorylation and gp130 gene expression",
      "citation": {
        "db": "PubMed",
        "db_id": "11281729"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "0e01935ad9fa91723593d3475e94996c"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "Previous studies have demonstrated that IL-6 treatment results in the activation of signal transducer and activator of transcription3 (STAT3) in prostate cancer cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "15486993"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "6db0abba3b0cde92fe8caf069e3c9d47"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "Immunoprecipitation and transactivation studies showed a direct interaction between amino acids 234-558 of the AR NTD and STAT3 following IL-6 treatment of LNCaP cells. These results demonstrate that activation of the human AR NTD by IL-6 was mediated through MAPK and STAT3 signal transduction pathways in LNCaP prostate cancer cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "11751884"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "5fd7644370e9b40f2fd73fc64cc17653"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "IL-1beta-activated NF-kappaB associated with 2 IL-6 responsive elements (STAT3 binding site) on the rat gamma fibrinogen promoter and blocked STAT3 binding to these regions. The competitive binding of NF-kappaB and STAT3 on the overlapping binding site provides a mechanism for the inhibition by IL-1beta of the IL-6-mediated transactivation of rat gamma fibrinogen.",
      "citation": {
        "db": "PubMed",
        "db_id": "11071643"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "94a057bd80a9d0dbd2ddabefdb903d31"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "results indicate that BCL-6 negatively regulates proliferation of the monocytic/macrophage lineage by suppressing an autocrine IL-6/STAT3-mediated gene expression program.",
      "citation": {
        "db": "PubMed",
        "db_id": "15507530"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "ff4e314bf236d0d97ba534370f018204"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "The protein tyrosine kinases JAK1, JAK2 and Tyk2 and STATs (signal transducers and activators of transcription) 1 and 3 are activated in response to interleukin-6 (IL-6) in human fibrosarcoma cells",
      "citation": {
        "db": "PubMed",
        "db_id": "7537214"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "228d00dd32e08ef5541bbcf6042c6718"
    },
    {
      "line": 166,
      "relation": "increases",
      "evidence": "We show that Socs3 deficiency results in prolonged activation of signal transducer and activator of transcription 1 (STAT1) and STAT3 after IL-6 stimulation but normal activation of STAT1 after stimulation with interferon-gamma (IFN-gamma)",
      "citation": {
        "db": "PubMed",
        "db_id": "12754505"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 117,
      "target": 44,
      "key": "b4d225fe6d2c086065bbeed1759bea06"
    },
    {
      "line": 179,
      "relation": "increases",
      "evidence": "IRAK-1 activation and recruitment is essential for activation of TRAF6 (TNF-associated factor 6), which is an essential adaptor for MyD88-dependent NF-kB activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "19842832"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 119,
      "target": 55,
      "key": "61250ec4249660ddb7f34141272306bf"
    },
    {
      "line": 179,
      "relation": "increases",
      "evidence": "Schematic representation of NE-induced IL-8 signal transduction pathway in human bronchial epithelial cells. In bronchial epithelial cells, NE activates an as yet unidentified receptor. The cytosolic protein MyD88 acts as an adaptor coupling the receptor complex to IRAK. The signal is relayed downstream via TRAF-6 to the I?B kinases (IKKs) (via NIK/MEKK1), resulting in phosphorylation and degradation of I?B?, and subsequent release and translocation of NF?B to the nucleus where it transactivates IL-8 gene expression.",
      "citation": {
        "db": "PubMed",
        "db_id": "11461907"
      },
      "annotations": {
        "cl": {
          "0002328": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 119,
      "target": 55,
      "key": "74ffa9fc6f1c830469c83b6f02b4ad20"
    },
    {
      "line": 179,
      "relation": "increases",
      "evidence": "FIGURE 8. Model for neutrophil signaling mechanisms triggered by bacterial DNA. Although the activation of the intermediates indicated in the figure have been probed, a causal relationship between TIR pathway activation and MAPKs, AP-1 and NF-kB, has not been directly determined.",
      "citation": {
        "db": "PubMed",
        "db_id": "16951367"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 119,
      "target": 55,
      "key": "a31d6b45b92a39876b188832d5f306f4"
    },
    {
      "line": 179,
      "relation": "increases",
      "evidence": "Except for TLR3, all TLR ligation events recruit the adaptor MyD88, followed by the IRAK family of protein kinases, leading to the activation of TRAF6.",
      "citation": {
        "db": "PubMed",
        "db_id": "20981241"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 119,
      "target": 55,
      "key": "6ddab44902d8e43549e042a09e504388"
    },
    {
      "line": 179,
      "relation": "increases",
      "evidence": "Phosphorylated IRAK1 dissociates from the complex and activates TRAF6.",
      "citation": {
        "db": "PubMed",
        "db_id": "22566960"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 119,
      "target": 55,
      "key": "0d4782efb00638f926a405bdc0d7aa0f"
    },
    {
      "line": 179,
      "relation": "increases",
      "evidence": "small interfering RNA silencing of TRAF6 expression inhibited MyD88-induced and IRAK-1-induced activation, and supplementation with the TRAF6 dominant-negative mutant did not restore the IRAK-1-induced activation. Expression of IRAK-1, but not MyD88, induced the oligomerization of TRAF6",
      "citation": {
        "db": "PubMed",
        "db_id": "18070982"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 119,
      "target": 55,
      "key": "45728645a004e6c67e4e073b4b81d42f"
    },
    {
      "line": 92,
      "relation": "increases",
      "evidence": "Further, TRAF6 is involved in the activation of JNK and IRAK4 is involved for the activation of IKK and PKCzeta in a Talpha1-induced system.",
      "citation": {
        "db": "PubMed",
        "db_id": "17567943"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 75,
      "target": 25,
      "key": "6583ac867de071b765100fcf98e59137"
    },
    {
      "line": 93,
      "relation": "increases",
      "evidence": "Then, IRAK4 activates IRAK1 and IRAK2.",
      "citation": {
        "db": "PubMed",
        "db_id": "22661952"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 75,
      "target": 119,
      "key": "23237c36c8f748c421c10b69e8e95895"
    },
    {
      "line": 93,
      "relation": "increases",
      "evidence": "In this report, we demonstrate that IRAK-4 is recruited to the IL-1R complex upon IL-1 stimulation and is required for the recruitment of IRAK-1 and its subsequent activation/degradation.",
      "citation": {
        "db": "PubMed",
        "db_id": "15292196"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 75,
      "target": 119,
      "key": "7c75ae92f535015e813b149cb924df8c"
    },
    {
      "line": 93,
      "relation": "increases",
      "evidence": "MyD88 promotes association with IRAK4 and IRAK1.  During the formation of this complex, IRAK4 is activated, leading to the hyperphosphorylation of IRAK1, which then induces interaction of TRAF6 with the complex.",
      "citation": {
        "db": "PubMed",
        "db_id": "12893815"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 75,
      "target": 119,
      "key": "80e5c3e6a7d160532f3ea264713c7ff8"
    },
    {
      "line": 94,
      "relation": "increases",
      "evidence": "In order to investigate the role of IRAK-4 kinase function in vivo, we generated \\\"knock-in\\\" mice where the wild-type IRAK-4 gene is replaced with a mutant gene encoding kinase-deficient IRAK-4 protein (IRAK-4 KD). IRAK-4 kinase is rendered inactive by mutating the conserved lysine residues in the ATP pocket essential for coordinating ATP. Analyses of embryonic fibroblasts and macrophages obtained from IRAK-4 KD mice demonstrated lack of cellular responsiveness to stimulation with IL-1beta or Toll-like receptor 4 (TLR4) and TLR7 agonists. IRAK-4 KD cells were severely impaired in NF-kappaB, JNK, and p38 activation in response to IL-1beta or TLR7 ligand.",
      "citation": {
        "db": "PubMed",
        "db_id": "18510099"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 75,
      "target": 32,
      "key": "d968ea0cb29b9859240c18020472037e"
    },
    {
      "line": 94,
      "relation": "increases",
      "evidence": "In this report, we demonstrate that IRAK-4 is recruited to the IL-1R complex upon IL-1 stimulation and is required for the recruitment of IRAK-1 and its subsequent activation/degradation.",
      "citation": {
        "db": "PubMed",
        "db_id": "15292196"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 75,
      "target": 32,
      "key": "35cb9cc664af10dd7d54bd9a1a8a517b"
    },
    {
      "line": 225,
      "relation": "increases",
      "evidence": "DNA affinity assays utilizing nuclear extracts from RAW 264.7 cells show that NF-kappaB cRel and p50 bind to the kappaB-E within nt -122 to -93 of the p35 exon 2 promoter while IRF-1 binds to the IRF-E within nt -157 to -113 but not the one within nt -122 to -93. Thus, cRel with IRF-1 induce p35 expression through a small region of the p35 exon 2 promoter during IFN-γ and LPS costimulation of macrophages.",
      "citation": {
        "db": "PubMed",
        "db_id": "15871905"
      },
      "annotations": {},
      "source": 121,
      "target": 113,
      "key": "1aee9fb73b185b9b382c76e12a01ace6"
    },
    {
      "line": 2,
      "relation": "directlyIncreases",
      "evidence": "We began with the use of transient promoter reporter assays to determine whether IRF5 was a direct mediator of IL-6 and TNF-α expression, both of which were recently shown to be dependent on IRF5 (23). Results clearly demonstrated that IRF5 could transactivate all examined promoter reporter constructs, to different degrees, in both uninfected and virus-infected cells; virus infection gave a significant increase in promoter activity that was mediated by IRF5. Binding of IRF5 on the endogenous promoters in THP-1 cells was observed",
      "citation": {
        "db": "PubMed",
        "db_id": "20935208"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 123,
      "target": 117,
      "key": "588a154d417ba404337a0f6e0de5a556"
    },
    {
      "line": 51,
      "relation": "increases",
      "evidence": "IRGM1 (IRGM in human), a member of immunity-related small GTPase family, is essential for the actin-dependent CD36 mediated oxLDL uptake by macrophage",
      "citation": {
        "db": "PubMed",
        "db_id": "23689639"
      },
      "annotations": {},
      "source": 86,
      "target": 18,
      "key": "a869aa0a97618d720ab2dc41c02258c3"
    },
    {
      "line": 51,
      "relation": "increases",
      "evidence": "The absence of Irgm1 led to decreased actin remodeling at the leading edge of migrating macrophages,",
      "citation": {
        "db": "PubMed",
        "db_id": "19920210"
      },
      "annotations": {},
      "source": 86,
      "target": 18,
      "key": "a6b917f2ae4728cebcfecfbc5c22246c"
    },
    {
      "line": 150,
      "relation": "increases",
      "evidence": "Dominant negative JAK2 (delta JAK2) lacking the C-terminus kinase domain, suppressed IL-3/GM-CSF induced c-fos activation",
      "citation": {
        "db": "PubMed",
        "db_id": "9209304"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 124,
      "target": 26,
      "key": "2353489a9a01eb0324c965711a3a064e"
    },
    {
      "line": 151,
      "relation": "increases",
      "evidence": "In contrast, enhanced thrombopoietin signaling, conferred by enforced expression of constitutively active JAK2 or c-MPL, induced phosphorylation of STAT3 and STAT5, but not STAT1, and failed to rescue megakaryocyte maturation.",
      "citation": {
        "db": "PubMed",
        "db_id": "18060035"
      },
      "annotations": {
        "cl": {
          "0000556": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 124,
      "target": 33,
      "key": "f37126fe35dacb36e2516a18664579d8"
    },
    {
      "line": 151,
      "relation": "increases",
      "evidence": "GM-CSF signals through JAK2 and STAT5 and stimulates the expression of STAT5 target genes, such as pim-1 and CIS.",
      "citation": {
        "db": "PubMed",
        "db_id": "11867689"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 124,
      "target": 33,
      "key": "00368ef03035c2e97f3a21d54c457edf"
    },
    {
      "line": 151,
      "relation": "increases",
      "evidence": "EPO induced STAT5 DNA binding activity was inhibited in cells treated with JAK2 inhibitor AG490.",
      "citation": {
        "db": "PubMed",
        "db_id": "10940312"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 124,
      "target": 33,
      "key": "8ff3c676f0a88924c107dd3e8ddce4a8"
    },
    {
      "line": 151,
      "relation": "increases",
      "evidence": "Transcription of the genes encoding both ERalpha (Esr1) and ERbeta (Esr2) is stimulated by PRL through the Jak2-Stat5 pathway and Stat5-response elements that are located in each of the Esr promoters.",
      "citation": {
        "db": "PubMed",
        "db_id": "12670737"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 124,
      "target": 33,
      "key": "c0adfc56b211f4373abeeeef1bfa4a81"
    },
    {
      "line": 151,
      "relation": "increases",
      "evidence": "mice lacking a functional gene for IL-5 or IL-5 receptor alpha chain (IL-5Ralpha) display a number of developmental and functional impairments in B cells and eosinophils. IL-5 receptor (IL-5R) comprises alpha and betac chains. IL-5 specifically binds to IL-5Ralpha and induces the recruitment of betac to IL-5R. Although precise mechanisms on cell-lineage-specific IL-5Ralpha expression remain elusive, several transcription factors including Sp1, E12/E47, Oct-2, and c/EBPbeta have been shown to regulate its expression in B cells and eosinophils. JAK2 and JAK1 tyrosine kinase are constitutively associated with IL-5Ralpha and betac, respectively, and are activated by IL-5 stimulation. IL-5 activates at least three different signaling pathways including JAK2/STAT5 pathway, Btk pathway, and Ras/ERK pathway.",
      "citation": {
        "db": "PubMed",
        "db_id": "19231596"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 124,
      "target": 33,
      "key": "24d56348a19c715f1c21f0b39c4bb9f3"
    },
    {
      "line": 151,
      "relation": "increases",
      "evidence": "Study on signal transduction through Mp1 revealed that Tpo induces activation of JAK2 and Tyk2, which in turn activate STAT1, STAT3 and STAT5. Further, Tpo stimulates transcription factors GATA-1 and NF-E2, which induce differentiation markers, GPIIb/IIIa and Pm-1.",
      "citation": {
        "db": "PubMed",
        "db_id": "9209416"
      },
      "annotations": {
        "cl": {
          "0000556": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 124,
      "target": 33,
      "key": "5763510915d77338a33a49302f81afe3"
    },
    {
      "line": 167,
      "relation": "increases",
      "evidence": "AgLDL increases Rho A translocation (2-fold) from the cytoplasm to the cell membrane in control but not in simvastatin-treated VSMC. Exoenzyme C3, a specific Rho A inhibitor, completely prevents agLDL-induced TF overexpression and partially agLDL-TF activation. Blocking LRP1, the receptor of agLDL, with anti-LRP1 antibodies or inhibiting LRP1 expression by small interference RNA treatment (siRNA-LRP1) impairs agLDL-induced TF overexpression and activation. CONCLUSIONS: These results demonstrate that TF induction by agLDL depends on LRP1 expression and requires Rho A translocation to the cellular membrane.",
      "citation": {
        "db": "PubMed",
        "db_id": "17141748"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "source": 127,
      "target": 126,
      "key": "dd5b68969268a56a0965e20f37a868b3"
    },
    {
      "line": 170,
      "relation": "increases",
      "evidence": "Similar to C1q and mannose-binding lectin, SP-A and SP-D bound to apoptotic\ncells in a localized, patchy pattern and drove apoptotic cell ingestion by phagocytes through a mechanism dependent on calreticulin\nand CD91.",
      "citation": {
        "db": "PubMed",
        "db_id": "12244199"
      },
      "annotations": {},
      "source": 127,
      "target": 17,
      "key": "9b8993c1c84fe5d435a62f5f71ea2da6"
    },
    {
      "line": 171,
      "relation": "increases",
      "evidence": "sLRP1, which was purified from human plasma, and full-length LRP1, purified from mouse liver, activated cell signaling when added to cultures of RAW 264.7 cells and BMMs. Robust activation of p38 MAPK and JNK was observed. The IKK-NF-??B pathway was transiently activated.",
      "citation": {
        "db": "PubMed",
        "db_id": "20610799"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 127,
      "target": 27,
      "key": "8d7408f75625540035dcc2c587bb5934"
    },
    {
      "line": 204,
      "relation": "decreases",
      "evidence": "Degradation of IkappaBalpha was also partially blocked in MEKK3 knockdown cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "17116170"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 128,
      "target": 144,
      "key": "8cba1890de5326de5478e8cf23feeb72"
    },
    {
      "line": 34,
      "relation": "directlyIncreases",
      "evidence": "We show that TAK1 physically interacts with NIK and with IKK2, and both XIAP or active TAK1 can stimulate IKK2 kinase activity",
      "citation": {
        "db": "PubMed",
        "db_id": "10807933"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 129,
      "target": 107,
      "key": "9393df26aa6aa23d96b0c2fd93d2fd8c"
    },
    {
      "line": 35,
      "relation": "increases",
      "evidence": "TAK1 has been most studied in view of its molecular role in TLR/IL-1R-mediated IKK activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "21197425"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 129,
      "target": 25,
      "key": "a492a3644bf93835494c57af9eb23f52"
    },
    {
      "line": 35,
      "relation": "increases",
      "evidence": "Analysis of upstream signaling events revealed that TLR 2/4-mediated MyD88-dependent participation of IL-1R-activated kinase (IRAK)1, TNF receptor-associated factor (TRAF)6 and TGFbeta-activated kinase  (TAK)1 is essential to induce cystatin-mediated IkB kinase (IKK)/NF-kB activation in macrophages.",
      "citation": {
        "db": "PubMed",
        "db_id": "21182083"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 129,
      "target": 25,
      "key": "6c3a82d1baacf0577ec889f6f5e06f65"
    },
    {
      "line": 35,
      "relation": "increases",
      "evidence": "All living organisms are exposed constantly to microorganisms that are present in the environment and need to cope with invasion of these organisms into the body. The vertebrate immune response can be divided into innate and acquired immunity, with innate immunity being the first line of defence against pathogens. By contrast, acquired immune responses are slower processes, which are mediated by T and B cells, both of which express highly diverse antigen receptors that are generated through DNA rearrangement and are thereby able to respond to a wide range of potential antigens. This highly sophisticated system of antigen detection is found only in vertebrates and has been the subject of considerable research. Far less attention has been directed towards innate immunity, as it has been regarded as a relatively nonspecific system, with its main roles being to destroy pathogens and to present antigen to the cells involved in acquired immunity. However, recent studies have shown that the innate immune system has a greater degree of specificity than was previously thought and that it is highly developed in its ability to discriminate between self and foreign pathogens1. This discrimination relies, to a great extent, on a family of evolutionarily conserved receptors, known as the Toll-like receptors (TLRs), which have a crucial role in early host defence against invading pathogens1, 2. Furthermore, accumulating evidence indicates that activation of the innate immune system is a prerequisite for the induction of acquired immunity, particularly for the induction of a T helper 1 (TH1)-cell response3, 4. This marked shift in our thinking has changed our ideas about the pathogenesis and treatment of cancers, and infectious, immune and allergic diseases. In the past few years, our knowledge of TLR signalling and the responses these receptors control has greatly increased. In this review, we discuss the TLRs, focusing on their signalling pathways.  TLR/IL-1R superfamily: structure and function  The discovery of the TLR family began with the identification of Toll, a receptor that is expressed by insects and was found to be essential for establishing dorsoventral polarity during embryogenesis5. Subsequent studies revealed that Toll also has an essential role in the insect innate immune response against fungal infection6. Homologues of Toll were identified through database searches, and so far, 11 members of the TLR family have been identified in mammals. The TLRs are type I integral membrane glycoproteins, and on the basis of considerable homology in the cytoplasmic region, they are members of a larger superfamily that includes the interleukin-1 receptors (IL-1Rs). By contrast, the extracellular region of the TLRs and IL-1Rs differs markedly: the extracellular region of TLRs contains leucine-rich repeat (LRR) motifs, whereas the extracellular region of IL-1Rs contains three immunoglobulin-like domains (Fig. 1a).     Figure 1 |  TLR structure and signalling.  a | Toll-like receptors (TLRs) and interleukin-1 receptors (IL-1Rs) have a conserved cytoplasmic domain, that is known as the Toll/IL-1R (TIR) domain. The TIR domain is characterized by the presence of three highly homologous regions (known as boxes 1, 2 and 3). Despite the similarity of the cytoplasmic domains of these molecules, their extracellular regions differ markedly: TLRs have tandem repeats of leucine-rich regions (known as leucine rich repeats, LRR), whereas IL-1Rs have three immunoglobulin (Ig)-like domains. b | Stimulation of TLRs triggers the association of MyD88 (myeloid differentiation primary-response protein 88), which in turn recruits IRAK4 (IL-1R-associated kinase 4), thereby allowing the association of IRAK1. IRAK4 then induces the phosphorylation of IRAK1. TRAF6 (tumour-necrosis-factor-receptor-associated factor 6) is also recruited to the receptor complex, by associating with phosphorylated IRAK1. Phosphorylated ...",
      "citation": {
        "db": "PubMed",
        "db_id": "15229469"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 129,
      "target": 25,
      "key": "c947300c09ba523bd9659d53eed28814"
    },
    {
      "line": 35,
      "relation": "increases",
      "evidence": "To test whether TAK1, NIK, or PI3K is involved in mediating iron-induced IKK activation, we used an adenoviral vector expressing a DN mutant of each kinase and a green fluorescent protein-expressing vector as a control. Transduction of each DN at m.o.i. of 50 completely prevents iron-induced IKK activation (Fig. 2, A?C). Furthermore, use of the PI3K inhibitor LY294002 results in similar abrogation of IKK activation (Fig. 2D). Addition of U0126, the MEK1 inhibitor, also prevents IKK activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "17172471"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 129,
      "target": 25,
      "key": "490a4f9ff26b4d7f0fda67207408564f"
    },
    {
      "line": 35,
      "relation": "increases",
      "evidence": "TAK1 is thought to activate two divergent pathways that lead to the transcription factors NF-kB and AP-1 through kinase cascades involving the canonical I?B kinase complex (IKK-a, IKK-b, and IKK-g) and MAP kinases (ERK, JNK, p38), respectively, to induce the expression of target genes.",
      "citation": {
        "db": "PubMed",
        "db_id": "15642149"
      },
      "annotations": {
        "cl": {
          "0000451": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 129,
      "target": 25,
      "key": "c56f34069ec3eabd6c00e057a429883a"
    },
    {
      "line": 35,
      "relation": "increases",
      "evidence": "TAK1 activates the IkB kinase (IKK) complex (composed of IKKa, IKKb, and NEMO/IKKa) that in turn phosphorylates the NF-bB inhibitor IkB to induce its K48 polyubiquitination and proteasomal degradation",
      "citation": {
        "db": "PubMed",
        "db_id": "19632174"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 129,
      "target": 25,
      "key": "c20616f255761a38b42c26741b5f0bf2"
    },
    {
      "line": 35,
      "relation": "increases",
      "evidence": "Frequently, this IKK activation is mediated by another upstream kinase, TAK1 (Fig. 4C). (Baud and Karin, 2009).",
      "citation": {
        "db": "PubMed",
        "db_id": "20965422"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 129,
      "target": 25,
      "key": "7edb11c6605d5abfb4a2a4403826238e"
    },
    {
      "line": 36,
      "relation": "increases",
      "evidence": "The IRAK4:IRAK1:TRAF6 complex then interacts at the membrane with another preformed complex consisting of TAK1, TAB1 and TAB2.  This interaction induces phosphorylation of TAB2 and TAK1.  TAK1 is subsuequently activated in the cytoplasm, leading to the activation of IKK.  Activation leads to phosphorylation and degradation of IKB and consequent release of NFKB. Activation of TAK1 also results in the activation of MAP kinases and JNK.",
      "citation": {
        "db": "PubMed",
        "db_id": "12893815"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 129,
      "target": 77,
      "key": "5e03c8438da60021fb14d705657e9d2c"
    },
    {
      "line": 29,
      "relation": "increases",
      "evidence": "Thus, LPS-stimulated Tpl2(-/-) macrophages express low levels of COX-2 and PGE2, compared with wild-type Tpl2(+/+) cells. {Tpl2 Official Gene Symbol: MAP3K8}",
      "citation": {
        "db": "PubMed",
        "db_id": "12234923"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 130,
      "target": 2,
      "key": "0ef449a661ffe84050a4a79e7a888484"
    },
    {
      "line": 40,
      "relation": "increases",
      "evidence": "It is likely that Tpl2 functions downstream of multiple TLRs, including TLR2, TLR7, and TLR9, to induce TNF-α production in response to group B streptococcus.",
      "citation": {
        "db": "PubMed",
        "db_id": "19923465"
      },
      "annotations": {},
      "source": 130,
      "target": 50,
      "key": "3d9087ec8f7953e541b5cd323d0ed440"
    },
    {
      "line": 75,
      "relation": "increases",
      "evidence": "acrolein exclusively increased the phosphorylation of ERK among these MAPK, suggesting a role for the ERK pathway in acrolein-induced 5-LO expression with subsequent production of LTB(4).",
      "citation": {
        "db": "PubMed",
        "db_id": "20153347"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 131,
      "target": 94,
      "key": "1c84aad44c73dc699443461570770fdd"
    },
    {
      "line": 222,
      "relation": "increases",
      "evidence": "acrolein exclusively increased the phosphorylation of ERK among these MAPK, suggesting a role for the ERK pathway in acrolein-induced 5-LO expression with subsequent production of LTB(4).",
      "citation": {
        "db": "PubMed",
        "db_id": "20153347"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 132,
      "target": 94,
      "key": "59cdd2001377a3b908e191665b432c02"
    },
    {
      "line": 102,
      "relation": "increases",
      "evidence": "The key role of the up-regulated mer tyrosine kinase (Mertk) in dexamethasone induced enhancement of phagocytosis could be demonstrated in human monocyte derived macrophages by gene silencing as well as blocking antibodies, and also in a monocyte-macrophage like cell line.",
      "citation": {
        "db": "PubMed",
        "db_id": "21731712"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 133,
      "target": 17,
      "key": "9dcc8de7c778bee934ea8ede1eb3fc3b"
    },
    {
      "line": 102,
      "relation": "increases",
      "evidence": "There was a 2.4-fold increase in the ratio of free-to-macrophage-associated apoptotic cells in the lesions from MertkKD;Apoe-/- mice (P<0.05), consistent with a marked defect in efferocytosis. (MertkKD is inactive Mertk mutant)",
      "citation": {
        "db": "PubMed",
        "db_id": "18451332"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 133,
      "target": 17,
      "key": "491be5e404412a2c45be871ff0584f39"
    },
    {
      "line": 229,
      "relation": "increases",
      "evidence": "This paper demonstrates that SR-A can bind and ingest bacteria directly,\nconsistent with a role in host defense in vivo,",
      "citation": {
        "db": "PubMed",
        "db_id": "10722588"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 138,
      "target": 17,
      "key": "f06f3ddecd778c0a41be593ce7cdae64"
    },
    {
      "line": 229,
      "relation": "increases",
      "evidence": "Our findings demonstrate that SR-AI/II mediate opsonin-independent phagocytosis of gram-positive bacteria",
      "citation": {
        "db": "PubMed",
        "db_id": "10620613"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 138,
      "target": 17,
      "key": "4622c3b3d603d3fe2daec0d52ef42e3f"
    },
    {
      "line": 83,
      "relation": "directlyIncreases",
      "evidence": "We previously demonstrated that human macrophages of different origin express the tyrosine kinase receptor recepteur d'origine nantaise, the human receptor for MSP (RON) and produce superoxide anion (O(2)(-)) when challenged with macrophage-stimulating protein (MSP), the endogenous ligand for RON.",
      "citation": {
        "db": "PubMed",
        "db_id": "16633352"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 139,
      "target": 140,
      "key": "a1bb264cd07a646d20d6bdc34bc125a5"
    },
    {
      "line": 83,
      "relation": "directlyIncreases",
      "evidence": "hepatocyte growth factor-like protein (HGFL), the RON-specific ligand (HGFL = MST1, RON = MST1R)",
      "citation": {
        "db": "PubMed",
        "db_id": "17616662"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 139,
      "target": 140,
      "key": "bfcdfc50a3d8a56f647d019e4fabf81d"
    },
    {
      "line": 83,
      "relation": "directlyIncreases",
      "evidence": "Scatter Factors control a complex genetic program known as 'invasive growth'. HGF (Scatter factor 1) and MSP (Scatter Factor 2) bind to tyrosine kinase receptors encoded by the proto-oncogenes MET and RON.",
      "citation": {
        "db": "PubMed",
        "db_id": "10871856"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 139,
      "target": 140,
      "key": "759f2f6da172bf34df9a3671648c2347"
    },
    {
      "line": 37,
      "relation": "increases",
      "evidence": "MSP activates the transcription factor NF-kappaB;",
      "citation": {
        "db": "PubMed",
        "db_id": "16633352"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 140,
      "target": 27,
      "key": "6c8ceed2b2d9cc99c0b7110cd7ae9747"
    },
    {
      "line": 175,
      "relation": "directlyIncreases",
      "evidence": "MyD88 promotes association with IRAK4 and IRAK1.  During the formation of this complex, IRAK4 is activated, leading to the hyperphosphorylation of IRAK1, which then induces interaction of TRAF6 with the complex.",
      "citation": {
        "db": "PubMed",
        "db_id": "12893815"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 141,
      "target": 75,
      "key": "b6284014134bdbfa70f64fddfcf4a8eb"
    },
    {
      "relation": "hasComponent",
      "source": 142,
      "target": 27,
      "key": "18daf0568be38eabc155940e935136eb"
    },
    {
      "relation": "hasComponent",
      "source": 143,
      "target": 27,
      "key": "931cba4379cc41ee585acf65e96e0de0"
    },
    {
      "relation": "hasVariant",
      "source": 144,
      "target": 145,
      "key": "9189bbd696e08ae7137bdc34b83014b8"
    },
    {
      "relation": "hasVariant",
      "source": 144,
      "target": 146,
      "key": "a168833b9b225c376b1d124a625abee5"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "It also associates specifically with phosphorylated IkappaBalpha and beta-catenin destruction motifs, probably functioning in multiple transcriptional programs by activating the NF-kappaB pathway and inhibiting the beta-catenin pathway.",
      "citation": {
        "db": "PubMed",
        "db_id": "11850407"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "d8d6c3c66ce6699a3a629325d6cca7de"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Upon phosphorylation by IKKs, I{kappa}B proteins are recognized and ubiquitinated by members of the Skp1-Culin-Roc1/Rbx1/Hrt-1-F-box (SCF or SCRF) family of ubiquitin ligases (for review, see Ben-Neriah 2002Go) and subsequently degraded (Modified from full text).",
      "citation": {
        "db": "PubMed",
        "db_id": "15371334"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "62d7a11d8e8f64cc30c48f9058975e62"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Activation-induced induction of transcription factor NFkappaB in T lymphocytes is regulated by its inhibitor IkappaBalpha. NFkappaB activation has been demonstrated to occur either by phosphorylation on serine residues 32 and 36 of the inhibitor, IkappaBalpha, followed by ubiquitination and degradation of the inhibitor by the 26S proteasome, or by a proteasome-independent mechanism involving tyrosine phosphorylation, but not degradation.",
      "citation": {
        "db": "PubMed",
        "db_id": "16271147"
      },
      "annotations": {
        "cl": {
          "0000542": true
        }
      },
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "907bb66e74167408e7df8eefc0d6fc6e"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "ursodeoxycholic acid UDCA inhibited TGF-beta1-induced degradation of nuclear factor kappaB (NF-kappaB) and its inhibitor IkappaB (p < 0.05).",
      "citation": {
        "db": "PubMed",
        "db_id": "14514686"
      },
      "annotations": {
        "cl": {
          "0000182": true
        }
      },
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "3c16c12b2fa1d44e36a4954e667f0a5d"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "NFKB PDTC Preclinical treatment (44) PS-341 Preclinical treatment (45,46)",
      "citation": {
        "db": "PubMed",
        "db_id": "14587863"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "1577054ca9411d6eb5fdf95a9be83512"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "# from full text # Here we show that UVC radiation leads to activation of a signaling pathway, distinct from the IKK pathway, which induces I?B? degradation in a manner dependent on phosphorylation of a cluster of C-terminal sites. The kinase that phosphorylates these sites is CK2.",
      "citation": {
        "db": "PubMed",
        "db_id": "14580335"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "9e03dc6c1ca3c8881577278c19e92f55"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Two related kinases, IkappaB kinase alpha (IKKalpha) and IKKbeta, phosphorylate the IkappaB proteins, leading to their degradation and the subsequent activation of gene expression by NF-kappaB",
      "citation": {
        "db": "PubMed",
        "db_id": "10779355"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "a2e29620c86e1b828ce70b09f5b72c18"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Reconstitution of NEMO-deficient Jurkat cells with wild-type, but not NEMOL329P, restored TNF-alpha-induced IkappaB degradation. Similar results were obtained for TNF-alpha-induced IkappaB degradation (Fig. 3c, d) and NF-kappaB binding (Fig. 3e) in NEMO-deficient mouse embryonic fibroblast (MEF) subclones reconstituted with wildtype NEMO or NEMOL329P.",
      "citation": {
        "db": "PubMed",
        "db_id": "16547522"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "e55831160379775caf2c67b68f16ce6c"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "TNF induced NF-kappaB activation as measured by DNA binding but deletion of PKR abolished this activation.This inhibition was associated with suppression of inhibitory subunit of NF-kappaB (IkappaB)alpha kinase (IKK) activation, IkappaBalpha phosphorylation and degradation, p65 phosphorylation and nuclear translocation, and NF-kappaB-dependent reporter gene transcription.",
      "citation": {
        "db": "PubMed",
        "db_id": "16924232"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "3b2ebd3f89c3b6df59c02b7d808784f9"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Figures 2C and D show that exposure to hyperoxia induced a degradation of I?B?, supporting the EMSA data for hyperoxia-induced NF-?B activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "15477018"
      },
      "annotations": {
        "cl": {
          "0002328": true
        }
      },
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "90b9055203d59283886b458bc4de075a"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "overexpressing PKC-zeta results in lower steady-state protein levels of free IkappaBalpha, which is dependent on S293.",
      "citation": {
        "db": "PubMed",
        "db_id": "10764587"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "04b4e4e4eaba319c185d8768776f76b4"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Activation of NF-kappaB mainly occurs via IkappaB kinase (IKK)-mediated phosphorylation of inhibitory molecules, including IkappaBalpha",
      "citation": {
        "db": "PubMed",
        "db_id": "15653325"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "7d0293e988b5b57ce816f431a3ef54fb"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "SUMO-1 modification was found to antagonize IkappaBalpha ubiquitination and protect it from degradation",
      "citation": {
        "db": "PubMed",
        "db_id": "10788439"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "09be8ad86dbcb12d26f883128e64a888"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "from the paper:",
      "citation": {
        "db": "PubMed",
        "db_id": "11909978"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "1537c1167812c8cbaa203ea8ce9ca8ec"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "PKC (protein kinase C) enzymes which phosphorylate IkappaBalpha, leading to its degradation",
      "citation": {
        "db": "PubMed",
        "db_id": "15330761"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "39aa7b4aefbe31618a903e845c00611b"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Expression of SphKG82D dramatically blocked the degradation of IKBa (Fig. 5a) and inhibited the NF-KB DNA binding activity in a dose-dependent manner (Fig. 5, b and c).",
      "citation": {
        "db": "PubMed",
        "db_id": "11777919"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "614cea52eda7f244875cd1750dea1720"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Treatment of A549 cells with TGF-beta1-induced IkappaB kinase alpha/beta (IKKalpha/beta) phosphorylation, IkappaBalpha phosphorylation, IkappaBalpha degradation, p65 Ser536 phosphorylation, and kappaB-luciferase activity. The TGF-beta1-mediated increases in IKKalpha/beta phosphorylation, p65 Ser536 phosphorylation, and kappaB-luciferase activity were inhibited by LY 294002, an Akt inhibitor",
      "citation": {
        "db": "PubMed",
        "db_id": "17307160"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "907e476b7307d4c9d2de7969f1af3821"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Figure 1. Pathways to MUC5AC expression in COPD",
      "citation": {
        "db": "PubMed",
        "db_id": "17615396"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "5d50763857cfd7547e6e2ee35cf697e5"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Since activation of NF-B in A549 cells is dependent on IKK2, which phosphorylates serines 32 and 36 of IB as a prelude to IB degradation and activation of NF-B (Catley et al., 2005",
      "citation": {
        "db": "PubMed",
        "db_id": "17322026"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "366525fc7e0ecd67fa479bd4f50f96b1"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Ubiquitin-tagged Ikappa Balpha  is degraded by the proteasome releasing NF-kappa B for migration to the nucleus. As a first approach to check the role of NF-kappa B in PKR-induced apoptosis, the NF-kappa B induction pathway was blocked by using the specific proteasome inhibitors, lactacystin and PSI.",
      "citation": {
        "db": "PubMed",
        "db_id": "10373514"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "ad394371a2e0423aeea47a7618cb67d9"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Activation of NF-kappaB by TNF-alpha occurred within 15 min and coincided with rapid degradation of IkappaBalpha. Co-treatment with NO donors did not prevent IkappaBalpha phosphorylation or degradation. However, after 2 h of TNF-alpha stimulation, NO donors inhibited NF-kappaB activation and augmented IkappaBalpha resynthesis and nuclear translocation by 2.5- and 3-fold, respectively. This correlated with a 75% reduction in TNF-alpha-induced VCAM-1 expression. In a time-dependent manner, NO donors alone caused the nuclear translocation of IkappaBalpha",
      "citation": {
        "db": "PubMed",
        "db_id": "9388244"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "0897a888dfad0cd25c9def47af67706e"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "We found that IL-1 caused rapid phosphorylation of ERK1/2, JNK, p38, MKK3/6, Akt, IKK, c-Jun, ATF-2, ATF-1, CREB, p65, and IKBa, induced the degradation of IKBa and IKBe, and activated the synthesis of c-fos (Fig. 4)",
      "citation": {
        "db": "PubMed",
        "db_id": "19074142"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "eeb7bf54d37cd0bfd1be65ac9436b608"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "neutrophil stimulation with pro-inflammatory signals results in degradation of IkappaBalpha that occurs in both cytoplasm and nucleus.",
      "citation": {
        "db": "PubMed",
        "db_id": "12244195"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "c84a6dccfb8e31e2990653e9eaa43a99"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Moreover, immunopurified beta-TrCP ubiquitinates phosphorylated IkappaBalpha at specific lysines in the presence of Ub-activating (E1) and -conjugating (Ubch5) enzymes.",
      "citation": {
        "db": "PubMed",
        "db_id": "9990853"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "729e889cebdd435e86fc7fdb2b791259"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "The microtubule disassembly also induced IkappaB degradation.",
      "citation": {
        "db": "PubMed",
        "db_id": "11306700"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "580e0b72d939b50f789fd0ee95d98a3b"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "CHUK specifically phosphorylates IkappaB-alpha on both serine 32 and serine 36, modifications that are required for targeted degradation of IkappaB-alpha via the ubiquitin-proteasome pathway",
      "citation": {
        "db": "PubMed",
        "db_id": "9244310"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "2bfa6fe0e04ffe4b7e19eca345d9e11c"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "The activation of TLR2 by Pam3CSK4 induced the degradation of the NF-kB inhibitor IkBa in human monocyte-derived macrophages. NF-kB activation was blocked by S1P at low micromolar concentrations. Statistically significant inhibition of TLR2-dependent NF-kB activation was observed with 1 mM S1P, which argues in favour of a receptor-dependent and physiologically relevant effect (Figure 4A).",
      "citation": {
        "db": "PubMed",
        "db_id": "18411230"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "565af14d5825d39a7e2814d2751a3198"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Furthermore, TWEAK induced rapid phosphorylation of IkappaB-alpha in human keratinocytes.",
      "citation": {
        "db": "PubMed",
        "db_id": "15140220"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "d7589dd8eddb4c0b4e27b5625ba5e51e"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Phosphorylation of IkappaBalpha at serine 32 (S32) and serine 36 (S36) is necessary for this stimuli-induced degradation. IKKalpha/beta kinases and p90(rsk1)are involved in stimuli-induced targeting of one or both of these IkappaBalpha sites.",
      "citation": {
        "db": "PubMed",
        "db_id": "10398585"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "0f9b7083052f9bff68ac6df0c057d3ba"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "The mechanism of adiponectin action in endothelial cells has been further investigated. TNF-A activates nuclear transcription factor NF-KB in these cells by stimulating protein kinase NIK (NF-kB inducing kinase), which phosphorylates the NF-kB inhibitor, IkB, initiating its degradation and thus leading to NF-KB activation. NF-KB stimulates the expression of cytokines and adhesion molecules involved in the inflammatory process.",
      "citation": {
        "db": "PubMed",
        "db_id": "15916985"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "ec91a1d0db2ac28fc180d16efb6053d6"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "5alpha-dihydrotestosterone achieved this effect through maintenance of IkappaBalpha protein levels in the face of phorbol ester, a stimulus that results in IkappaBalpha degradation",
      "citation": {
        "db": "PubMed",
        "db_id": "8824277"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "5114151e19ba631a5a4c19129660a9a9"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "fro full text Results - Plumbagin inhibited TPA-induced DNA-binding activities of NF-kB, c-Fos, and c-Jun/IkBa degradation and phosphorylation in A549 cells",
      "citation": {
        "db": "PubMed",
        "db_id": "19768635"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "7c4efca165e71a8162f2e2f10f5f50db"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "phosphorylation and ubiquitination-dependent degradation of IkappaBalpha, the cytoplasmic inhibitor of NFkappaB, via the inducible IkappaB kinase (IKK) complex, liberates NFkappaB to translocate into the nucleus and to transcriptionally activate its target genes, including the IL2 gene",
      "citation": {
        "db": "PubMed",
        "db_id": "12044776"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "5aed1e9148d974dd2b64d1d9fccf7d83"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "IL-33 rapidly activated ERK1/2, JNK, p38, and NF-kB signaling cascades, as evidenced by phosphorylation of MAP kinases and phosphorylation and degradation of the NF-kB inhibitor IkB-a.",
      "citation": {
        "db": "PubMed",
        "db_id": "18955562"
      },
      "annotations": {
        "cl": {
          "0000767": true
        }
      },
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "e47548cb63266aa67f60cfa6b174548b"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Here we show that beta-arrestin2 directly interacts with IkappaBalpha (inhibitor of NF-kappaB, the key molecule in innate and adaptive immunity) and thus prevents the phosphorylation and degradation of IkappaBalpha. Consequently, beta-arrestin2 effectively modulates activation of NF-kappa",
      "citation": {
        "db": "PubMed",
        "db_id": "15125834"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "83876963bf8549b98d32455a465b9b3b"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "PAR-4 was found to directly inhibit the phosphorylation and degradation of I kappa B alpha, which led to the loss of NF kappa B activity causing repression of endogenous and radiation-induced Bcl-2 protein.",
      "citation": {
        "db": "PubMed",
        "db_id": "12170775"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "bda45af89c3c14a451186c1d7d66fd85"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "SAA induced IkappaB-alpha degradation, RelA serine 536 (S536) phosphorylation, NF-kappaB transcriptional activity",
      "citation": {
        "db": "PubMed",
        "db_id": "15724247"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "d33831fcc964d7dd3ac9a77e33f69b5a"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Consistent with this, these reagents also eliminate the ability of the Skp1-CUL1-HOS-ROC1 E3 ligase complex to support the ubiquitination of IkappaBalpha.",
      "citation": {
        "db": "PubMed",
        "db_id": "10748083"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "f291d796d7606e8ee8753f528c636d0b"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Cytoplasmic and total cell protein extracts were analyzed by Western blotting for total IkBa and IkBa phosphorylated at serine residues 32 and 36. LPS exposure induced the rapid (within 15 min) phosphorylation and degradation of IkBa in both THP-1 cells (p,0.0001 for both processes; Figure 8, A and B) and elutriated primary human monocytes (p =0.003 and p,0.0001, respectively, ANOVA post hoc contrast of LPS vs. control for each; Figure 8, C and D).",
      "citation": {
        "db": "PubMed",
        "db_id": "19956541"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "0ceedafc6998a093db7bb595e5a2a848"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "In human neutrophils, TNF-alpha (200 U/ml) induced rapid I kappa B-alpha degradation",
      "citation": {
        "db": "PubMed",
        "db_id": "15162444"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "da53d8f0dcdd710423380d7081480654"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "We demonstrated recently that BCL11B controls expression from the IL (interleukin)-2 promoter through direct binding to the US1 (upstream site 1). In the present study, we provide evidence that BCL11B also participates in the activation of IL-2 gene expression by enhancing NF-kappaB (nuclear factor kappaB) activity in the context of TCR (T-cell receptor)/CD28-triggered T-cell activation. The enhanced IkappaB degradation in cells with increased levels of BCL11B was specific for T-cells activated through the TCR, but not for cells activated through TNFalpha (tumour necrosis factor alpha) or UV light, and was caused by increased activity of IkappaB kinase, as indicated by its increase in phosphorylation.",
      "citation": {
        "db": "PubMed",
        "db_id": "18831712"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "ea330d5286540b79fd0849e8ad3b5708"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "As shown in Fig. 10C, TNF-a rapidly induced complete degradation of I-kB-a",
      "citation": {
        "db": "PubMed",
        "db_id": "10946303"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "23abe19a09f9c83e30a9ae8222cbcb82"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "The actual recognition of N-terminally phosphorylated IKappaBs is carried out by aWD repeat- and F box-containing protein called beta-TrCP (Ben-Neriah, 2002). Upon ubiquiti-nation, the IKappaB proteins are rapidly degraded by the proteasome,",
      "citation": {
        "db": "PubMed",
        "db_id": "11983155"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "6fa347af3b2146f95fac42942e2f4716"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "The lipopolysaccharide-induced degradation of IL-1R-associated kinase 1, IkappaBalpha, and IkappaBbeta was inhibited by elafin",
      "citation": {
        "db": "PubMed",
        "db_id": "16980310"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "7cabc541d572595b95b7995706f9849e"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Inducers of NF-kB, which include inflammatory cytokines, reactive oxygen species, and viral products, activate a dimeric IkB kinase (IKK) complex, which phophorylates IkBa leading to subsequent ubiquitination and degradation of IkBa and release of NF-kB proteins [33,34].",
      "citation": {
        "db": "PubMed",
        "db_id": "14561188"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "1ed6196a3e2b2b3804bf24fe09547349"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "These studies provide new evidence that the protein kinase CKII physically associates with I kappa B alpha in vivo, induces multisite (serine/threonine) phosphorylation, and is required for the basal and HIV-induced degradation of I kappa B alpha in vitro.",
      "citation": {
        "db": "PubMed",
        "db_id": "8622692"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "1da0b820e7d7992a8faa7759d3a546bd"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "In contrast to the serine 32/34 phosphorylation that triggers ubiquitination and degradation of IkappaBalpha, c-Abl-mediated phosphorylation at tyrosine 305 is associated with an increase of the IkappaBalpha protein stability. We also demonstrate that c-Abl targets the nuclear subpopulation of IkappaBalpha for phosphorylation and induces it to accumulate in the nucleus",
      "citation": {
        "db": "PubMed",
        "db_id": "12167702"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "c8b6239740df0ffd62ed9865631b22f7"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "The IRAK4:IRAK1:TRAF6 complex then interacts at the membrane with another preformed complex consisting of TAK1, TAB1 and TAB2.  This interaction induces phosphorylation of TAB2 and TAK1.  TAK1 is subsuequently activated in the cytoplasm, leading to the activation of IKK.  Activation leads to phosphorylation and degradation of IKB and consequent release of NFKB. Activation of TAK1 also results in the activation of MAP kinases and JNK.",
      "citation": {
        "db": "PubMed",
        "db_id": "12893815"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "3570078743c8c35a733799e5b8df1960"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "CD86 stimulation also increased the level of IkappaB-alpha phosphorylation but in a protein kinase C-independent manner",
      "citation": {
        "db": "PubMed",
        "db_id": "15024018"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "3937733bcee177ff24e9b4ad9f0b2556"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "In human embryonic kidney 293 cells, IL-1beta induces IkappaB kinase beta (IKKbeta) activation, IkappaBalpha degradation, NF-kappaB transactivation, and weak Akt activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "11976320"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "89ddf14e07adb7e1e019db18f01c7d24"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "we found that IL-33R signaling induced a time-dependent activation of Erk1/2, protein kinase B (PKB), JNK1/2, NF-kB, and p38, and degradation of IkB (supplemental Figure 1B).",
      "citation": {
        "db": "PubMed",
        "db_id": "20200353"
      },
      "annotations": {
        "cl": {
          "0000097": true
        }
      },
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "806ec8322be7e64b2a79f38ced7fe35c"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "To exclude off-target effects, SphK1 expression was also downregulated with siRNAs targeted to two other regions of the SphK1 sequence and both inhibited TNF-alpha-induced phosphorylation of IkBalpha and IKKalpha/beta (Supplementary Fig. 2a). Similar results were obtained in several other cell types (Supplementary Fig. 2b), suggesting that SphK1 has a general role in the canonical NF-kappaB pathway.  To conclusively demonstrate the involvement of SphK1, we also used pharmacological and genetic approaches. The specific SphK1 inhibitor, SK1-I, which decreases intracellular S1P levels 6, reduced TNF-alpha-induced I?B? degradation and phosphorylation of IKKalpha/beta (Fig. 1b)",
      "citation": {
        "db": "PubMed",
        "db_id": "20577214"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "34c4aeec7720464450b4fc714f68c8b9"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "The Bcl-2-mediated loss of IkappaBalpha could be prevented by the proteasome inhibitor lactacystin, consistent with the notion that the targeted degradation of IkappaBalpha consequent to overexpression of Bcl-2 utilizes the ubiquitin-proteasome pathway.  This was further tested in human 293 cells in which the N-terminal region of IkappaBalpha was identified to be an important regulatory site for Bcl-2. Deletion of this region or a serine to alanine substitution mutant at amino acids 32 and 36, which are defective for both phosphorylation and degradation, were more resistant than wild type IkappaBalpha to the inhibitory effects of Bcl-2.",
      "citation": {
        "db": "PubMed",
        "db_id": "9727009"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "dad9caeca3481bf334f48b5331e2c557"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "We investigated its role in NF-?B activation and ROS production induced by TNF-? by using rapamycin (sirolimus), a well-characterized immunosuppressant and potent inhibitor of the signaling cascade. As described above, the phosphorylation and subsequent degradation of I?B play a critical role in regulating NF-?B translocation to the nucleus and subsequent transcriptional regulation. In Figure 6, we asked if rapamycin has any effect on TNF-?-induced degradation of I?B?; clearly, it did. I?B? is largely stabilized by the pretreatment.",
      "citation": {
        "db": "PubMed",
        "db_id": "18463678"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "fa2702e8d5ecbdb83de7c02bf8f2347f"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Pretreatment with EGF protected monolayers by increasing native PKC-beta1 activity, decreasing IkappaBalpha phosphorylation/degradation, suppressing NF-kappaB activation (p50/p65 subunit nuclear translocation/activity), enhancing stable actin (increased F-actin-to-G-actin ratio), increasing stability of actin cytoskeleton, and reducing barrier hyperpermeability.",
      "citation": {
        "db": "PubMed",
        "db_id": "14602581"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "ec3a55db40143031d37f4dc6679cc786"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Simultaneous overexpression of selenophosphate synthetase and phospholipid-hydroperoxide GSH peroxidase (PHGPx) [250] blocks activation of NF-kB by IL-1. Overexpression of SOD [84] or GSH peroxidase [81, 211] abolished NF-kB activation by preventing degradation of IkB after stimulation with TNF-a. The precise mechanism(s) through which oxidants and reductants influence activation of NF-kB is presently unknown; however, there is evidence that antioxidant enzyme (AOE372), a redox-sensitive thioredoxin peroxidase, regulates IkB phosphorylation [246]. Phosphatases The phosphatases are an important component of most signal transduction pathways, because failure to reverse kinase actions can disrupt normal cellular functions. For example, transfection of human fibroblasts with constitutively active ras (hRasV12) inhibits cell growth and ultimately results in a senescentlike phenotype [441]. Similarly, constitutive ERK activation has an inhibitory effect on cell cycle progression [442,443]. Both the serine/threonine phosphatases and the PTPs are known to be redox-sensitive [82,144,153,156,271,281, 444-449]. The mechanism of redox effects on activity is probably best understood for the PTPs. Without exception, the PTPs contain a highly conserved region of 11 amino acid residues in their catalytic domain; specifi- cally, (Ile/Val)-His-Cys-X-Ala-Gly-X-X-Arg-(Ser/Thr)- Gly, where X is a nonconserved amino acid [17]. Either oxidation or mutation of the cysteine renders these molecules inactive [17,281]. H2O2 is a potent inhibitor of PTPs. As in the case of other oxidants, H2O2 probably oxidizes the thiolate anion at the catalytic site [280]. Because formation of a phosphorylcysteine intermediate seems to be critical to PTP activity [450-452], blocking it through oxidation of the cysteine inactivates the molecules. In many cases, treatment of cells with H2O2 stimulates increases in protein phosphorylation by inhibiting phosphatase-catalyzed removal of phosphate groups. Furthermore, mitogens that increase cellular ox- idant production may stimulate phosphorylation indirectly by decreasing phosphatase activity. Additional mechanisms are involved in stimulation of pathways activated by growth factors that increase oxidant production, however, because there are known instances in which the oxidants they produce have no effect on protein phosphorylation. For example, TGF-b1 stimulates phosphorylation of numerous proteins and has been shown to cause a large increase in H2O2 production; however, its effects on protein phosphorylation are not blocked by catalase [453]. Furthermore, H2O2 is effective in promoting phosphorylation of phospholipase D, the PDGF receptor, and PKC-a even after pretreatment of Swiss 3T3 fibroblasts with orthovanadate to inhibit phosphatases [454]. Thus, although diminished phosphatase activity may partially account for increased phosphorylation in some cases, it cannot totally account for oxidation effects on phosphorylation in every case. SPECIFICITY In general, there is good agreement between studies on redox effects on any given gene; albeit, not all oxidizing or reducing treatments exert equivalent effects. This is clearly demonstrated in studies of pag , which encodes a protein associated with cellular proliferation. Pag protein inhibits the tyrosine kinase activity of the Abelson (abl ) protein by binding to its SH3-binding domain [455]. BSO, menadione, sodium arsenate, and diethyl maleate all stimulate pag expression, but H2O2 does not [269]. Conversely, H2O2 stimulates c-fos expression (Table 1), although 4-hydroynonenal (a product of v-6-polyunsaturated fatty acid peroxidation) not only fails to induce c-fos expression but is actually inhibitory to c-fos induction by EGF and PDGF [185]. Similarly, some oxidants such as diamide decrease hypoxia-induced signals [201], although others such as H2O2 increase them [124]. As might be expected, the effects of any stimu...",
      "citation": {
        "db": "PubMed",
        "db_id": "10699758"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "464e560dbce77e9737d96ee301f3e895"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "TNF-alpha induced both phosphorylation and degradation of IKappaB-alpha in A549 cells within several minutes",
      "citation": {
        "db": "PubMed",
        "db_id": "15489375"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "d928db79b006f8e59791bab63bb2134a"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "agents that inhibit NF?B activation are desired, and are currently being pursued,based on strategies that seek to maintain levels of endogenous NF?B-inhibiting I?B-family proteins, by either suppressing the IkB kinases (IKKs) responsible for phosphorylation of IkBalpha (which induces its polyubiquitination) or blocking the proteolytic activity of the 26s proteasome responsible for degrading IkB following ubiquitination (Figure 2A).",
      "citation": {
        "db": "PubMed",
        "db_id": "12559172"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "89d42d98cf5635dca8d133571237efa9"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Similar to wild-type A549 cells, treatment with TNF-? for 30 min induced I?B? degradation in vector control cells (Fig. 4B). On the other hand, TNF-?-induced I?B? degradation was blunted in DN I?B mutant cells (Fig. 4B), further supporting that these DN I?B mutant cells are less efficient in response to a NF-?B activator compared to the vector control cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "15477018"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "153d0fd38fe84ac01d70ae180785d250"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Stimulation of the MDMs with CSM for 30 min induced the phosphorylation of IRAK which was abolished by adding NAC (Fig. 6A). Moreover, CSM and LPS (as a control) degradated I?B-? and preincubation of MDMs with NAC suppressed the degradation of I?B-? induced by CSM (Fig. 6D).",
      "citation": {
        "db": "PubMed",
        "db_id": "19409098"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "1050c9fb745cb5ad1041a227525b815b"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Moreover, IGF-I-mediated dephosphorylation of IkappaBalpha protects this molecule from tumor necrosis factor alpha (TNFalpha)-stimulated degradation; therefore, IGF-I also inhibits the nuclear translocation of NFkappaB (p65) induced by TNFalpha exposure.",
      "citation": {
        "db": "PubMed",
        "db_id": "10973957"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "cf926160af77450c211b39faaa4e479f"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "the I-kappaB kinase (IKK) is present and may phosphorylate I-kappaB during platelet activation. Coupled with intracellular calcium flux, this leads to I-kappaB dissociation from the NF-kappaB/I-kappaB complex and proteolysis.",
      "citation": {
        "db": "PubMed",
        "db_id": "12297126"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "d5d9231c526742ab516672216e9a5163"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "reducing endogenous levels of ASC using siRNA enhanced TNF- and LPS-induced degradation of the IKK substrate, IkappaBalpha.",
      "citation": {
        "db": "PubMed",
        "db_id": "12486103"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "f75eb58a1bb49ae1fabfe21db8b9a591"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "HSP27 does not affect I-kappaBalpha phosphorylation but enhances the degradation of phosphorylated I-kappaBalpha by the proteasome. The interaction of HSP27 with the 26S proteasome is required to activate the proteasome and the degradation of phosphorylated I-kappaBalpha. A protein complex that includes HSP27, phosphorylated I-kappaBalpha, and the 26S proteasome is formed",
      "citation": {
        "db": "PubMed",
        "db_id": "12897149"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "7a0b18a5f0293985a363e35e9b56ea0a"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "The incubation of ECs for 1 h in the presence of TNF-a alone induced significant degradation of IkB-a.",
      "citation": {
        "db": "PubMed",
        "db_id": "20351055"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "7000d803db07785940c27322f9822453"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "OPN also induces NFkappaB activation through phosphorylation and degradation of IkappaBalpha by inducing the IKK activity.",
      "citation": {
        "db": "PubMed",
        "db_id": "12771144"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "6d14b1ef479bb8de86ad801eac72cef9"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "MIP-1alpha treatment stimulated the degradation of IkappaBalpha, a cytoplasmic inhibitor of NF-kappaB",
      "citation": {
        "db": "PubMed",
        "db_id": "11152622"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "2f493ddda3168e2e2fcf96f13606dc03"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "ctivation of NF-kappaB by TNF and IL-1 is initiated by the phosphorylation of the inhibitory subunit, IkappaB, which targets IkappaB for degradation and leads to the release of active NF-kappaB.",
      "citation": {
        "db": "PubMed",
        "db_id": "9418855"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "ef9a55a4bb5f1798f37d8236fb743eed"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "The degradation of IKappaB-alpha at 20 min after stimulation by LPS was completely abolished in the presence of paxilline",
      "citation": {
        "db": "PubMed",
        "db_id": "16951373"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "409f1a86f7fffd97b4888fbd5d374d42"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "BetaTrCP and HOS are closely related F-box proteins, which play key roles in ubiquitination and degradation of beta-catenin and IkappaB through associating with those phosphorylated substrates and recruiting SCF E3 ubiquitin ligase",
      "citation": {
        "db": "PubMed",
        "db_id": "11850814"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "db7a127b37fc89e8046731bff8e7ad5c"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "CSM-induced activation of TLR-4 has been shown to induce IRAK1 phosphorylation and TRAF6 degradation. An increase in IkB phosphorylation and degradation is also observed which ultimately leads to the translocation of NF-kB (p65) into the nucleus. The ability of cigarette smoke condensate (CSC) to activate NF-kB has also been demonstrated in another study using U937 cells. CSC has been shown to induce the activation of IKK (-a and -b) at 15 minutes post treatment, which resulted in increased phosphorylation of I?-B? at serine 32, resulting in Ik-Ba degradation and subsequent activation of NF-kB [53].",
      "citation": {
        "db": "PubMed",
        "db_id": "19842832"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "05c968029fa2e99ec7b5b86af6543c5b"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "Immunoblotting analyses revealed that constitutively active AKT2 significantly promoted IkBalpha degradation (Fig. 4D).",
      "citation": {
        "db": "PubMed",
        "db_id": "12048203"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "ef6413934b4cd838c4394a919c3cfb81"
    },
    {
      "line": 1,
      "relation": "directlyDecreases",
      "evidence": "In turn, IKK2 phosphorylates inhibitor of NF-kappaB (I-kappaBalpha), leading to its ubiquitination and subsequent degradation by the proteasome. This frees up the p65 and p50 subunits of NF-kappaB, which translocate to the nucleus. Intranuclear NF-kappaB then binds to kappaB recognition sites in the 5'-promoter (upstream) region of inflammatory genes, resulting in increased gene transcription, messenger RNA, and synthesis of inflammatory proteins.",
      "citation": {
        "db": "PubMed",
        "db_id": "16865089"
      },
      "annotations": {},
      "subject": {
        "modifier": "Degradation"
      },
      "source": 144,
      "target": 144,
      "key": "97a8a454d125e095d4e339b2884b9695"
    },
    {
      "line": 226,
      "relation": "directlyDecreases",
      "evidence": "from the paper:",
      "citation": {
        "db": "PubMed",
        "db_id": "11909978"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 144,
      "target": 27,
      "key": "0af7ec4898af89e5de9d52062dfed06c"
    },
    {
      "line": 226,
      "relation": "directlyDecreases",
      "evidence": "This was accompanied by reduced lung caspase-3 activity and defective degradation of NF-kappaB inhibitor IkappaB-alpha.",
      "citation": {
        "db": "PubMed",
        "db_id": "18372427"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 144,
      "target": 27,
      "key": "94d661c22a62a80a0a21126523cf3561"
    },
    {
      "line": 226,
      "relation": "directlyDecreases",
      "evidence": "The key event in the NF-?B activation is the IL-1-induced phosphorylation and degradation of the inhibitory cytoplasmic protein I?B, which leads to the release of NF-?B, its translocation to the nucleus and binding and transcriptional regulation of its target genes",
      "citation": {
        "db": "PubMed",
        "db_id": "21776333"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 144,
      "target": 27,
      "key": "03876cca4b9d8e376dff709689007904"
    },
    {
      "line": 226,
      "relation": "directlyDecreases",
      "evidence": "Exercise resulted in up to 2-fold increases in IKKalpha/beta phosphorylation in the soleus and red gastrocnemius muscles throughout the time course studied. In red gastrocnemius muscles, NF-kappaB activity increased 50% 1-3 h following 60 min of treadmill exercise, and returned to basal by 5 h. Contraction of isolated extensor digitorum longus (EDL) muscles in vitro increased IKKalpha/beta phosphorylation 10-fold and this was accompanied by a parallel increase in IkappaBalpha phosphorylation.",
      "citation": {
        "db": "PubMed",
        "db_id": "15888549"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 144,
      "target": 27,
      "key": "13801ec58c326b2b56a69656ec66975d"
    },
    {
      "line": 226,
      "relation": "directlyDecreases",
      "evidence": "TAK1 activates the IkB kinase (IKK) complex (composed of IKKa, IKKb, and NEMO/IKKa) that in turn phosphorylates the NF-bB inhibitor IkB to induce its K48 polyubiquitination and proteasomal degradation",
      "citation": {
        "db": "PubMed",
        "db_id": "19632174"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 144,
      "target": 27,
      "key": "1cb41e24c83adbcff583c0d4a4e5962d"
    },
    {
      "line": 226,
      "relation": "directlyDecreases",
      "evidence": "Here, we demonstrate that in astrocyte cultures IGF-I regulates NFkappaB, a transcription factor known to play a key role in the inflammatory reaction. IGF-I induces a site-specific dephosphorylation of IkappaBalpha (phospho-Ser(32)) in astrocytes.",
      "citation": {
        "db": "PubMed",
        "db_id": "10973957"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 144,
      "target": 27,
      "key": "d94792e70aadcdff2e1ab2f6a53cbc4e"
    },
    {
      "line": 226,
      "relation": "directlyDecreases",
      "evidence": "In most cell types, the NFkB p50-p65 dimer is bound to one of the closely related endogneous  inhibitory proteins, collectively referred to as IkB, and is held inactive in the cyotplasm. A variety of extracellular signaling, including LPS, cytokines, stress factors have been reported to activate NFkb through phosphorylation of IkB at serine-32 and serine-36, dissociation of IkB from the complex, and translocation of the p50-p65 dimer fromt he cytolplasm to the nucleus.",
      "citation": {
        "db": "PubMed",
        "db_id": "12882972"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 144,
      "target": 27,
      "key": "23274ec089bd1001ec630bdff2f5543a"
    },
    {
      "line": 226,
      "relation": "directlyDecreases",
      "evidence": "Since activation of NF-B in A549 cells is dependent on IKK2, which phosphorylates serines 32 and 36 of IB as a prelude to IB degradation and activation of NF-B (Catley et al., 2005",
      "citation": {
        "db": "PubMed",
        "db_id": "17322026"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 144,
      "target": 27,
      "key": "59dd2cb6b8a090a1dacfc505a74b1c03"
    },
    {
      "line": 7,
      "relation": "directlyIncreases",
      "evidence": "Phosphorylation of IkappaBalpha at serine 32 (S32) and serine 36 (S36) is necessary for this stimuli-induced degradation. IKKalpha/beta kinases and p90(rsk1)are involved in stimuli-induced targeting of one or both of these IkappaBalpha sites.",
      "citation": {
        "db": "PubMed",
        "db_id": "10398585"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 145,
      "target": 144,
      "key": "a78467dc22917dad60c30dff65ec72f9"
    },
    {
      "line": 7,
      "relation": "directlyIncreases",
      "evidence": "Since activation of NF-B in A549 cells is dependent on IKK2, which phosphorylates serines 32 and 36 of IB as a prelude to IB degradation and activation of NF-B (Catley et al., 2005",
      "citation": {
        "db": "PubMed",
        "db_id": "17322026"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 145,
      "target": 144,
      "key": "776969075a661bc5df71407f7bbf0b4d"
    },
    {
      "line": 7,
      "relation": "directlyIncreases",
      "evidence": "Activation-induced induction of transcription factor NFkappaB in T lymphocytes is regulated by its inhibitor IkappaBalpha. NFkappaB activation has been demonstrated to occur either by phosphorylation on serine residues 32 and 36 of the inhibitor, IkappaBalpha, followed by ubiquitination and degradation of the inhibitor by the 26S proteasome, or by a proteasome-independent mechanism involving tyrosine phosphorylation, but not degradation.",
      "citation": {
        "db": "PubMed",
        "db_id": "16271147"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 145,
      "target": 144,
      "key": "35d80c6608517198448dc7184bb41292"
    },
    {
      "line": 7,
      "relation": "directlyIncreases",
      "evidence": "Upon phosphorylation by IKKs, I{kappa}B proteins are recognized and ubiquitinated by members of the Skp1-Culin-Roc1/Rbx1/Hrt-1-F-box (SCF or SCRF) family of ubiquitin ligases (for review, see Ben-Neriah 2002Go) and subsequently degraded (Modified from full text).",
      "citation": {
        "db": "PubMed",
        "db_id": "15371334"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 145,
      "target": 144,
      "key": "8afd53e7fb43740fd126845962615d3d"
    },
    {
      "line": 7,
      "relation": "directlyIncreases",
      "evidence": "Figure 1. Pathways to MUC5AC expression in COPD",
      "citation": {
        "db": "PubMed",
        "db_id": "17615396"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 145,
      "target": 144,
      "key": "ee2696e33170192df8f510b04a30f305"
    },
    {
      "line": 264,
      "relation": "directlyIncreases",
      "evidence": "Since activation of NF-B in A549 cells is dependent on IKK2, which phosphorylates serines 32 and 36 of IB as a prelude to IB degradation and activation of NF-B (Catley et al., 2005",
      "citation": {
        "db": "PubMed",
        "db_id": "17322026"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 146,
      "target": 144,
      "key": "75ade5588a1c06284cd0b3bbff0d2329"
    },
    {
      "line": 264,
      "relation": "directlyIncreases",
      "evidence": "Upon phosphorylation by IKKs, I{kappa}B proteins are recognized and ubiquitinated by members of the Skp1-Culin-Roc1/Rbx1/Hrt-1-F-box (SCF or SCRF) family of ubiquitin ligases (for review, see Ben-Neriah 2002Go) and subsequently degraded (Modified from full text).",
      "citation": {
        "db": "PubMed",
        "db_id": "15371334"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 146,
      "target": 144,
      "key": "0ed06f0216caa8cb697431c3981d8def"
    },
    {
      "line": 264,
      "relation": "directlyIncreases",
      "evidence": "Figure 1. Pathways to MUC5AC expression in COPD",
      "citation": {
        "db": "PubMed",
        "db_id": "17615396"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 146,
      "target": 144,
      "key": "56950447ae60a29655d8e45bd9d70ac3"
    },
    {
      "line": 264,
      "relation": "directlyIncreases",
      "evidence": "Phosphorylation of IkappaBalpha at serine 32 (S32) and serine 36 (S36) is necessary for this stimuli-induced degradation. IKKalpha/beta kinases and p90(rsk1)are involved in stimuli-induced targeting of one or both of these IkappaBalpha sites.",
      "citation": {
        "db": "PubMed",
        "db_id": "10398585"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 146,
      "target": 144,
      "key": "07e4f4ed9265b4974da8091e9172d629"
    },
    {
      "line": 264,
      "relation": "directlyIncreases",
      "evidence": "Activation-induced induction of transcription factor NFkappaB in T lymphocytes is regulated by its inhibitor IkappaBalpha. NFkappaB activation has been demonstrated to occur either by phosphorylation on serine residues 32 and 36 of the inhibitor, IkappaBalpha, followed by ubiquitination and degradation of the inhibitor by the 26S proteasome, or by a proteasome-independent mechanism involving tyrosine phosphorylation, but not degradation.",
      "citation": {
        "db": "PubMed",
        "db_id": "16271147"
      },
      "annotations": {},
      "object": {
        "modifier": "Degradation"
      },
      "source": 146,
      "target": 144,
      "key": "8e79514205cb7153c0d9f7119957e2eb"
    },
    {
      "line": 199,
      "relation": "directlyDecreases",
      "evidence": "In most cell types, the NFkB p50-p65 dimer is bound to one of the closely related endogneous  inhibitory proteins, collectively referred to as IkB, and is held inactive in the cyotplasm. A variety of extracellular signaling, including LPS, cytokines, stress factors have been reported to activate NFkb through phosphorylation of IkB at serine-32 and serine-36, dissociation of IkB from the complex, and translocation of the p50-p65 dimer fromt he cytolplasm to the nucleus.",
      "citation": {
        "db": "PubMed",
        "db_id": "12882972"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 147,
      "target": 27,
      "key": "48abf20f574a193f4cc5b49a5b644cf1"
    },
    {
      "line": 17,
      "relation": "increases",
      "evidence": "NOD2 ligation induced the transcription and protein expression of IRGM in human alveolar macrophages",
      "citation": {
        "db": "PubMed",
        "db_id": "22531915"
      },
      "annotations": {},
      "source": 102,
      "target": 86,
      "key": "be24f1db3bcc76fafe66a1175eab8f2b"
    },
    {
      "line": 103,
      "relation": "increases",
      "evidence": "NOD2 ligation induced the transcription and protein expression of the antimicrobial peptide LL37",
      "citation": {
        "db": "PubMed",
        "db_id": "22531915"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "source": 102,
      "target": 61,
      "key": "159bb8ae90aa22b5fb4fc38435c4619c"
    },
    {
      "line": 104,
      "relation": "increases",
      "evidence": "NOD2 was expressed in human alveolar macrophages, and significant amounts of IL-1β, IL-6, and TNF-α were produced upon ligand recognition with muramyldipeptide (MDP).",
      "citation": {
        "db": "PubMed",
        "db_id": "22531915"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "source": 102,
      "target": 114,
      "key": "2aed6db8a6997d50cf3cb70e77df801c"
    },
    {
      "line": 77,
      "relation": "directlyIncreases",
      "evidence": "NO is generated in COPD from the enzyme inducible NO synthase (iNOS), which is expressed in macrophages and lung parenchyma of patients with COPD, particularly in patients with severe disease. (also in PMIDS:10934109 ,12797490)",
      "citation": {
        "db": "PubMed",
        "db_id": "15602009"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 148,
      "target": 8,
      "key": "3b20d9f7e722e96f3f0d17c612ab74ef"
    },
    {
      "line": 78,
      "relation": "positiveCorrelation",
      "evidence": "In COPD patients we also observed a significant increase in iNOS expression in neutrophils and macrophages.",
      "citation": {
        "db": "PubMed",
        "db_id": "10934109"
      },
      "annotations": {},
      "source": 148,
      "target": 166,
      "key": "f71a66706d6736c2ef987d49c862457e"
    },
    {
      "line": 148,
      "relation": "increases",
      "evidence": "Previously, we demonstrated that lipopolysaccharide (LPS, TLR4 ligand)-increased macrophage motility required the participation of Src and FAK, which was inducible nitric oxide synthase (iNOS)-dependent.",
      "citation": {
        "db": "PubMed",
        "db_id": "20849883"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 148,
      "target": 41,
      "key": "387183a980163102241f084a60ffa6b7"
    },
    {
      "line": 59,
      "relation": "increases",
      "evidence": ".....rapid export of caspase-1-processed IL-1 beta from monocytes/macrophages in response to activation of P2X7 receptors (P2X7R) by extracellular ATP.",
      "citation": {
        "db": "PubMed",
        "db_id": "17641058"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 152,
      "target": 63,
      "key": "869b6b98dd9b01dacd3d55d401efe8c4"
    },
    {
      "line": 112,
      "relation": "decreases",
      "evidence": "As a result, the IL-6 produced by RAW264.7 cells is an inducer of TNFalpha expression in 3T3-L1 adipocytes, and the IL-6 secretion is inhibited by the activation of PPARalpha.",
      "citation": {
        "db": "PubMed",
        "db_id": "17320860"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 155,
      "target": 117,
      "key": "55ac3dec73318236be63566b384b622a"
    },
    {
      "line": 234,
      "relation": "decreases",
      "evidence": "PPARdelta overexpression exerted a remarkable inhibitory effect on monocyte-macrophage differentiation induced by VD that was, at least partly, reverted by stimulation with a highly specific PPARdelta ligand.",
      "citation": {
        "db": "PubMed",
        "db_id": "19056929"
      },
      "annotations": {},
      "source": 156,
      "target": 20,
      "key": "bccf794d9d8457dd665d2289a96b4dd9"
    },
    {
      "line": 234,
      "relation": "decreases",
      "evidence": "The peroxisome proliferator activated receptor delta is required for the differentiation of THP-1 monocytic cells by phorbol ester.",
      "citation": {
        "db": "PubMed",
        "db_id": "14670086"
      },
      "annotations": {},
      "source": 156,
      "target": 20,
      "key": "a2eb6291fd029be277e3acc04d57ec7a"
    },
    {
      "line": 90,
      "relation": "increases",
      "evidence": "IGF-I, but not vitamin D3, caused a sevenfold increase in the enzymatic activity of both PI 3-kinase and atypical PKC-zeta. Inhibition of IGF-I-inducible PI 3-kinase with either wortmannin or LY294002 abrogated the IGF-I-induced activation of PKC-zeta and totally blocked the enhancement in macrophage differentiation caused by IGF-I. These data establish that PKC-zeta is a putative downstream target of PI 3-kinase that is activated during IGF-I-promoted macrophage differentiation.",
      "citation": {
        "db": "PubMed",
        "db_id": "9570559"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 158,
      "target": 20,
      "key": "1eafc0a8f80be3775bd054b8600f8d7e"
    },
    {
      "line": 220,
      "relation": "increases",
      "evidence": "Previously, we demonstrated that lipopolysaccharide (LPS, TLR4 ligand)-increased macrophage motility required the participation of Src and FAK, which was inducible nitric oxide synthase (iNOS)-dependent.",
      "citation": {
        "db": "PubMed",
        "db_id": "20849883"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 161,
      "target": 24,
      "key": "85d80aa6dc8430ea2de2a565c506e1d0"
    },
    {
      "line": 22,
      "relation": "increases",
      "evidence": "Furthermore, Iba1 colocalized with a small GTPase Rac in the membrane ruffles and the phagocytic cups.   The Iba1 mutants also suppressed membrane ruffling induced by dominant active Rac1V12",
      "citation": {
        "db": "PubMed",
        "db_id": "10934045"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "source": 162,
      "target": 17,
      "key": "497782c4ff08a14c1479c4f38ce45c40"
    },
    {
      "line": 22,
      "relation": "increases",
      "evidence": "We show that inhibition of Rho GTPases by Clostridium difficile toxin B prevents apoptotic cell phagocytosis and inhibits the accumulation of both F-actin and phosphotyrosine. Importantly, the Rho GTPases Rac1 and Cdc42 are required for apoptotic cell uptake whereas Rho inhibition enhances uptake.",
      "citation": {
        "db": "PubMed",
        "db_id": "11231156"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "source": 162,
      "target": 17,
      "key": "68c6e44d5796da2c87699f2a1c443af7"
    },
    {
      "line": 23,
      "relation": "increases",
      "evidence": "Rho, Rac and Cdc42 regulate actin organization and cell adhesion in\nmacrophages",
      "citation": {
        "db": "PubMed",
        "db_id": "9099945"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "source": 162,
      "target": 18,
      "key": "cccfd47207ce9b362acc65abe8ad3ca7"
    },
    {
      "line": 23,
      "relation": "increases",
      "evidence": "In confluent serum-starved Swiss 3T3 cells, rac1 rapidly stimulated actin filament accumulation at the plasma membrane, forming membrane ruffles",
      "citation": {
        "db": "PubMed",
        "db_id": "1643658"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "source": 162,
      "target": 18,
      "key": "d8584e8f80ebb07bc98324d016421214"
    },
    {
      "relation": "hasComponent",
      "source": 163,
      "target": 27,
      "key": "8d2fff18f4d94f00a5d48e65ade70b73"
    },
    {
      "relation": "hasComponent",
      "source": 165,
      "target": 27,
      "key": "0d8d265fc00c2cbfe3f68cf410a13d45"
    },
    {
      "line": 280,
      "relation": "decreases",
      "evidence": "we found that Rac1 enhanced the engulfment of apoptotic cells, whereas RhoA inhibited the process",
      "citation": {
        "db": "PubMed",
        "db_id": "16439364"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "source": 126,
      "target": 23,
      "key": "e2e33afada4328712ac87d7f8e107336"
    },
    {
      "line": 281,
      "relation": "decreases",
      "evidence": "Transient expression of dominant-negative mutants of RhoA and RhoB induced a significant increased in CD36 promoter activity. Finally, the actin cytoskeleton disrupter cytochalasin D upregulated CD36. These data indicate that Rho proteins are important modulators of CD36 expression, and strongly suggest that statins increased CD36 expression by disrupting cytoskeleton organization by inactivating Rho GTPases.",
      "citation": {
        "db": "PubMed",
        "db_id": "14698043"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "source": 126,
      "target": 67,
      "key": "e696f1dcab076e12cda66e18a1d092f3"
    },
    {
      "line": 282,
      "relation": "increases",
      "evidence": "The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors",
      "citation": {
        "db": "PubMed",
        "db_id": "1643657"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "source": 126,
      "target": 18,
      "key": "a62d15f3637e668306fc4e6bb9ce58c7"
    },
    {
      "line": 282,
      "relation": "increases",
      "evidence": "Rho induces the assembly of contractile actin-based microfilaments such as stress fibres",
      "citation": {
        "db": "PubMed",
        "db_id": "9823474"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "source": 126,
      "target": 18,
      "key": "6280c8bfa85f47b45cacf7c8cd1d0049"
    },
    {
      "line": 283,
      "relation": "increases",
      "evidence": "C3 transferase exoenzyme, an inhibitor of Rho, abolished BK-induced NF-kappaB activation at 10 microg/ml and significantly inhibited BK-stimulated IL-1beta synthesis at 5 microg/ml. A dominant-negative form of RhoA (T19N) inhibited BK-stimulated reporter gene expression in a dose-dependent and kappaB-dependent manner. These results demonstrate that BK stimulates NF-kappaB activation and IL-1beta synthesis in A549 cells, and that RhoA is both necessary and sufficient to mediate this effect.",
      "citation": {
        "db": "PubMed",
        "db_id": "9510209"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 126,
      "target": 27,
      "key": "29dfae86c4238a9a345ec8370fb13fac"
    },
    {
      "line": 283,
      "relation": "increases",
      "evidence": "Similarly, although all three Rho GTPases were able to activate NF-kB transcription activity in the WT- or STAT3-reconstituted KO cells, they were ineffective in inducing a luciferase-based NF-kB transcription reporter construct in the KO (STAT3 -/-) cells (Fig. 7B).",
      "citation": {
        "db": "PubMed",
        "db_id": "15705584"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 126,
      "target": 27,
      "key": "6d151b18d1e36b6f6fe4f6e434fa2efe"
    },
    {
      "line": 283,
      "relation": "increases",
      "evidence": "Thrombin stimulates MAP kinase and NF-kappaB pathways through Rho.",
      "citation": {
        "db": "PubMed",
        "db_id": "18474218"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 126,
      "target": 27,
      "key": "8d79f21187f01899627276bc9f0be405"
    },
    {
      "line": 283,
      "relation": "increases",
      "evidence": "Expression of constitutively active form of RhoA (RhoACAT) was capable of inducing NF-kB activity in the absence of thrombin challenge, and depletion of cofilin-1 inhibited this response (Fig. 6).",
      "citation": {
        "db": "PubMed",
        "db_id": "19483084"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 126,
      "target": 27,
      "key": "89f32ef8527d91dd4bc762cb77813cfb"
    },
    {
      "line": 283,
      "relation": "increases",
      "evidence": "(Jubilant) Pretreatment with C3 transferase exoenzyme, an inhibitor of Rho small GTP binding proteins (Rho A, B and C) inhibited the bradykinin induced NFkB activity. Treatment with calpain I or PDTC completely inhibited the DNA binding activity of NFkB. Transfection of cell with dominant negative RhoA-T19N inhibited the bradykinin induced NFkB activity. A dominant-negative form of RhoA (T19N) inhibited BK-stimulated reporter gene expression in a dose-dependent and kappaB-dependent manner.",
      "citation": {
        "db": "PubMed",
        "db_id": "9510209"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 126,
      "target": 27,
      "key": "075f8f927d80b03ea149412afdf7f41d"
    },
    {
      "line": 283,
      "relation": "increases",
      "evidence": "We show here the transient activation of the small GTPase Rac, followed by a rise in reactive oxygen species (ROS), as necessary early steps in a signal transduction cascade that lead to NFkappaB activation and collagenase-1 (CL-1)/matrix metalloproteinase-1 production after integrin-mediated cell shape changes.",
      "citation": {
        "db": "PubMed",
        "db_id": "12119354"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 126,
      "target": 27,
      "key": "7d59758fdbb2667af5d71cccce0cd59f"
    },
    {
      "line": 283,
      "relation": "increases",
      "evidence": "In this study, we report that stimulation of TLR2 in human epithelial and monocytic cells leads to rapid and transient activation of RhoA. RhoA cooperated with the canonical I-kappaB kinase-mediated pathway that induces the release of NF-kappaB, in regulating the trans activation of the NF-kappaB subunit p65/RelA by affecting Ser(311) phosphorylation, and subsequent cytokine production.",
      "citation": {
        "db": "PubMed",
        "db_id": "15210811"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 126,
      "target": 27,
      "key": "7770ab728e4a1f7d40f82cfd837800dc"
    },
    {
      "line": 283,
      "relation": "increases",
      "evidence": "Overexpression of the dominant negative mutants of RhoA, Rac1, and Cdc42 significantly inhibited NT-induced NF-kappaB-dependent reporter gene expression and NF-kappaB DNA binding activity.",
      "citation": {
        "db": "PubMed",
        "db_id": "12584113"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "GTP binding",
          "identifier": "0005525"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 126,
      "target": 27,
      "key": "b9fb5ef659c604dfda0c6ce31f4bff41"
    },
    {
      "line": 249,
      "relation": "increases",
      "evidence": "SP-A Increased IL-1β from Macrophages Stimulated\nwith Flagellin",
      "citation": {
        "db": "PubMed",
        "db_id": "24312669"
      },
      "annotations": {},
      "source": 37,
      "target": 114,
      "key": "fd7d7c1e3396a5a317eee73a09ad2330"
    },
    {
      "line": 250,
      "relation": "increases",
      "evidence": "\"Using qRT-PCR, we found that IRAK-M [IRAK3] mRNA expression is significantly increased when macrophages are treated with SP-A [SFTPA1] or Surventa, especially at 6 and 12 h.  In accordance with the mRNA studies, IRAK-M protein levels were increased by SP-A or Surventa.\" (p. L610)",
      "citation": {
        "db": "PubMed",
        "db_id": "22886503"
      },
      "annotations": {},
      "source": 37,
      "target": 70,
      "key": "5ff295b5f16efe2cc74730b817f1138c"
    },
    {
      "line": 73,
      "relation": "directlyDecreases",
      "evidence": "Only SIRT6 and SIRT1 significantly repressed NF-kB reporter gene activity, whereas catalytically inactive SIRT6 and SIRT1 mutant proteins did not (Figure 3A).",
      "citation": {
        "db": "PubMed",
        "db_id": "19135889"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 62,
      "target": 27,
      "key": "cc2bc8a28001f01fa99aee5ee55d6839"
    },
    {
      "line": 74,
      "relation": "decreases",
      "evidence": "A sirtuin inhibitor, splitomycin, and SIRT1 knockdown by RNA interference led an increase in MMP9 expression in human monocytic U937 cells and in primary sputum macrophages, which was detected by RT-PCR, Western blot, activity assay, and zymography.",
      "citation": {
        "db": "PubMed",
        "db_id": "19376817"
      },
      "annotations": {
        "cl": {
          "0000235": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 62,
      "target": 136,
      "key": "07ebdb73ac1fed8b55ba88ca683801ae"
    },
    {
      "line": 161,
      "relation": "directlyIncreases",
      "evidence": "we provide evidence that Ski-mediated repression of PU.1 is due to Ski's ability to recruit histone deacetylase 3 to PU.1 bound to DNA.",
      "citation": {
        "db": "PubMed",
        "db_id": "17621263"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 38,
      "target": 99,
      "key": "e6dc0407c7e79fc4a48fd4fa4435f365"
    },
    {
      "line": 233,
      "relation": "decreases",
      "evidence": "Here we show that overexpression of suppressors of cytokine signaling (SOCS)-1 and SOCS-3 in liver causes insulin resistance and an increase in the key regulator of fatty acid synthesis in liver, sterol regulatory element-binding protein (SREBP)-1c.",
      "citation": {
        "db": "PubMed",
        "db_id": "15240880"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 76,
      "target": 44,
      "key": "4ef3ec35429bcacaa85b5ae83269037b"
    },
    {
      "line": 233,
      "relation": "decreases",
      "evidence": "We demonstrated that SOCS3 deletion in the liver resulted in hyperactivation of STAT3 and promoted ConA- and chemical-induced liver fibrosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "16474852"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 76,
      "target": 44,
      "key": "72460dc88a8b9222880b55b1111c88bb"
    },
    {
      "line": 233,
      "relation": "decreases",
      "evidence": "We further show that activation of STAT3 was inhibited by SOCS3 overexpression as well as by anti-IL-6 treatment during IgG IC-induced lung injury, as determined by EMSA.",
      "citation": {
        "db": "PubMed",
        "db_id": "16785559"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 76,
      "target": 44,
      "key": "ce50e0b661c2b1429209b2892eba174f"
    },
    {
      "line": 233,
      "relation": "decreases",
      "evidence": "By contrast, Socs3 was found to be a major regulator of IL-23-mediated Stat3 phosphorylation and Th17 generation, and Stat3 directly binds to the IL-17A and IL-17F promoters. We conclude that Socs3 is an essential negative regulator of IL-23 signaling, inhibition of which constrains the generation of Th17 differentiation.",
      "citation": {
        "db": "PubMed",
        "db_id": "16698929"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 76,
      "target": 44,
      "key": "75caacd976cd005bab08a869a1e637d7"
    },
    {
      "line": 233,
      "relation": "decreases",
      "evidence": "(from text) Here we show that phosphorylation of STAT3 is prolonged in mouse Socs3-deficient macrophages  after stimulation with interleukin-6 (IL-6) but not IL-10, indicating that SOCS3 specifically affects signaling mediated by IL-6 and gp130.",
      "citation": {
        "db": "PubMed",
        "db_id": "12754506"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 76,
      "target": 44,
      "key": "044bbbe09606c26620df7776e513bd75"
    },
    {
      "line": 233,
      "relation": "decreases",
      "evidence": "Restoration of SOCS-3 in lung cancer cells where SOCS-3 was methylation-silenced resulted in the down-regulation of active STAT3, induction of apoptosis, and growth suppression.",
      "citation": {
        "db": "PubMed",
        "db_id": "14617776"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 76,
      "target": 44,
      "key": "4bf4978ccdf7c997c08575f4823a61cc"
    },
    {
      "line": 107,
      "relation": "increases",
      "evidence": "These results show that GM-CSF, via PU.1, enables AM responses to P. aeruginosa LPS by regulating expression of a specific subset of components of the TLR-4 signaling pathway.",
      "citation": {
        "db": "PubMed",
        "db_id": "16917076"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 39,
      "target": 22,
      "key": "2ffb8651dfa5d18453054b12aafc373c"
    },
    {
      "line": 107,
      "relation": "increases",
      "evidence": "ethanol ingestion decreased cellular expression and nuclear binding of PU.1, the master transcription factor that activates GM-CSF-dependent macrophage functions",
      "citation": {
        "db": "PubMed",
        "db_id": "16272341"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 39,
      "target": 22,
      "key": "ef14d48214fd016bf67cdf5d44a1bc50"
    },
    {
      "line": 108,
      "relation": "increases",
      "evidence": "PU.1 appears to be essential for specification of monocytic precursors. Importantly, retroviral transduction of PU.1 into PU.1 -/- progenitors restores responsiveness to myeloid-specific cytokines and development of mature granulocytes and macrophages. Thus PU.1 controls myelopoiesis by regulating both proliferation and differentiation pathways.",
      "citation": {
        "db": "PubMed",
        "db_id": "9687512"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 39,
      "target": 20,
      "key": "7c079796b4ffafc0564075c7cb2d9f4e"
    },
    {
      "line": 108,
      "relation": "increases",
      "evidence": "Rb promotes differentiation of macrophages by opposing the inhibitory functions of Id2 on the transcription factor PU.1, a master regulator of macrophage differentiation.",
      "citation": {
        "db": "PubMed",
        "db_id": "15616565"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 39,
      "target": 20,
      "key": "a2b589af61d4a842c701a4bd174af263"
    },
    {
      "line": 108,
      "relation": "increases",
      "evidence": "PU.1 activates the transcription\nof miR-424, and this up-regulation is involved in stimulating\nmonocyte differentiation through miR-424-dependent\ntranslational repression of NFI-A.",
      "citation": {
        "db": "PubMed",
        "db_id": "18056638"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 39,
      "target": 20,
      "key": "f1c01f624078b01e3a7240232d9ea2bf"
    },
    {
      "line": 65,
      "relation": "directlyIncreases",
      "evidence": "In the first case, recruited FAK autophosphorylates at 397Y and associates with c-Src or Fyn, which further phosphorylates it at 925Y. Phosphorylated FAK binds to the Grb2-Sos complex and activates the Ras-ERK cascade [60,61].",
      "citation": {
        "db": "PubMed",
        "db_id": "14984767"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 41,
      "target": 161,
      "key": "f9b380b9b4508a8a6203bd08d6dc3474"
    },
    {
      "line": 66,
      "relation": "increases",
      "evidence": "inhibiting Src deterred the cigarette smoke-mediated induction of matrix metalloproteinase-9 and -12 in alveolar macrophages",
      "citation": {
        "db": "PubMed",
        "db_id": "24111605"
      },
      "annotations": {
        "cl": {
          "0000235": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 41,
      "target": 136,
      "key": "7af1e1364daf2e66c55c82592001f5ca"
    },
    {
      "line": 67,
      "relation": "increases",
      "evidence": "inhibiting Src deterred the cigarette smoke-mediated induction of matrix metalloproteinase-9 and -12 in alveolar macrophages",
      "citation": {
        "db": "PubMed",
        "db_id": "24111605"
      },
      "annotations": {
        "cl": {
          "0000235": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 41,
      "target": 135,
      "key": "76333f0873c6c264207a1d829eac1bcd"
    },
    {
      "line": 251,
      "relation": "increases",
      "evidence": "Despite the presence of IL-1beta mRNA, IL-1beta protein was markedly reduced in the absence of Stat1 activation in macrophages derived from IFN-beta (/) and Stat1(/) mice or in the absence of caspase-1 activity, which itself was dependent on Stat1 activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "17032168"
      },
      "annotations": {},
      "source": 42,
      "target": 114,
      "key": "5521671897cb312a3f2fa8f01adc6196"
    },
    {
      "line": 183,
      "relation": "decreases",
      "evidence": "Upon LPS stimulation of STAT3-null macrophages, TNF-\nproduction was up to 3-fold higher than in wild-type macrophages. Alternatively, STAT3 binding sites exist within\nthe TNF promoter, and STAT3 may play a suppressive role that is\nalleviated by expression of the DN STAT3",
      "citation": {
        "db": "PubMed",
        "db_id": "14688368"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 44,
      "target": 50,
      "key": "145a960ad5e79a8977e0f514f36fd9dc"
    },
    {
      "line": 214,
      "relation": "decreases",
      "evidence": "baseline TNF-α levels were significantly increased in the STAT3−/− mice. TNF-α, which is expressed by macrophages and other resident lung cells, induces intracellular signaling events that promote the development of emphysema (Riches et al., 1996; Churg et al., 2004). Thus, our findings indicate that STAT3 expression can impact on the disease by countering TNF-α expression in the lung.",
      "citation": {
        "db": "PubMed",
        "db_id": "24101903"
      },
      "annotations": {},
      "source": 44,
      "target": 50,
      "key": "890ab20c0090d583fe7682e9490e8c56"
    },
    {
      "line": 184,
      "relation": "increases",
      "evidence": "Although STAT3 is essential for IL-6-induced macrophage differentiation of M1 cells, GATA-1 had little or no effect on tyrosine phosphorylation, DNA binding, and transcriptional activities of STAT3 in Western blot analysis, electropholic mobility shift assay (EMSA), and luciferase assays.",
      "citation": {
        "db": "PubMed",
        "db_id": "10666199"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 44,
      "target": 20,
      "key": "355f077889160c06f6bf56d8ecec1b83"
    },
    {
      "line": 197,
      "relation": "increases",
      "evidence": "These observations suggested that the inverse gene expression of PGIS and TXS in macrophages contributes to immune responses by modulating the relative levels of prostacyclin and thromboxane A2.",
      "citation": {
        "db": "PubMed",
        "db_id": "9202154"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 45,
      "target": 4,
      "key": "b5d0435098b80a72ac84be08c1349c60"
    },
    {
      "line": 200,
      "relation": "increases",
      "evidence": "Preincubation of monocytes or macrophages with LXR agonists before RARα agonist treatment enhances synergistically the expression of several RARα target genes. One of these genes encodes transglutaminase (TGM)2, a key factor required for macrophage phagocytosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "19628791"
      },
      "annotations": {},
      "source": 46,
      "target": 17,
      "key": "9570a4f7fa7c0fb5ca079758d2ff3723"
    },
    {
      "line": 200,
      "relation": "increases",
      "evidence": "Cultured TG2-/- macrophages demonstrated diminished phagocytosis",
      "citation": {
        "db": "PubMed",
        "db_id": "16410462"
      },
      "annotations": {},
      "source": 46,
      "target": 17,
      "key": "221d70823809ec15b6d5ab6178601fc1"
    },
    {
      "line": 201,
      "relation": "increases",
      "evidence": "we examined ABCA1 induction in GM-CSF?treated bone marrow?derived macrophages observed to have low basal ABCA1 expression. RA robustly induced ABCA1 protein and mRNA expression in TG2+/+ but not TG2-/- bone marrow macrophages",
      "citation": {
        "db": "PubMed",
        "db_id": "16410462"
      },
      "annotations": {},
      "source": 46,
      "target": 85,
      "key": "f16d733bab9c20912f294ae01a7165d4"
    },
    {
      "line": 162,
      "relation": "increases",
      "evidence": "MyD88 was vital for all TLR2 and TLR4 responses. MyD88 interacted with the Toll/IL-1R domains of TLR1, TLR2, TLR4, and TLR6.",
      "citation": {
        "db": "PubMed",
        "db_id": "19717524"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 47,
      "target": 141,
      "key": "618004f64be72eda6e6f214612a8d9ac"
    },
    {
      "line": 163,
      "relation": "increases",
      "evidence": "Figure 4. IFN-g suppresses TLR2-induced feedback inhibition by decreasing IL-10 production and downstream Stat3 activation, thereby interrupting a TLR2-induced feedback-inhibition loop. Suppression of IL-10 expression results in increased production of the inflammatory cytokines such as TNF (curated directly from figure image) - bw",
      "citation": {
        "db": "PubMed",
        "db_id": "17502339"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 47,
      "target": 26,
      "key": "e99abe6e04f657afd27dcdcc52d6bd42"
    },
    {
      "line": 13,
      "relation": "increases",
      "evidence": "The downstream signaling pathway from TLR3 leads to activation of IFN regulatory factor (IRF)-3 and/or NF-kappaB and subsequent expression of numerous proinflammatory factors.....We report that RSV infection of RAW264.7 macrophages time-dependently stimulate the rapid activation of TLR3 and NF-kappaB, as well as subsequent NF-kappaB-dependent gene expression such as those encoding TNF-alpha and inducible nitric oxide synthase",
      "citation": {
        "db": "PubMed",
        "db_id": "18312297"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 48,
      "target": 27,
      "key": "b98e259a3468a01fb474f8559718c976"
    },
    {
      "line": 13,
      "relation": "increases",
      "evidence": "Poly-IC treatment clearly induced NF-kB activation (Fig. 5A).",
      "citation": {
        "db": "PubMed",
        "db_id": "21646299"
      },
      "annotations": {
        "cl": {
          "0002328": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 48,
      "target": 27,
      "key": "d3db8b41d26900451d753d9e90dd4380"
    },
    {
      "line": 13,
      "relation": "increases",
      "evidence": "Modified assertion",
      "citation": {
        "db": "PubMed",
        "db_id": "12539043"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 48,
      "target": 27,
      "key": "fcfa20fd6f1dcf3d8c1dcfae220927b7"
    },
    {
      "line": 13,
      "relation": "increases",
      "evidence": "Double-stranded RNA is a marker for viral infection that is recognized by TLR3. TLR3 triggering activates specific signaling pathways that culminate in the activation of NF-kappaB and IRF3 transcription factors, as well as apoptosis",
      "citation": {
        "db": "PubMed",
        "db_id": "18202435"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 48,
      "target": 27,
      "key": "9e6b265ef6c4890d5c80b5fedbfe52da"
    },
    {
      "line": 13,
      "relation": "increases",
      "evidence": "Viral infection or TLR3 engagement causes activation of the transcription factors IRF-3 and NF-kappaB",
      "citation": {
        "db": "PubMed",
        "db_id": "16281057"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 48,
      "target": 27,
      "key": "6bf4013d5c3de7b37d3d38e2195e39fa"
    },
    {
      "line": 13,
      "relation": "increases",
      "evidence": "Viral infection, or the binding of double-stranded RNA to Toll-like receptor 3, results in the coordinate activation of IRF3 and NF-kappaB.",
      "citation": {
        "db": "PubMed",
        "db_id": "12692549"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 48,
      "target": 27,
      "key": "19977a285db5f33c49ba58b9af3a775d"
    },
    {
      "line": 13,
      "relation": "increases",
      "evidence": "TLR3 and TLR4 activate IRF3 and NF-kappaB through the TRIF-dependent pathway",
      "citation": {
        "db": "PubMed",
        "db_id": "16143103"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 48,
      "target": 27,
      "key": "10594a3386a4fdd2b32a906f1fd420b1"
    },
    {
      "line": 14,
      "relation": "increases",
      "evidence": "In addition to activating NF-kappaB, TLR3/4 pathways also stimulate interferon regulatory factor 3 activation.",
      "citation": {
        "db": "PubMed",
        "db_id": "16115877"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 48,
      "target": 122,
      "key": "7c54e885ecdaedc1e8eea344083c4b97"
    },
    {
      "line": 14,
      "relation": "increases",
      "evidence": "F ig. 2. Effect of Toll-like receptor signalling on macrophage cholesterol metabolism. Stimulation of TLR3 or TLR4 leads to TRIFdependent activation of IRF3, which inhibits transcription of liver X receptor-dependent genes, many of which (e.g. ATP-binding cassette transporter A1, PLTP, apoE and ABCG-1) are critically involved in the efflux of cholesterol from macrophages.",
      "citation": {
        "db": "PubMed",
        "db_id": "20375591"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 48,
      "target": 122,
      "key": "a2f57021f281b1567b901b2e8b81c7ce"
    },
    {
      "line": 14,
      "relation": "increases",
      "evidence": "Double-stranded RNA is a marker for viral infection that is recognized by TLR3. TLR3 triggering activates specific signaling pathways that culminate in the activation of NF-kappaB and IRF3 transcription factors, as well as apoptosis",
      "citation": {
        "db": "PubMed",
        "db_id": "18202435"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 48,
      "target": 122,
      "key": "49bf4af2ab60735390caf7892d3b6450"
    },
    {
      "line": 14,
      "relation": "increases",
      "evidence": "TLR3 and TLR4 activate IRF3 and NF-kappaB through the TRIF-dependent pathway",
      "citation": {
        "db": "PubMed",
        "db_id": "16143103"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 48,
      "target": 122,
      "key": "291668bc53c0dd244fe2f2874b8ff9b8"
    },
    {
      "line": 14,
      "relation": "increases",
      "evidence": "Viral infection, or the binding of double-stranded RNA to Toll-like receptor 3, results in the coordinate activation of IRF3 and NF-kappaB.",
      "citation": {
        "db": "PubMed",
        "db_id": "12692549"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 48,
      "target": 122,
      "key": "1816b1ae1e58964a2f92ca8c20f6750f"
    },
    {
      "line": 14,
      "relation": "increases",
      "evidence": "Viral infection or TLR3 engagement causes activation of the transcription factors IRF-3 and NF-kappaB",
      "citation": {
        "db": "PubMed",
        "db_id": "16281057"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 48,
      "target": 122,
      "key": "28005ea72d8427edd91408c2c6d61005"
    },
    {
      "line": 80,
      "relation": "directlyIncreases",
      "evidence": "he binding of TNF to the cell surface receptor TNF-R1 causes the recruitment of the adapter protein TRADD to the cytoplasmic domain of the receptor. TRADD then serves to recruit additional signaling molecules, including FADD, TRAF2, and RIP1 (Chen and Goeddel 2002).",
      "citation": {
        "db": "PubMed",
        "db_id": "15545623"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 50,
      "target": 51,
      "key": "bda72f45135df64362437d1a066695eb"
    },
    {
      "line": 80,
      "relation": "directlyIncreases",
      "evidence": "The results support the following pathway, whereby TNF-alpha enhances expression of ICAM-1 in NHBE cells: TNF-alpha --> TNF-RI --> PC-PLC --> DAG --> PKC --> (NF-kappaB?) --> ICAM-1 mRNA --> ICAM-1 surface expression.",
      "citation": {
        "db": "PubMed",
        "db_id": "10837365"
      },
      "annotations": {
        "cl": {
          "0002328": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 50,
      "target": 51,
      "key": "f8cd2ceb0508eae706be9612e35574fe"
    },
    {
      "line": 80,
      "relation": "directlyIncreases",
      "evidence": "Consistent with the in vivo findings, p75 blockade resulted in significant reduction of TNF-induced VCAM-1 and E-selectin expression by 28 and 23%, respectively (P < 0.05), but had no significant effect on ICAM-1 (Fig. 4A). On the other hand, as with in vivo experiments, p55 blockade significantly decreased the expression of all adhesion molecules",
      "citation": {
        "db": "PubMed",
        "db_id": "21378027"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 50,
      "target": 51,
      "key": "dcb807780bd989d3ecacaf194e09573b"
    },
    {
      "line": 80,
      "relation": "directlyIncreases",
      "evidence": "To determine the cytotoxic effects and the type of cell death facilitated by TNF in A549 cells, we treated cells with TNF and analyzed cell death based on morphological and biochemical assays. The death rate of A549 cells increased with increasing concentration of TNF (Fig. 1b), and cell death was characterized by cytoplasmic condensation and pyknotic nuclei without apoptotic body formation (Fig. 1c). Dose-dependent release of LDH into the culture medium was also noted (Fig. 1d); this is frequently encountered after necrotic cell death due to rupture of the cell membrane....Thus, TNF triggers necrotic rather than apoptotic cell death in A549 cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "20963496"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 50,
      "target": 51,
      "key": "7e2827273f4b97a5dc6dc2283a5cdbe0"
    },
    {
      "line": 80,
      "relation": "directlyIncreases",
      "evidence": "TABLE 1. Cytokine/chemokines, their receptors, and functions.",
      "citation": {
        "db": "PubMed",
        "db_id": "17615396"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 50,
      "target": 51,
      "key": "50473e97d6828b500a3e3de8f5aa8537"
    },
    {
      "line": 80,
      "relation": "directlyIncreases",
      "evidence": "After being processed by such metalloproteinases as TNF-a-converting enzyme (TACE) between residues alanine76 and valine77, the soluble form of TNF-a of 157 amino acid residues (17 kDa) is released and mediates its biological activities through Type 1 and 2 TNF receptors (TNF-R1 also known as TNFRSF1A, CD120a and TNF-R2 also known as",
      "citation": {
        "db": "PubMed",
        "db_id": "20194223"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 50,
      "target": 51,
      "key": "9b14fad25a91997355b503b1ba2e54d6"
    },
    {
      "line": 80,
      "relation": "directlyIncreases",
      "evidence": "Fig. 4. Both cIAP1 and 2 are recruited to TNF-R1 upon TNFa treatment and are required for Rip1 polyubiquitination.",
      "citation": {
        "db": "PubMed",
        "db_id": "18697935"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 50,
      "target": 51,
      "key": "2f5a31b2412364f643024ee112cfec63"
    },
    {
      "line": 80,
      "relation": "directlyIncreases",
      "evidence": "Because RIP1 and TRAF2 are downstream effectors of the TNF receptor, it is possible that MNNG induces TNF through RIP1 and TRAF2 to trigger cell death. To investigate this possibility, we examined the sensitivity of TNFR1-/- MEF cells to MNNG treatment and found that it is comparable with that of WT MEF cells (Fig. 6c). As expected, TNFR1-/- MEF cells are resistant to TNF-induced cell death (Fig. 6c). These results exclude the possibility that RIP1 and TRAF2 function in the TNF signaling pathway in MNNG-treated cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "16446354"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 50,
      "target": 51,
      "key": "20b0cfd0cd8952d825c368dc72a42bae"
    },
    {
      "line": 80,
      "relation": "directlyIncreases",
      "evidence": "To confirm that TNFalpha protein synthesized in the brain of the transgenic animal is biologically active, we quantified expression of TRADD protein. Homogenates of brain sampled from TNFalpha-Tg and non-Tg rats were incubated with a primary antibody that recognizes rat TRADD only after it has been activated through binding of TNFalpha to p55/TNFR1, thereby implying biological activity of the cytokine. Regional expression of TRADD protein was uniformly higher in TNFalpha-Tg rat brain than in non-Tg controls by statistically significant margins.",
      "citation": {
        "db": "PubMed",
        "db_id": "18947406"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 50,
      "target": 51,
      "key": "90272cfedce314b5021eff8d43998eeb"
    },
    {
      "line": 81,
      "relation": "increases",
      "evidence": "Treatment with TNF caused a rapid and transient increase in JNK activation in wild-type cells that was maximal at 15 min and declined to basal levels within 45 min (data not shown).",
      "citation": {
        "db": "PubMed",
        "db_id": "15545623"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 32,
      "key": "c3ebd2119005e5f9b506241c56b48a94"
    },
    {
      "line": 81,
      "relation": "increases",
      "evidence": "TNF can also activate JNK (Kyriakis et al. 1994; Sluss et al. 1994) by a TRAF2-dependent mechanism (Yeh et al. 1997).",
      "citation": {
        "db": "PubMed",
        "db_id": "15545623"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 32,
      "key": "5e23e155246d0d42b7d3945e41a21796"
    },
    {
      "line": 81,
      "relation": "increases",
      "evidence": "Treatment with TNF induced increased JUN N-terminal kinase activity within 5 min of stimulation.",
      "citation": {
        "db": "PubMed",
        "db_id": "9729047"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 32,
      "key": "e6067fe8fc717a129107b21f00cc9371"
    },
    {
      "line": 81,
      "relation": "increases",
      "evidence": "As shown in Figs. 3A-C, TNF-alpha induced transient phosphorylation of ERK1/2, JNK, and p38 in HUVECs, with the maximal response being seen within 15 min, followed by a decline to the basal level within 60 min. In addition, pretreatment for 1 h with the indicated concentrations of PD98059 (an ERK1/2 inhibitor), SP600125 (a JNK inhibitor), or SB203580 (a p38 inhibitor) inhibited the TNF-alpha-induced VCAM-1 expression seen at 6 h of TNF-alpha treatment (Figs. 3D-F).",
      "citation": {
        "db": "PubMed",
        "db_id": "21767632"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 32,
      "key": "af805bb8bfeafb698d74f1db1d856ee3"
    },
    {
      "line": 81,
      "relation": "increases",
      "evidence": "Indoxyl sulfate treatment enhanced the activation of JNK, p38 MAPK, and NF-kB in TNF-alpha-activated HUVEC. Inhibitors of JNK and NF-kB attenuated indoxyl sulfate-induced E-selectin expression in HUVEC and subsequent THP-1 adhesion.",
      "citation": {
        "db": "PubMed",
        "db_id": "20937831"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 32,
      "key": "2892ecff15757e03f8414bfc40020de4"
    },
    {
      "line": 81,
      "relation": "increases",
      "evidence": "JNK activity after TNF stimulation was determined by an in vitro kinase assay. RALA hepatocytes were infected with the adenoviruses Ad5LacZ as a control, or Ad5IkappaB, which blocks NF-kappaB activation. TNF treatment of RALA hepatocytes infected with Ad5LacZ resulted in JNK activation within 1 hour, which deceased significantly at 2 hours, and ceased within 3 hours (Fig. 1A). In contrast, in Ad5IkappaB-infected cells, JNK activity increased within 1 hour and remained markedly elevated at 2 and 3 hours after TNF treatment.",
      "citation": {
        "db": "PubMed",
        "db_id": "11915022"
      },
      "annotations": {
        "cl": {
          "0000182": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 32,
      "key": "e54a5d1ead0e518dd8584278a0624403"
    },
    {
      "line": 81,
      "relation": "increases",
      "evidence": "In the case of TNF-alpha-treated cells, activation of ERK1/2 was transient, with a maximum at 10-20 min and decreasing to the baseline at 30 min, whereas strong activation of p38 kinase was sustained up to 60 min. Activation of JNK was transient, with maximum levels detected at 10 min.",
      "citation": {
        "db": "PubMed",
        "db_id": "11149911"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 32,
      "key": "a0bda6f1716b935b2a55fa9158756b0a"
    },
    {
      "line": 81,
      "relation": "increases",
      "evidence": "mong the MAPKs, it was interesting that whereas TNF-induced c-Jun N-terminal kinase (JNK) activation was abolished, activation of p44/p42 MAPK and p38 MAPK was potentiated in PKR-deleted cells.",
      "citation": {
        "db": "PubMed",
        "db_id": "16924232"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 32,
      "key": "bd9a6314d63404dd831ca54785d0161e"
    },
    {
      "line": 81,
      "relation": "increases",
      "evidence": "In addition, TNF-a activates the JNK pathway, mediating an increased serine phosphorylation of IRS-1 and reducing insulin- stimulated tyrosine phosphorylation of IRS-1",
      "citation": {
        "db": "PubMed",
        "db_id": "15936183"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 32,
      "key": "54ca233c708bee2456e4e865b8f83ef5"
    },
    {
      "line": 81,
      "relation": "increases",
      "evidence": "We found that the activation of JNK and p38 MAPK by UV, anisomycin and TNF-a was very similar between Perk+/+ and Perk-/- MEFs (Figure 5).",
      "citation": {
        "db": "PubMed",
        "db_id": "16124869"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 32,
      "key": "620bec13aa9e060d59c4b62bb4943132"
    },
    {
      "line": 81,
      "relation": "increases",
      "evidence": "Although TRAF2 is known to be required for TNF-induced JNK and NF-kappaB activation",
      "citation": {
        "db": "PubMed",
        "db_id": "12897154"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 32,
      "key": "10a607363adb3e19e9568938530fd33e"
    },
    {
      "line": 81,
      "relation": "increases",
      "evidence": "TNF facilitates cell death via the activation of downstream molecules including Jun N-terminal kinase (JNK) or ROS [9, 30].",
      "citation": {
        "db": "PubMed",
        "db_id": "20963496"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 32,
      "key": "b2ef77f4159b7d26637c5c32bc67e1c5"
    },
    {
      "line": 81,
      "relation": "increases",
      "evidence": "Fibroblast growth factor (Yoshida et al., 1997), insulin-like growth factor-1 (Rhoads et al., 1997), epidermal growth factor (Heinrich and Kraiem, 1997), endothelin-1 (Salamonsen et al., 1997), oncostatin M (Isozaki et al., 1997), nerve growth factor (Courtney et al., 1997), tumor necrosis factor alpha (Yoshida et al., 1997), and interleukin-1alpha  and beta  (Lu et al., 1997) activate Jun kinase and increase c-jun gene expression.",
      "citation": {
        "db": "PubMed",
        "db_id": "12021409"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 32,
      "key": "c23653cfe89c6dee07203f163e8e6f2b"
    },
    {
      "line": 81,
      "relation": "increases",
      "evidence": "IkBa degradation and JNK phosphorylation were observed in both ATF3+/+ and ATF3-/- MEF cells upon stimulation with TNF-a, but only in ATF3+/+ cells following treatment with Kdo2- Lipid A (Fig. 2A).",
      "citation": {
        "db": "PubMed",
        "db_id": "21152039"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 32,
      "key": "d91b9e889f67ee350ba152abef5fcf92"
    },
    {
      "line": 81,
      "relation": "increases",
      "evidence": "As shown in Fig. 1A, all three types of MAPK were activated by TNF in wild-type fibroblasts. By contrast, in Rip-/- cells, the activation of these three types of MAPK was decreased to ~40% for p38, ~70% for ERK and ~60% for JNK (Fig. 1A). The protein levels of p38, ERK, and JNK in Rip-/- cells were similar to those in wild-type cells (Fig. 1A).",
      "citation": {
        "db": "PubMed",
        "db_id": "12776182"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 32,
      "key": "47122380b69ba63d3e095e9589318e9d"
    },
    {
      "line": 81,
      "relation": "increases",
      "evidence": "JNK is activated by TNF-alpha in cardiomyocytes",
      "citation": {
        "db": "PubMed",
        "db_id": "12409315"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 50,
      "target": 32,
      "key": "557a63f75dc62b6f23a18561d6d9337f"
    },
    {
      "line": 82,
      "relation": "increases",
      "evidence": "IL-1beta-induced MMP-12 activity and gene expression was down-regulated by the corticosteroid dexamethasone but up-regulated by the inflammatory cytokine tumour necrosis factor (TNF)-alpha through enhancing activator protein-1 activation by IL-1beta.",
      "citation": {
        "db": "PubMed",
        "db_id": "16359550"
      },
      "annotations": {},
      "source": 50,
      "target": 135,
      "key": "902c052b800734b8a1e5068533e63212"
    },
    {
      "line": 82,
      "relation": "increases",
      "evidence": "overexpression of TNF produced an increase in neutrophils, parenchymal B cell nodules, MMP-12, cathepsin K, and emphysema in the absence of smoke (176).",
      "citation": {
        "db": "PubMed",
        "db_id": "18223159"
      },
      "annotations": {},
      "source": 50,
      "target": 135,
      "key": "d5ffdbf37dcd3c184c3b7c3351c64df0"
    },
    {
      "line": 82,
      "relation": "increases",
      "evidence": "Tumor necrosis factor-alpha (TNF-alpha) is known to cause an upregulation of MMP-12 via an activation of activator protein-1 (AP-1) in monocytes....  Both MMP-12 mRNA and protein were upregulated by the treatment with TNF-alpha in time- and concentration-dependent manners. Both BMS-345541 and SP600125 inhibited the upregulation of MMP-12 induced by TNF-alpha",
      "citation": {
        "db": "PubMed",
        "db_id": "20051654"
      },
      "annotations": {},
      "source": 50,
      "target": 135,
      "key": "3b800e5cfbde98f2862c96c7d0d74e2b"
    },
    {
      "line": 182,
      "relation": "increases",
      "evidence": "We found that TRADD is required for TNFR1 to induce NF-kappaB activation and caspase-8-dependent apoptosis but is dispensable for TNFR1-initiated, RIP1-dependent necrosis.",
      "citation": {
        "db": "PubMed",
        "db_id": "16611992"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 51,
      "target": 53,
      "key": "39b68a2ee303ae548ea6b5219db3ddb8"
    },
    {
      "line": 182,
      "relation": "increases",
      "evidence": "TRADD was essential for TNFR1 signaling in mouse embryonic fibroblasts (MEFs) but partially dispensable in macrophages; abundant expression of the adaptor RIP in macrophages  may allow some transmission of TNFR1 signals in the absence of TRADD.",
      "citation": {
        "db": "PubMed",
        "db_id": "18641653"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 51,
      "target": 53,
      "key": "418a14e23f518183bc47c20b7fd79725"
    },
    {
      "line": 63,
      "relation": "increases",
      "evidence": "The TNFR1-containing fibroblasts had significantly higher levels of JNK activation than the TNFR2-containing fibroblasts ( Figure 5A), substantiating TRADD as the more effective initiator of TRAF2 signaling.",
      "citation": {
        "db": "PubMed",
        "db_id": "10892748"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 53,
      "target": 54,
      "key": "812d9e7c698f9fa27e44d1cbe7a86a94"
    },
    {
      "line": 63,
      "relation": "increases",
      "evidence": "The N-terminal domain (N-TRADD) promotes the recruitment of TRAF2 to TNFR1 by binding to the C-terminal of TRAF2, leading to the activation of JNK/AP1 and NF-kappa B.",
      "citation": {
        "db": "PubMed",
        "db_id": "10911999"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 53,
      "target": 54,
      "key": "6a036723618960656bf07fd548f22878"
    },
    {
      "line": 8,
      "relation": "directlyIncreases",
      "evidence": "Tumor necrosis factor receptor-associated factors 2 and 6 (TRAF2 and -6) act as the ubiquitin E3 ligases to mediate Lys(63)-linked TAK1 polyubiquitination at the Lys(158) residue in vivo and in vitro. Lys(63)-linked TAK1 polyubiquitination at the Lys(158) residue is required for TAK1-mediated IKK complex recruitment.....Our findings demonstrate that Lys(63)-linked polyubiquitination of TAK1 at Lys(158) is essential for its own kinase activation and its ability to mediate its downstream signal transduction pathways in response to TNFalpha and IL-1beta stimulation.",
      "citation": {
        "db": "PubMed",
        "db_id": "20038579"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 54,
      "target": 129,
      "key": "3fe8c0d75626deb91a23bd985939678c"
    },
    {
      "line": 237,
      "relation": "increases",
      "evidence": "Overexpressed TRAF2 or TRAF6 activate JNK, p38, or IKK in the absence of extracellular stimulation.",
      "citation": {
        "db": "PubMed",
        "db_id": "10346818"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 54,
      "target": 32,
      "key": "4284672bfa33527134f42af5f31c2a4d"
    },
    {
      "line": 237,
      "relation": "increases",
      "evidence": "Although TRAF2 is known to be required for TNF-induced JNK and NF-kappaB activation",
      "citation": {
        "db": "PubMed",
        "db_id": "12897154"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 54,
      "target": 32,
      "key": "cbca03dedef36bc0de0316d6cc8aed9d"
    },
    {
      "line": 275,
      "relation": "directlyIncreases",
      "evidence": "Here we show that the MAPKK kinase TAK1 acts upstream of NIK in the IL-1-activated signalling pathway and that TAK1 associates with TRAF6 during IL-1 signalling.",
      "citation": {
        "db": "PubMed",
        "db_id": "10094049"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 55,
      "target": 129,
      "key": "5525bff7a3664f19f8d64f7a67569f80"
    },
    {
      "line": 275,
      "relation": "directlyIncreases",
      "evidence": "All living organisms are exposed constantly to microorganisms that are present in the environment and need to cope with invasion of these organisms into the body. The vertebrate immune response can be divided into innate and acquired immunity, with innate immunity being the first line of defence against pathogens. By contrast, acquired immune responses are slower processes, which are mediated by T and B cells, both of which express highly diverse antigen receptors that are generated through DNA rearrangement and are thereby able to respond to a wide range of potential antigens. This highly sophisticated system of antigen detection is found only in vertebrates and has been the subject of considerable research. Far less attention has been directed towards innate immunity, as it has been regarded as a relatively nonspecific system, with its main roles being to destroy pathogens and to present antigen to the cells involved in acquired immunity. However, recent studies have shown that the innate immune system has a greater degree of specificity than was previously thought and that it is highly developed in its ability to discriminate between self and foreign pathogens1. This discrimination relies, to a great extent, on a family of evolutionarily conserved receptors, known as the Toll-like receptors (TLRs), which have a crucial role in early host defence against invading pathogens1, 2. Furthermore, accumulating evidence indicates that activation of the innate immune system is a prerequisite for the induction of acquired immunity, particularly for the induction of a T helper 1 (TH1)-cell response3, 4. This marked shift in our thinking has changed our ideas about the pathogenesis and treatment of cancers, and infectious, immune and allergic diseases. In the past few years, our knowledge of TLR signalling and the responses these receptors control has greatly increased. In this review, we discuss the TLRs, focusing on their signalling pathways.  TLR/IL-1R superfamily: structure and function  The discovery of the TLR family began with the identification of Toll, a receptor that is expressed by insects and was found to be essential for establishing dorsoventral polarity during embryogenesis5. Subsequent studies revealed that Toll also has an essential role in the insect innate immune response against fungal infection6. Homologues of Toll were identified through database searches, and so far, 11 members of the TLR family have been identified in mammals. The TLRs are type I integral membrane glycoproteins, and on the basis of considerable homology in the cytoplasmic region, they are members of a larger superfamily that includes the interleukin-1 receptors (IL-1Rs). By contrast, the extracellular region of the TLRs and IL-1Rs differs markedly: the extracellular region of TLRs contains leucine-rich repeat (LRR) motifs, whereas the extracellular region of IL-1Rs contains three immunoglobulin-like domains (Fig. 1a).     Figure 1 |  TLR structure and signalling.  a | Toll-like receptors (TLRs) and interleukin-1 receptors (IL-1Rs) have a conserved cytoplasmic domain, that is known as the Toll/IL-1R (TIR) domain. The TIR domain is characterized by the presence of three highly homologous regions (known as boxes 1, 2 and 3). Despite the similarity of the cytoplasmic domains of these molecules, their extracellular regions differ markedly: TLRs have tandem repeats of leucine-rich regions (known as leucine rich repeats, LRR), whereas IL-1Rs have three immunoglobulin (Ig)-like domains. b | Stimulation of TLRs triggers the association of MyD88 (myeloid differentiation primary-response protein 88), which in turn recruits IRAK4 (IL-1R-associated kinase 4), thereby allowing the association of IRAK1. IRAK4 then induces the phosphorylation of IRAK1. TRAF6 (tumour-necrosis-factor-receptor-associated factor 6) is also recruited to the receptor complex, by associating with phosphorylated IRAK1. Phosphorylated ...",
      "citation": {
        "db": "PubMed",
        "db_id": "15229469"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "source": 55,
      "target": 129,
      "key": "36d1511536279b93e2340ff9971d264b"
    },
    {
      "line": 276,
      "relation": "directlyIncreases",
      "evidence": "The PAC1 receptor is more selective for PACAP while the VPAC1 and VPAC2 receptors can be potently activated by VIP or PACAP .",
      "citation": {
        "db": "PubMed",
        "db_id": "16483357"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 57,
      "target": 58,
      "key": "65b94a05e25c426b62d8ba76ef2fda71"
    },
    {
      "line": 276,
      "relation": "directlyIncreases",
      "evidence": "Their actions have been shown to be mediated by three different receptor subtypes: PAC1-R, which has exclusive affinity for PACAP, and VPAC1-R and VPAC2-R, which have equal affinity for PACAP and VIP.",
      "citation": {
        "db": "PubMed",
        "db_id": "15514088"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 57,
      "target": 58,
      "key": "5b1d6b291b1855316f384155966f7db8"
    },
    {
      "line": 276,
      "relation": "directlyIncreases",
      "evidence": "VIP/VPAC1 interaction is associated with a cAMP increase and activation of a cAMP/p38 MAPK pathway, which regulates MMP-9, CD35, and CD11b exocytosis, and a cAMP/EPAC/PI-3K/ERK pathway",
      "citation": {
        "db": "PubMed",
        "db_id": "18174366"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 57,
      "target": 58,
      "key": "2cb28ce9cc394a059a33b19d9b13a12e"
    },
    {
      "line": 276,
      "relation": "directlyIncreases",
      "evidence": "VIP has been shown to down-regulate interleukin 8 (IL-8) secretion significantly in MDM after LPS stimulation.....The high VPAC1 expression in AM may reflect the chronic pro-inflammatory environment found in the lung of COPD patients.",
      "citation": {
        "db": "PubMed",
        "db_id": "20026142"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "source": 57,
      "target": 58,
      "key": "7fd12b00d4afae22b9d1b7bde0144317"
    },
    {
      "line": 176,
      "relation": "decreases",
      "evidence": "The VPAC1 antagonist, but not PACAP6?38, reversed the inhibitory activity of VIP on NF-?B binding and on the changes in the composition of the Ets-2-binding complexes (Fig.6). This is in accordance with the fact that the VPAC1 agonist showed a similar effect than that of VIP on NF-?B- and Ets-2-binding complexes (Fig. 6).",
      "citation": {
        "db": "PubMed",
        "db_id": "10542221"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "catalytic activity",
          "identifier": "0003824"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 58,
      "target": 27,
      "key": "8d88e56dbd837892ca9bdba868c51f60"
    },
    {
      "line": 286,
      "relation": "decreases",
      "evidence": "In addition, stable, inducible expression of PLZF in U937 cells inhibited the ability of 1,25(OH)(2)D(3) to induce surface expression of the monocytic marker CD14 and morphologic changes associated with differentiation",
      "citation": {
        "db": "PubMed",
        "db_id": "11719366"
      },
      "annotations": {},
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "go",
            "name": "intracellular",
            "identifier": "0005622"
          },
          "toLoc": {
            "namespace": "go",
            "name": "cell surface",
            "identifier": "0009986"
          }
        }
      },
      "source": 59,
      "target": 66,
      "key": "1ecbded5758da8f02790cd791dccbe8a"
    },
    {
      "line": 287,
      "relation": "directlyDecreases",
      "evidence": "It was found that PLZF interacts directly with VDR......Overexpression of PLZF in a monocytic cell line abrogated 1,25(OH)(2)D(3) activation from both a minimal VDR responsive reporter and the promoter of p21(WAF1/CIP1), a target gene of VDR.",
      "citation": {
        "db": "PubMed",
        "db_id": "11719366"
      },
      "annotations": {},
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 59,
      "target": 56,
      "key": "2fd075055b72c31cdc84e125c011c6c9"
    },
    {
      "line": 245,
      "relation": "directlyIncreases",
      "evidence": "the transcriptional activity of the AP1 subunit c-Jun is enhanced through phosphorylation on Ser63/73 by members of the JNK subfamily in response to inflammatory cytokines",
      "citation": {
        "db": "PubMed",
        "db_id": "12682725"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 32,
      "target": 26,
      "key": "346024d079d2138003a753e6a9896dbe"
    },
    {
      "line": 245,
      "relation": "directlyIncreases",
      "evidence": "JunB binds directly to the P1 site and synergizes with c-Maf to activate an IL-4 luciferase reporter gene. JunB-control of IL-4 expression is mediated by the phosphorylation of JunB at Thr102 and -104 by JNK MAP kinase",
      "citation": {
        "db": "PubMed",
        "db_id": "9889198"
      },
      "annotations": {},
      "subject": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "kinase activity",
          "identifier": "0016301"
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "namespace": "go",
          "name": "nucleic acid binding transcription factor activity",
          "identifier": "0001071"
        }
      },
      "source": 32,
      "target": 26,
      "key": "f865694b027a9181eed7bc3e8c05a2ce"
    },
    {
      "line": 78,
      "relation": "positiveCorrelation",
      "evidence": "In COPD patients we also observed a significant increase in iNOS expression in neutrophils and macrophages.",
      "citation": {
        "db": "PubMed",
        "db_id": "10934109"
      },
      "annotations": {},
      "source": 166,
      "target": 148,
      "key": "0630d2efbe52999733e0e89e879b0412"
    },
    {
      "line": 304,
      "relation": "positiveCorrelation",
      "evidence": "The total counts of iNOS-\nexpressing cells assessed by immunoreactivity were almost the same in COPD and asthma patients, indicating that NO hyper production occurs in COPD as well as in asthmatic airways",
      "citation": {
        "db": "PubMed",
        "db_id": "10934109"
      },
      "annotations": {},
      "source": 166,
      "target": 8,
      "key": "14eab2a4823e71fb6dc7c81ff585885b"
    }
  ]
}